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Summary 
 
The aim of this study was biochemical, molecular and genetic characterization of the 
Drosophila gene frühstart. Previous analysis revealed that Frühstart is a mitotic inhibitor that 
specifically counteracts protein phosphatase String and in this way delays mitosis in the ventral 
furrow cells to prevent an interference of mitotic events and morphogenetic movements during 
ventral furrow formation. Subsequent studies demonstrated that frs is also sufficient and 
partially required for pausing the rapid nuclear cycles after the last (13th) cleavage division 
during cellularisation process.  
This study revealed several unknown physiological and biochemical features of Frs. Ectopic 
expression of Frs in later stages of Drosophila embryonic development, revealed that Frs can 
also inhibit normally occurring cell cycle and shortcut G2 with G1 phases by blocking M phase, 
what leads the cell cycle to endoreplication process. The endoreplication phenotype caused by 
Frs over-expression is consistent with the Cdk1 or CycA phenotype, when the physiological 
function of one of them is disrupted. To find a molecular link between mitotic Cdk1 and Frs, a 
set of Frs biochemical interactors was found and the interactions were analysed in a wide range 
of molecular techniques. It was shown that Frs interacts with two different sets of proteins: 
nucleoporins and cyclins. 
Molecular analysis of the amino acid sequence of Frs revealed leucine rich region (putative 
NES) that is required for Frs-Nup50 complex formation, two main phosphorylation sites (T22 
and T48) and a KxL motif that is essential for direct interaction with the hydrophobic patch of 
cyclins. The physiological meaning of these motifs was confirmed by frs ventral furrow rescue 
phenotype assay, which showed that the KxL motif that is required for proper Frs-Cyclins 
complex formation in vitro is also essential for Frs function in the embryo. Moreover, the 
rescue assay revealed that the two main phosphorylation sites of Frs appear to be partially 
required for proper Frs activity whereas the putative NES motif that is required for interaction 
with nucleoporins is not essential for Frs anti-mitotic activity in vivo. 
The surface plasmon resonance data demonstrated a binding preference of Frs for mitotic 
cyclins and showed that Frs has much higher affinity for mitotic CycA compared to G1/S CycE. 
Moreover, no interaction with the Cdk subunit was observed in contrast to the members of two 
already established cyclin dependent kinase inhibitor families INK4 and CIP/KIP. This showed 
that the function of Frs is based on a new mechanism of Cdk inhibition. 
In this work I demonstrated that blocking of the hydrophobic patch by Frs is sufficient to 
inhibit entry into mitosis 14 and that the hydrophobic patch plays an important role in cell cycle 
regulation during Drosophila mid-blastula transition. 
                                                                                                                                                           Zusammenfassung 
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Zusammenfassung 
 
Das Ziel dieser Arbeit war die biochemische, molekulare und genetische Charakterisierung 
des Drosophila Gens frühstart. In früheren Studien konnte bereits gezeigt werden, daß Frs als 
mitotischer Inhibitor wirkt, der spezifisch der Funktion der Protein-Phosphatase String 
entgegenwirkt, dadurch die Mitosen in den Zellen der Ventralfurche verzögert und so diesen 
Zellen erlaubt, die für die Ventralfurchenbildung erforderlichen morphogenetischen Prozesse 
ohne Störungen durch mitotische Zellteilungen zu durchlaufen. Darüber hinaus wurde gezeigt, 
daß frs ausreichend und zum Teil notwendig ist, um die schnellen syncytialen Kernteilungen 
nach der 13. Teilung und während der nachfolgenden Zellularisierung auszusetzen.  
Die vorliegende Arbeit beschreibt verschiedene weitergehende und bisher unbekannte 
physiologische und biochemische Eigenschaften von Frs. So wird gezeigt, daß durch die 
ektopische Expression von Frs in späteren embryonalen Entwicklungsstadien auch der reguläre 
Zellzyklus inhibiert werden kann, diese Inhibition durch Blockierung der M-Phase verursacht 
wird und der damit verbundene direkte Übergang von der G2 zur G1 Phase zu 
Endoreplikationen in den betroffenen Zellen führt. Dieser durch Frs-Überexpression 
verursachte Phänotyp ist konsistent mit den Phänotypen von Cdk1 und CycA Mutanten. Um 
eine molekulare Verbindung zwischen Cdk1 und Frs herstellen zu können, wurde in dieser 
Arbeit nach mit Frs interagierenden Faktoren gesucht, deren Interaktionen mit Hilfe vielfältiger 
biochemischer Methoden analysiert wurden. Frs interagiert hauptsächlich mit zwei 
verschiedenen Arten von Proteinen: Nukleoporinen und Cyclinen. Durch molekulare in vitro 
Analyse konnte gezeigt werden, daß die Aminosäuresequenz von Frs neben einer Leuzin-
reichen Region (putatives NES), die für die Bildung des Frs-Nup50-Komplexes notwendig ist, 
zwei Haupt-Phosphorylierungsstellen (T22 and T48) und ein KxL-Motiv enthält, das essentiell 
für die direkte Interaktion von Frs mit dem hydrophoben Patch von Cyclinen ist. Die 
physiologische Funktion dieser Motive wurde in Rescue-Experimenten überprüft. So konnte 
gezeigt werden, daß das KxL-Motiv essentiell für die Frs-Funktion im Embryo ist. Die beiden 
Phosphorylierungsstellen tragen in vivo teilweise, das putative NES-Motiv hingegen überhaupt 
nicht zur antimitotischen Aktivität von Frs bei. Mit Hilfe von surface-plasmon-resonance-
Analyse wurde zudem gezeigt, daß Frs bevorzugt an mitotische Cycline bindet und eine viel 
höhere Affinität für das mitotische Cyclin A als für das G1/S spezifische Cyclin E aufweist. Mit 
der gleichen Methode konnte keinerlei Interaktion von Frs mit der Cdk-Untereinheit 
nachgewiesen werden. Somit unterscheidet sich das Bindungsverhalten von Frs von dem bereits 
bekannter Mitglieder der Cyklin-abhängigen Kinase-Inhibitor-Familien INK4 und CIP/KIP, 
was darauf schließen läßt, daß die Funktion von Frs auf einem neuen Mechanismus der Cdk-
Inhibierung basiert. Zusammenfassend bleibt festzustellen, daß die Bindung von Frs an den 
hydrophoben Patch ausreichend ist, um den Eintritt in Mitose 14 zu inhibieren und das der 
hydrophobe Patch somit eine wichtige Rolle in der Zellzyklusregulation während des 
Drosophila- Midblastula-Übergangs spielt. 
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Abbreviations 
 
A  adenine (if DNA) or alanine (if protein) 
aa  amino acid(s) 
Ab  antibodies 
Amp  ampicillin 
AmpR  ampicillin resistant 
APS  ammonium peroxodisulphate 
ATP  adenosine triphosphate 
b  bar (Drosophila gene, genetic marker*) 
bp  base pair(s) 
BSA  bovine serum albumin 
C  cytosine 
ca  claret (Drosophila gene, genetic marker*) 
cDNA  complementary DNA 
Ci  Curie 
cn  cinnabar (Drosophila gene, genetic marker*) 
CSM  Complete Supplement Mixture (yeast medium) 
CyO  curly O (Drosophila gene, balancer and genetic marker*) 
DAPI  4',6'-Diamidino-2-phenylindole 
DEPC  diethyl pyrocarbonate 
ddH2O  double distilled (deionized) water 
Df  deficiency 
dH2O  distilled (deionized) water  
DMSO  dimethyl sulfoxide 
DNA  deoxyribonucleic acid 
dNTP’s 2'-deoxynucleotide triphosphahtes 
DTT  1,4-dithiothreitol 
e  ebony (Drosophila gene, genetic marker*) 
E. coli  Escherichia coli 
e.g.  for instance (exempli gratia) 
EDTA  ethylenediaminetetraacetic acid 
EGTA  ethyleneglycol-bis(β-aminoethyl)-N,N,N’,N’-tetraacetic acid 
emb  embargoed (Drosophila homolog of crm1 gene) 
et al.  and others 
FACS  fluorescence-activated cell sorting 
FCS  fetal calf serum 
Frs  Frühstart protein 
frs  frühstart gene 
g  gram 
GFP  green fluorescent protein 
GSH  glutathione 
GST  glutathione-S-transferase 
h  hour(s) 
HEPES N-(2-Hydroxyethyl)piperazine-N'-(2-ethanesulfonic acid) 
His  histidine 
HS-  heat-shock 
Ig  immunoglobulin 
IPTG  isopropyl-ß-D-thiogalactopyranoside 
k  kilo- 
kbp  kilo base pairs 
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kDa  kilo Dalton 
LiAc  lithium acetate 
l  liter(s) 
lacZ  β-Galactosidase 
LB  Luria-Bertani medium 
Leu  leucine 
Ly  lyra (Drosophila gene, genetic marker*) 
m  mili- 
M  mol per liter or mouse (monoclonal antibodies) 
µ  micro- 
µl  micro liter(s) 
MBT  mid-blastula transition 
MCS  multiple cloning site 
min  minute(s) 
ml  milliliter(s) 
MOPS             3-(N-Morpholino)-propanesulfonic acid 
MS  mass spectrometry 
Myc  protein tag 
n  nano- 
nt  nucleotide(s) 
OD  optical density 
ONPG  2-Nitrophenyl-β-galactopyranoside 
ORF  open reading frame 
P  P-element (Drosophila DNA transposable element) 
p  pico- or plasmid if in front of the construct name 
PAA  acrylamide/bisacrylamide (19:1) mix 
PEG  polyethylene glycol 
PBS  phosphate buffered saline 
PBST  phosphate buffered saline + 2% Tween®20 
PCR  Polymerase Chain Reaction 
PMSF  phenylmethylsulphonylfluoride 
R  rabbit (polyclonal antybodies) 
Rb  Retinoblastoma protein 
RNA  ribonucleic acid 
RNase  RNA degrades protein 
Roi  rough eye (Drosophila gene, genetic marker*) 
rpm  revolutions per minute 
RT  room temperature (~20oC) 
ry  rosy (Drosophila gene, genetic marker*) 
SDS  sodiumdodecylsulphate 
SDS-PAGE SDS-polyacrylamide gel electrophoresis 
se  sepia (Drosophila gene, genetic marker*) 
sec  seconds 
Sp  sternopleural (Drosophila gene, genetic marker*)) 
stg  string (Drosophila gene) 
T  thymidine 
TCA  Trichloroacetic acid 
TEMED N,N,N,N -tetramethyl-ethylenediamine 
tev  cleavage site for Tev protease 
TM3  tropomyosin 3 (Drosophila gene, balancer and genetic marker*) 
TRIS  (hydroxymethyl)aminomethane hydrochloride 
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Trp  tryptophan 
UAS  upstream activating sequence 
Ura  uracil 
o/n  overnight (~16 h) 
rpm  revolutions per minute 
U  unit(s) 
UV  ultraviolet light 
V  Volt 
VF  ventral furrow 
vol  volume 
v/v  volume per volume 
w  white (Drosophila gene, genetic marker*) 
w/o  with no 
wt  wild-type 
w/v  weight per volume 
X-Gal  5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside 
YPD  yeast/peptone/dextrose medium 
Y2H  yeast-two-hybrid system 
ZZ  protein tag 
°C  Celsius degree 
 
 
* - All additional information about Drosophila genes used in this work as genetic markers like 
origins, cytological locations, phenotypes and references are precisely described in "The 
Genome of Drosophila melanogaster" Dan L. Lindsey, Georgianna G. Zimm, Academic Press, 
Inc. 1992. 
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Introduction 
1. Drosophila melanogaster as a model organism 
Drosophila melanogaster is one of many animal models widely used in genetic, molecular 
and biochemical studies, however this small fruit fly has contributed more than any other 
organism to understanding how particular genes determine body pattern formation. Already 
hundred years ago the fruit fly was established as an ideal model for genetic studies. The 
advantages of Drosophila as experimental organism are numerous. It is economic, easy to breed 
and rapid in its reproductive cycle. The adult fly has only 4mm size with space requirement of 
1000 individuals per liter, a mature fertile female lays about 50 eggs per 24h and the generation 
time is only 14 days where the embryonic development occurs during first 24h. An additional 
advantage is the fact that flies have only four sequenced chromosomes (three main) that 
undergo recombination only in the female germ cells, are easy to mutagenize and screen for 
mutations. The small number of chromosomes allowed the development of several genetical 
instruments like balancer chromosomes with multiple inversions that prevent naturally 
occurring recombination, visible markers that allow the selection of expected progeny, and 
conditional lethal or sterile mutations making selection systems possible. These instruments 
have been and still are inestimable in the screens and genetic characterizations of the fly genes. 
Up to now about 20 000 Drosophila genes were determined, among which 5 000 were 
classified as essential for viability and less than 1000 as essential for fertility. In contrast to 
higher organisms, most of Drosophila genes code only one homolog of particular gene. In 
mammals as a result of gene duplication during millions of years of evolution the genomes 
contain two, three or even more homolog copies of one gene. Mutation of one gene homolog 
often does not expose its function because other homologues take over the activity. In 
Drosophila this occurrence, so call redundancy, is much less common and usually mutation of a 
gene in a straight line reveals its physiological function. Finally, it was found that nearly all 
Drosophila genes that were shown to be responsible for proper body pattern formation have 
close homologues on the protein and functional level in human and other mammals, for 
example homeoboxes. Due to this phenomenon, it was possible to progress rapidly in the 
vertebrate field by working in parallel with Drosophila and another simple organisms like 
mosquitoes or worms (Lawrence, P. A., 1992; Nüsslein-Volhard, 1995; Alberts et al., 2002). 
 
2. The Drosophila egg as a model system 
The small size of the Drosophila egg (about 0.5mm long and with a diameter of 0.15mm) 
makes it easy to handle in the laboratory. Collection of embryos, DNA transformation, 
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antibodies staining, cross sections and microscopy analysis do not raise any particular 
problems. After fertilization, the nucleus that is localized in the anterior-dorsal part of the 
embryo divides in 7 rapid synchronous rounds without cytokinesis that gives rise to a centrally 
localized syncytium. Subsequently, the majority of the nuclei migrates under the embryonic cell 
membrane forming a monolayer around the embryo and continues proliferation up to the 
moment when the 13th division is completed. These so called cleavage cell cycles give the 
syncytium that contains about 6000 nuclei. During cleavage cell cycles one full cell cycle round 
takes from 9 to 21 minutes and consists only of alternating M and S phases. Up to now, these 
are the fastest cell cycles identified among prokaryotes and eukaryotes. After the last (13th) 
cleavage division the cell cycle enters a pause of about one hour that allows cellularisation to 
take place and to enclose the nuclei in the newly synthesized cell membrane. About 60 minutes 
later, during gastrulation, the cell cycle resumes and morphogenetic movements - for example 
ventral furrow formation - and mitosis proceed in a coordinated way.  Monolayer syncytial 
blastoderm and cellular blastoderm embryos are used as quite simple models for studying 
biological phenomena like morphogen gradients, cell polarity, regulation of signaling during the 
cell cycle, cellularisation, morphogenetic movements and their coordination with most of the 
intracellular processes (Ashburner, M. 1989; Lawrence, P. A., 1992; Foe et al., 1993). 
 
3. Cell cycle and its modifications during Drosophila development 
The eukaryotic cell cycle is a cascade of events that occur between two subsequent cell 
divisions. Therefore, this is the process by which for example a fertilized mononuclear 
Drosophila egg becomes adult fly with blood cells, hairs, wings and complex internal organs. 
Several types of cell cycles exist, and are involved in cell differentiation during embryogenesis 
and morphogenesis as well as in the maintenance of stem cells in the adult fly (Figure 1). 
General cell cycle comprehends two main distinct phases. First, the interphase that is composed 
of G1 (Gap 1) phase, S (DNA synthesis) and G2 (Gap 2) phases, and second, the M phase 
(Mitosis) that consists of two closely tied processes, main mitosis where nuclear genetic 
material is equally distributed among the two daughter cells, and cytokinesis where the 
cytoplasm is dividing. Cells that have reached their final destination place in the tissue can stop 
proliferating and enter the so called GQ (Gap and Quiescence) phase. Cells that reach the state 
of quiescence can stay permanently in this phase or only for a particular period of time if it is 
necessary, and then they can move back to the general cell cycle and start to proliferate again 
(Figure 1d).  
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Figure 1. Different models of the cell cycle that take place during Drosophila development. a) Cell cycle with 
alternating only S and M phases characteristic for the first 13 divisions (cleavage stage) of early embryonic 
development. b) Postblastoderm divisions with M, S and G2 phases that occur in 14-16 divisions. c) Endocycles 
that take place during central midgut and salivary glands development d) General model of eukaryotic cell cycle 
present in later stages of Drosophila development. Where M - is M phase (mitosis), GQ - is GQ phase (Gap and 
Quiescence), G1 - is G1 phase (Gap 1), S - is S phase (DNA synthesis and replication) and G2 - is G2 phase (Gap 2). 
 
In the fertilized Drosophila embryo, the first 13 cell cycles contain only S and M alternating 
phases without cytokinesis determined by maternal components that are independent of zygotic 
transcription (Figure 1a). The interphase progressively extends during cycles 10 to 13 and G2 
phase appears for the first time after S phase of 14th division (Figure1b), what allows the onset 
of zygotic genes expression and coordination of the cell cycle events with morphogenetic 
movements during gastrulation. Throughout postblastoderm cell cycles (divisions 14 to 16), G2 
length is under developmental control, and groups of cells undergo mitosis in domains in 
response to patterning events (Lee and Orr-Weaver 2003). After the 16th mitotic division, 
epidermal cells exit mitosis and enter GQ phase whereas the nervous system cells continue 
proliferation process according to S-G2-M pattern. The cells that during late embryogenesis 
differentiate into larval tissues enter S-G cycles (Figure 1c) that continue during larval stages. 
Groups of cells that proliferate into adult tissues during pupation stage like epithelial cells of 
wing imaginal discs use the classical cell cycle mode G1-S-G2-M (Figure 1d, Lee and Orr-
Weaver 2003). In my project, I was interested in the regulation of cleavage stage cell cycle 
(Figure 1a, cycles from 1 to 13) especially transition from G2 into mitosis 14th where Frs anti-
mitotic activity takes place. 
The entry into mitosis depends on the phosphorylation state of Cdk1 (Cdc2) kinase and on the 
level of mitotic cyclins (Lee and Orr-Weaver 2003). During interphase, Cdk1 is cytoplasmic 
and inactivated through phosphorylation of its Thr14 and Tyr15 residues by Wee1 and Myt1 
kinases. The main trigger into mitosis is protein phosphatase String (Cdc25) that 
dephosphorylates Cdk1 Thr14 and Tyr15 sites, thus resulting in restoration of its kinase 
activity. In the early prophase, activated Cdk1 enters and accumulates in the nucleus as a 
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complex with mitotic cyclins A (required) and B (not required) and pushes the cell cycle into 
mitosis (Lehner and O'Farrell, 1989; Yang et al., 1998; Pavletich et al., 1999).  
Maternally contributed string during cleavage cell cycle is ubiquitously allocated in the 
embryo until the beginning of mitosis 13th when it gets degraded. All the mitoses following 
cellularisation (cycles 14 to 16) are zygotically controlled by transcription of string. The 
expression of string precedes exactly the mitotic pattern by a few minutes (Edgar and O'Farrell., 
1989). string is necessary for mitosis, since string mutants remain in interphase 14 throughout 
embryonic development. Furthermore, string is sufficient, when uniformly over-expressed, to 
force all the cells into mitosis (Edgar and O'Farrell., 1989). There is however an exception to 
this rule - the ventral furrow region. Here, the gap between appearance of string RNA and 
mitosis is at least 20 minutes longer than in the other regions of the embryo, which allows the 
cells to invaginate before they start dividing. This cell type specific mitotic delay is dependent 
on transcription factor snail (the main trigger for mesoderm development and ventral furrow 
formation) and correlates with ventral furrow formation. Thus, its function may be to prevent an 
interference of mitosis and ventral furrow formation. Premature mitosis as induced by uniform 
over-expression of string inhibits morphogenetic movements like the ventral furrow formation. 
Recently, Großhans and Wieshaus, 2000 described two novel mitotic inhibitors, tribbles (trbl) 
and frühstart (frs) that counteract String specifically in the cells involved in ventral furrow 
formation during gastrulation. They proposed that Frs and Trbl form a link between 
morphogenetic movements and mitotic control (Großhans and Wieschaus, 2000; Großhans et 
al., 2003). 
 
4. Synchronization of cell proliferation with morphogenetic movements in early 
Drosophila embryo as an example of switch in developmental programs 
The early development of Drosophila embryo is characterized by alternating stages of cell 
proliferation and morphogenetic movements. Both processes depend on the rearrangement of 
the cytoskeleton. Parallel use of cytoskeleton components may presumably cause interference 
between these two processes especially during Drosophila early embryogenesis when 
development progresses very fast (Foe, 1989; Foe et al., 1993; Großhans and Wieschaus, 2000). 
During the first 2 hours the fertilized egg intensively divides in 13 synchronous rounds without 
cytokinesis and the so called syncytial blastoderm is formed. After the 13th division, the 
embryonic cell cycle enters about one hour pause at G2 of 14th division that allows the 
morphogenetic program to switch on. During this cell cycle pause, cellularisation and 
gastrulation take place. During gastrulation the cells elongate and morphogenetic movements 
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rearrange their position to one another (Leptin 1995; Großhans and Wieshaus 2000). The most 
prominent of these morphogenetic movements is formation of the ventral furrow as a 
consequence of ventral cells invagination and mesoderm anlage formation (Großhans and 
Wieshaus 2000). During gastrulation, the cell cycle starts again and subsequent morphogenetic 
movements take place. After gastrulation, the mitotic program proceeds in an asynchronous 
way separated in about 25 different embryonic domains, thus allowing cell proliferation and 
morphogenetic movements to proceed at the same time in different parts of the embryo 
(Großhans and Wieshaus 2000).  
It is not clear yet how the transition between nuclear divisions and cellularisation is 
determined and the cell cycle is paused after exactly 13 divisions. It has been known since a 
long time, that the nucleocytoplasmic ratio is the initial determinant, since haploid embryos 
perform an extra division before the pause (Foe et al., 1993). An extra cleavage cycle is also 
observed in embryos injected with alpha-amanitin, an inhibitor of RNA polymerase II, which 
suggests that the nucleocytoplasmic ratio acts via zygotic gene or genes. Inhibition of zygotic 
gene expression does not disturb development prior to this point, which shows that the rapid 
nuclear divisions are solely controlled by factors supplied by the mother (Foe et al., 1993). Cell 
cycle progression of last three cleavage divisions (cycles 10-13) is controlled by maternal DNA 
repair checkpoint with protein kinases Grapes and Mei41 (Fogarty et al., 1997; Sibon et al., 
1997, 1999; Yu et al., 2000). The grapes checkpoint delays mitosis during cycles 10-13, what 
allows zygotic expression to start, and is involved in establishing the pause after 13th division 
(Fogarty et al., 1997; Sibon et al., 1997). Großhans et al. 2003 reported frühstart, the only so far 
known zygotic gene that participates in the cleavage cell cycle pause and 
mitotic/morphogenetic switch observed during mid-blastula transition. 
 
5. The role of Drosophila zygotic genes frühstart and tribbles in mid-blastula 
transition 
So far, two genes that are required for the mitotic delay in the ventral furrow region (Figure 2) 
were identified in genetic screens for mutations that disrupt mesoderm invagination during 
gastrulation process - tribbles and frühstart (Müller et al., 1999; Seher and Leptin 2000). 
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Figure 2. Frühstart ventral furrow phenotype. The pictures present wild-type Drosophila melanogaster embryos 
stage 6 (a) and stage 7 (b) and deficient for frs stage 6 (c) with premature mitosis in the ventral region and stage 7 
(d) with open, not properly formed ventral furrow. All embryos were stained with anti-pHistone3 antibody 
(Materials and Methods). 
 
Further analysis revealed that tribbles (trbl) and frühstart (frs) are uniformly expressed 
immediately after the last, 13th mitosis in the cleavage stage and reach a peak in the first half of 
cellularisation. When frs or trbl are expressed prematurely by RNA injection, the cell cycle 
stops already after 12 cycles (Großhans and Wieshaus, 2000; Großhans et al., 2003). 
Trbl protein consists of 488 aa residues and belongs to the Snf1/Nim1/Hsl1 family of 
serine/threonine protein kinases. In yeast, the kinase Nim1 (S. pombe) and Hsl1 (S.cerevisiae) 
are positive regulators for the entry into mitosis. Based on sequence homology, it was found 
that related but uncharacterized proteins also exist in higher vertebrates (Großhans et al., 2000). 
Trbl has probably no kinase activity, because several of the invariant residues in the kinase 
consensus sequence are changed and the subdomains I to V are only weakly conserved. In 
addition, a mutation in the catalytic center does not affect trbl activity. In contrast to 
Nim1/Hsl1, Trbl is a negative regulator of mitosis. A possible model is that trbl behaves like a 
dominant-negative allele of a homologue of Nim1/Hsl1 with kinase activity and competes for 
substrates or effectors (Großhans and Wieschaus, 2000). 
frs has a transcript of about 500 nucleotides and encodes a basic 90aa polypeptide that 
contains 19 basic residues and has an isoelectric point of 10 (Schulz and Miksch 1989).  frs 
mRNA is uniformly expressed at the beginning of cell cycle 14th, reaches the peak during 
cellularisation and persists until the end of gastrulation. Moreover, frs RNA is detectable until 
the germ band extension stage in a group of presumable aminoserosa anlage cells (Großhans et 
al., 2003). In order to investigate the subcellular localization of Frs, specific antibodies were 
                                                                                                                                                                    Introduction 
 20
applied for whole-mount stainings. Frs is uniformly distributed in the cytoplasm (Figure 3), 
despite its molecular weight that is far below the exclusion limit of the nuclear pores and its 
high content of basic amino acid residues (Großhans and Wieschaus, 2000).  
 
 
 
Figure 3. Polyclonal anti-Frs antibody staining of stage 5 (syncytial blastoderm) wild-type OrR embryo. DNA 
staining (white), Polyclonal anti-Frs antibodies (red). The scale bar represents 10µm. 
 
The frs primary structure does not display homology to any of the known proteins or motifs 
and because of that it was very hard to predict a biochemical function of this polypeptide. It was 
already described by Großhans and Wieschaus, 2000 and Großhans et al., 2003 that frs has two 
functions in the early development of the embryo. They found that frs delays mitosis during 
mesoderm invagination and controls the cell cycle pause after exactly the 13th mitosis during 
mid-blastula transition (MBT). The timing of MBT depends on nucleocytoplasmic ratio and is 
shifted in diploid (after 13th division) and haploid (after 14th division) similar to the frs mutant 
embryo where an additional mitosis takes place. These observation together with the fact that 
onset of frs expression is also correlated with N/C ratio (in the haploid embryo frs expression 
peak takes place after the 14th division, not after the 13th like in the diploid) suggest that frs 
gene expression may be involved in linking the N/C with the pause of cleavage cycles 
(Großhans et al., 2003).  
An additional interesting feature of frs gene is the fact that this mitotic inhibitor in contrast to 
other known cell cycle regulatory proteins is not crucial for cell cycle progression. This might 
suggest that frs is a kind of modulator or organizer of two biological processes, the cell cycle 
progression and morphogenetic movements, that take place in parallel during MBT (Großhans 
et al., 2003). In vivo data presented by Großhans et al., 2003 revealed that frs and trbl 
negatively control mitotic function of D-Cdc25 (string and twine) but the molecular explanation 
of this phenomenon still remains unclear. 
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6. Regulation of Drosophila cell cycle 
A group of proteins known as cyclin dependent kinases (Cdks) plays the major role in cell 
cycle control machinery. The kinase activity of Cdks undergoes cyclical changes during the cell 
cycle, what directly leads to increasing and decreasing of the phosphorylation level of 
regulatory proteins that govern most biological processes like cell growth, replication, mitosis 
and cytokinesis (Sherr, 1994; Scherr et al., 1994; Nurse, 1994; King et al., 1994). 
 
Cyclin dependent kinases 
Cdks belong to the Serine/Threonine protein kinase family. In all eukaryotes (except yeasts), 
different Cdks are responsible for controlling the progress through the different phases of the 
cell cycle. When a specific Cdk is activated, the cell cycle enters the stage that is controlled by 
this particular Cdk. If a Cdk is not activated or activated and inhibited, the cell cycle stops 
(Morgan, 1997). The best characterized and described member of the Cdk family is Cdk2. The 
monomeric form of Cdk2 consists of a N-terminal lobe rich in β-sheet, a C-terminal lobe rich in 
α-helix, and a deep cleft at the junction of N lobe and C lobe that forms the catalytic center 
containing the ATP binding site (Pavletich, 1999). It was also found that Cdk2 has two 
fragments among its tertiary structure that do not match to the canonical kinase pattern (De 
Bond et al., 1993). The first one is an α-helix with PSTAIR unique sequence that was found 
only in the Cdks, and the second one a regulatory T-loop with activating phosphorylation site 
(Figure 4, Pavletich, 1999). 
 
 
 
Figure 4. Crystal structure of monomeric, inactive form of Cdk2 protein. N and C lobes are marked in blue. 
PSTAIR helix is marked in red and T-loop in green (Adapted from Pavletich, 1999). 
                                                                                                                                                                    Introduction 
 22
Crystallographic studies revealed, at least to some extent, the molecular mechanisms by which 
cyclin dependent kinases are regulated (Knighton et al., 1991; De Bondt et al., 1993; Brotherton 
et al., 1998; Russo et al., 1998; Pavletich et al., 1999). All Cdk regulatory events, like Cdk 
phosphorylation or binding of Cdk regulator proteins, cause conformational changes in the 
kinase catalytic cleft or in its direct neighborhood. This demonstrates the high internal elasticity 
of the structure of Cdks, which partially explains their aptitude to switching on/off as a reaction 
on multiple regulatory signals (Pavletich et al., 1999). In Drosophila, two Cdks are involved in 
cell cycle regulation, Cdk2 that is responsible for G1/S transition and Cdk1 that is responsible 
for entry into mitosis. 
 
Mechanism of cell cycle activation 
Newly synthesized, monomeric Cdk does not have kinase activity because of its not yet 
properly folded structure. For full kinase activation, several subsequent regulatory processes 
have to take place (Figure 6). A number of different groups of regulatory proteins that control 
the cyclical alterations of Cdks activity, have already been described. Proteins known as 
cyclins, play the most important and primary role in Cdks regulation. In Drosophila 
melanogaster there are six known cyclins that are involved in Cdk control during cell cycle 
progression. Cyclins A, B, B3 and J are involved in G2/M transition and mitosis, while only 
CycA is essential for proper cell proliferation, development and viability of the fly (Lehner and 
o'Farrell, 1989; Jacobs et al., 1998; Kolonin and Finley, 2000). CycE, CycD and CycC are 
involved in the G1/S transition and if mutated, Drosophila viability is not affected (Foe et al., 
1993; Thomas et al., 1997; Edgar and Orr-Weaver, 2001, Emmerich et al., 2004). The structure 
of all cyclins in the main plan is similar. A destruction box sequence responsible for protein 
termination via ubiquitin ligases pathways is located in the N-terminal part of the protein and a 
motif of about 100aa, known as the cyclinbox, is found in the C-terminal part. The cyclinbox is 
required for Cyclin-Cdk complex formation and it contains a so called hydrophobic patch that is 
responsible for binding of the Cdk phosphorylation substrates as well as of some Cdks 
inhibitors (Polyak et al., 1994; Lacy et al., 2004; Loog 2005; Lowe et al., 2002). Cyclin binding 
to the non-activated form of Cdk induces conformational changes. The cyclin translocates Cdk 
PSTAIR helix deeper into the catalytic center and rotates it 90º. In parallel Cyclin-Cdk binding 
changes the position of the T-loop structure what leads to physical uncovering of the catalytic 
cleft and partial activation of the Cdk-Cyclin complex (Compare Figure 4 and figure 5, 
Pavletich, 1999, figure 6a and 6b). 
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Figure 5. Crystal structure of Cdk2-CycA complex. The PSTAIR helix (in red) and T-loop motif (in green) change 
their conformation and partially uncover the catalytic center of Cdk (Adapted from Pavletich, 1999).  
 
Subsequently, for full Cdk activation the T-loop motif has to be phosphorylated by CAK 
(Cyclin Activating Kinase) kinase (Russo et al., 1996; figure 6b and 6c). This phosphorylation 
causes successive conformational changes that complete the reorganization processes that take 
place in and around the Cdk catalytic center and makes Cdk-Cyclin complex fully active 
(Figure 6). 
 
 
Figure 6. Scheme of Cdk activation process. Monomeric form of Cdk is inactive (a). Cyclin binding causes 
conformational changes that partially activate Cdk kinase activity (a and b). Full Cdk activation requires 
phosphorylation of Cdk by CAK kinase (b and c). 
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When a particular event of the cell cycle is coming to be completed, the Cdk that coordinates 
it has to be switched off. The cell inhibits previously activated Cdks, either via Cdk-Cyclin 
complex inhibitory phosphorylation or via protein inhibitors that physically bind to the Cdk-
Cyclin complex and make it inactive. 
 
Inactivation of Cdk-Cyclin complex kinase activity by protein phosphorylation 
In Drosophila, Cdk1-CyclinA complex plays the main role in the entry into mitosis. During 
interphase, this complex is inactivated by phosphorylation of Cdk1 on Threonine 14 and 
Tyrosine 15 by the inhibitory kinases Wee1 and Myt1 (Russel and Nurse, 1987; Stumpff et al., 
2004). Close to the end of G2 phase, protein phosphatase String (Cdc25) dephosphorylates T14 
and Y15 of Cdk1 (Russel and Nurse, 1986; Millar and Russel, 1992) and in this way activates 
the Cdk1-CyclinA complex and pushes the cell cycle into mitosis (Edgar et al., 1994).  
 
 
 
Figure 7. Scheme of Cdk1-CyclinA complex inhibition via Cdk1 phosphorylation by kinases Wee1/Myt1 and 
activation via Cdk1 dephosphorylation by protein phosphatase String.   
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Activated Cdk1-Cyclin complex multi-phosphorylates protein phosphatase String, thus 
enhancing its activity. In parallel, phosphorylation of inhibitory kinase Wee1 by Cdk1-Cyclin 
complex inhibits its kinase activity and makes the positive feedback loop (Figure 7). At the end 
of mitosis this auto-activating process is disrupted by downstream regulation of String and the 
cell cycle goes into G1 phase (Edgar and O'Farrel, 1989; Edgar and O'Farrel, 1990). 
 
Inactivation of Cdk-Cyclin complex kinase activity by protein inhibition 
The second known manner of Cdk-Cyclin complex inactivation is via protein inhibition. The 
Cdk-Cyclin protein inhibitors are classified in two families according to the differences in their 
inhibitory mechanisms - CIP/KIP and INK4. There is also a third group of inhibitors that do not 
belong to any of these families and have not been well characterized yet.  
There are two well characterized G1/S Cdk-cyclin inhibitors that belong to the CIP/KIP 
family - p21 (Harper et al., 1995) and p27 with its Drosophila homolog Dacapo. Transient high 
level expression of Dacapo during the last (16th) zygotic cell division is required for arresting 
the cells in G1 phase of cycle 17 and for general exit from the cell cycle (Toyoshima and 
Hunter, 1994, Lane et al., 1996). CIP/KIP inhibitors block the Cdk-Cyclin kinase activity by 
binding to both complex subunits. The C-terminal end of G1/S inhibitor p27 binds to the 
catalytic cleft of Cdk2, whereas the N-terminus binds to the hydrophobic patch of CyclinE, 
resulting in inactivation of the complex. In addition, association of p27 with the Cdk-cyclin 
complex causes conformational changes of Cdk (Russo et al., 1996; Pavletich, 1999; Brown et 
al., 1999; Lacy et al., 2004). The function of the Cdk2 subunit is to phosphorylate (activate) via 
its catalytic center a set of substrates that are required for the cell cycle S phase. The cyclin 
hydrophobic patch is a docking site for some Cdk2 substrates (e.g. Rb, p53, E2F) that in order 
to be phosphorylated, they first have to bind and be recognized as proper substrates by the 
cyclin subunit (Adams et al., 1996; Adams et al., 1999; Lowe et al., 2002; Loog and Morgan, 
2005). Furthermore, the hydrophobic patch is required for binding of CIP/KIP protein inhibitors 
like p21 and p27 to the Cdk-Cyclin complex (Lowe et al., 2002; Lacy et al., 2004). It was also 
found that CIP/KIP inhibitors are themselves substrates of Cdks. Phosphorylated form of p27 is 
downregulated (ubiquitylated) by SCF ubiquitin ligase. The ubiquitylated form of p27 is 
immediately exported into the cytoplasm and degraded by the proteasome (Alberts et al., 2002; 
Vlach et al., 1997; Müller et al., 2000). 
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Inactivation of Cdk-Cyclin complex kinase activity by INK4 proteins 
The members of INK4 Cdks inhibitor family inactivate Cdk-Cyclin complex via binding to 
the Cdk subunit only. In contrast to CIP/KIP family, INK4 inhibitors like p16 and p19 do not 
bind directly to the catalytic cleft of Cdk but next to it. (Russo et al., 1998; Brotherton et al., 
1998; Pavletich, 1999). Moreover, the INK4 and cyclin binding sites on the Cdk do not overlap 
each other. Binding of the p16 inhibitor causes allosteric changes in the Cdk catalytic cleft and 
its surrounding motifs and by this it prevents Cdk-Cyclin complex formation. p16 is also able to 
bind to the already formed Cdk-Cyclin complex and by this also shut down Cdk kinase activity 
even if this association does not lead to disruption of the Cdk-Cyclin complex (Russo et al., 
1998; Pavletich, 1999). 
 
Uncharacterized cell cycle protein inhibitors 
The wide range of cell cycle studies revealed an additional, informal group of cell cycle 
inhibitors that have not been well characterized yet, at least on the molecular level. Several 
common features of these inhibitors might suggest that they share a common cell cycle 
regulatory mechanism. Members of this group are M/G1-S Sic1 (Saccharomyces cerevisiae), 
M/G1 Rum1 (Shizosaccharomyces pombe), mitotic Rux (Drosophila melanogaster) and also 
G2/M Frs (Drosophila melanogaster). In vivo studies revealed that Sic1, Rum1 and Rux are 
functional homologues and they can functionally replace each other (Sanchez-Diaz et al., 1998; 
Foley and Sprenger, 2001). What is striking is that these proteins almost do not share any 
sequence homology except for the RxL motif commonly used by Cdk substrates and some Cdk 
inhibitors to interact with Cdk-Cyclin complex via hydrophobic patch of the cyclin subunit (see 
above). More detailed molecular analysis revealed that Sic1 and Rux indeed bind directly to 
mitotic cyclins via this motif and specifically inhibit mitotic cyclin-Cdk complexes in vitro 
(Hodge and Mendenhall, 1999; Avedisov et al., 2000; Foley and Sprenger 2000). Negative 
control of mitotic cyclin-Cdk complexes by Sic1 and Rux in vivo, induced endocycles in 
proliferating epithelial cells of Drosophila wing imaginal discs (Foley at al., 1999; Thomas et 
al., 1997; Edgar and Orr-Weaver, 2001; Vidwans et al., 2002) what confirms their anti-mitotic 
specificity. There are additional common features within this group. All of these proteins are 
non-essential, as most likely they cooperate with other cell cycle regulatory mechanisms like 
cyclin proteolysis. Moreover, all of them are phosphorylated and subsequently degraded 
through the ubiquitin-dependent proteolytic pathway (Benito et al., 1997; Verma et al., 1997; 
Foley et al., 1999; Großhans and Wieschaus, 2000; Großhans et al., 2003; in the case of Frs, its 
phosphorylation is described in this work for the first time, while the significance of this 
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phosphorylation still remains not completely resolved). All the similarities described above 
suggest that these proteins might share a common molecular mechanism of inhibition of the cell 
cycle machinery but in order to reach a final conclusion, more detailed molecular analysis is 
required. 
 
Cell cycle regulation via nucleocytoplasmic transport 
The cell cycle progression is also regulated by nucleocytoplasmic trafficking of the proteins 
that are involved in cell cycle events. At the appropriate moment of the cell cycle, some of the 
cell cycle proteins must be imported into the nucleus while some others must be exported. The 
changes in the subcellular localisation of human Cdk1 during the cell cycle constitute a typical 
example. Close to the end of G2 phase, the protein phosphatase String (Cdc25) activates Cdk1-
CyclinB1 complex that is accumulated in the cytoplasm during S and G2 phases. Activated 
Cdk1-CyclinB1 complex is transported into the nucleus during prophase by importin α/β 
heterodimers in NLS-dependent way (Pines and Hunter, 1994; Görlich et al., 1994; Görlich et 
al., 1995; Yang et al., 2006). When mitosis is close to its end Cdk1-CycB1 complex is exported 
back to the cytoplasm via NES-dependent Crm1 pathway (Toyoshima et al., 1998; Yang et al., 
1998). Another example is p27 CIP/CIK inhibitor, which in order to be properly 
downregulated, must first be imported into the nucleus, get phosphorylated by Cdk2-CycE 
complex and be re-exported back to the cytoplasm in a Nup50 nucleoporin interaction 
dependent way where it is degraded in a ubiquitinylation dependent manner at the G1/S 
transition of the cell cycle (Müller et al., 2000). However, the detailed molecular mechanism of 
these processes, especially the initiating and terminating signals are unknown. Nuclear protein 
import requires a nuclear localization sequence (NLS) within the import substrate amino acid 
sequence. Experimental data revealed that NLS-containing substrates bind to importin-α which 
recruit importin-β to form a trimeric transport complex within the cytoplasm (Görlich et al., 
1996; Weis et al., 1996; Fasken et al., 2000). Subsequently, the NLS-importin-α/importin-β 
complex directly binds to nucleoporins that are components of the nucleopore basket. Primarily, 
the import complex-nucleoporins interaction is stabilized by Ran-binding protein 1 
(RanBP1)(Chi et al., 1996) and is likely stimulated by the interaction of Ran-GDP with pore 
components (Fasken et al., 2000). The mechanism that re-localizes the import complex from the 
cytoplasm to the nucleus through the nuclear pore is not completely understood up to now. In 
the nucleus, trimeric transport complex binds RanGTP, which dissociates the complex and 
disassembles the transported substrate (Rexach et al., 1995; Görlich et al., 1996; Fasken et al., 
2000). Importins α and β complex subunits are afterward exported back to the cytoplasm 
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(Kutay, U., 1997). The primary mechanism by which substrates are imported into the nucleus is 
highly conserved, and components required for import have been identified in yeast (Matsusaka 
et al., 1998), plant (Ivasaki et al., 1998), Drosophila (Bhattacharya and Steward, 2002; 
Allemand et al., 2002) and animal cells (Nicolas et al., 1997)(Fasken et al., 2000).  
In Drosophila, the nuclear export mechanism is driven by general export factor embargoed 
that is a functional and sequence homolog of human (71% identity) and yeast (S. pombe 49% 
identity) Crm1 protein (Collier et al., 2000). Embargoed (Emb) export factor requires two other 
proteins for its activity, small GTPase Ran and nuclear pore components (Görlich and Kutay, 
1999) like e.g. Nup50, Nup88, Nup153, Nup214 and Nup358 (Askjaer et al., 1999; Smitherman 
et al., 2000; Guan et al., 2000; Roth et al. 2003; Bernad et al., 2004). Emb binds directly to the 
proteins that contain leucine-rich nuclear export signal (NES). A consensus sequence for 
leucine-rich NES has been defined by detailed functional analysis and amino acid sequence 
comparison of several proteins that contain NES (Bogerd et al., 1996). Nevertheless, this 
consensus does not provide a safe way of predicting Emb substrates from protein sequences 
alone. Not all sequence motifs that look like leucine-rich NES also function as such in their 
original protein context (Görlich and Kutay, 1999). Cargo-NES/Emb/RanGTP nuclear complex 
is exported from the nucleus by Emb-guided interactions with nucleoporins and the nuclear 
pore complex (Adachi and Yanagida, 1989; Stade et al., 1997; Fornerod et al., 1997; Fasken et 
al., 2000).  In the cytoplasm, RanGTP is hydrolysed into RanGDP form what promotes 
dissociation of the export complex and recycling of Emb (Görlich and Kutay, 1999; Collier et 
al., 2000; Fasken et al., 2000). 
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Aim of the studies 
The main goal of this project was to study the molecular mechanisms of regulation of mitosis 
in the context of embryonic development. Specifically, the unknown biochemical function of 
the zygotic gene frühstart (frs), which has been shown to inhibit mitosis and to coordinate cell 
shape changes and cell division in the early Drosophila embryo (Seher and Leptin 2000, 
Großhans and Wieschaus 2000, Großhans et al., 2003), was investigated. 
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Materials 
1. Reagents 
All standard chemicals were purchased from Sigma-Aldrich (Steinheim, Germany), 
AppliChem GmbH (Darmstadt, Germany), Serva (Heidelberg, Germany), Merck (Darmstadt, 
Germany) or Gibco BRL (Eggenstein, Germany) unless otherwise mentioned. 
 
2. Radioactivity 
- Redivue adenosine 5'-[γ-32P] triphosphate, triethylammonium salt (6000Ci/mM, 10mCi/ml), 
Amersham Biosciences. 
- Redivue L-[35S] methionine (in vitro translation grade), (1000Ci/mmol, 15mCi/ml), 
Amersham Biosciences. 
 
3. Antibiotics 
- Ampicillin, stock (1000x): 100mg/ml, final concentration: 50-200µg/ml. 
-Penicillin/Streptomycin solution, stock (100x): final concentration 50U penicillin G and 50µg 
streptomycin sulfate per 1ml of medium (1% of stock). 
 
4. Enzymes 
All enzymes were purchased from Fermentas (Lithuania) and Roche Diagnostics GmbH 
(Penzberg, Germany) and used according to the instructions delivered by the producers unless 
otherwise mentioned.  
 
5. Peptides 
- C16 Frs peptide - contains the last 16 C-terminal amino acids of Frühstart sequence 
(YEADKNFIKARKSLNF). Synthesized by Peptide Specialty Laboratories GmbH, 
Heidelberg. 
- DmCdk1 peptide - contains the last 18 C-terminal amino acids of DmCdk1 sequence 
(CILEHPYFNGFQSGLVRN). Synthesized by SEQLAB Sequence Laboratories Goettingen 
GmbH. 
 
6. Antibodies and immunochemicals 
Primary antibodies 
- R Ab Frs   - J. Großhans (Großhans et al., 2003) 
- R Ab DmNup50  - P. Gawliński (this work). 
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- R Ab DmCdk1 - P. Gawliński (this work, according to Knoblich et al., 1994). 
- M Ab DmCdk1 PSTAIR - mouse IgG1 isotype, Sigma (Yamashita et al., 1991). 
- R Ab DmCycA  - gift from C. Lehner (Lehner et al., 1989).  
- M Ab DmCycA  - Developmental Studies Hybridoma Bank, University of Iowa. 
- M Ab DmCycB - Developmental Studies Hybridoma Bank, University of Iowa. 
- R Ab DmCycE  - gift from C. Lehner (Knoblich et al., 1994). 
- M Ab Anti-c-Myc  - Roche. 
- M Ab g-Tubulin - Sigma. 
- M Ab a-Tubulin - Sigma. 
- R Ab pHistone3  - Upstate. 
- M Ab b-Gal  - Boehringer. 
- M Ab BrdU   - Roche. 
- M Ab Dlg   - Developmental Studies Hybridoma Bank, University of Iowa. 
- Sheep anti-Dig-AP  - alkaline phosphatase, Fab fragments, Roche (preadsorbed on 
Drosophila wild-type embryos at 1:10). 
 
Secondary antibodies 
- Alexa 488, 546, 647 anti-mouse and anti-rabbit - Molecular probes. 
- Horse peroxidase (POD) anti-mouse IgG (H+L) - Sigma. 
- Horse peroxidase (POD) anti-rabbit IgG (H+L)  - Sigma. 
- Biotinylated anti-rabbit IgG (H+L) - Vector Laboratories, Inc., USA. 
- Biotinylated anti-mouse IgG (H+L) - Vector Laboratories, Inc., USA. 
  
Immunochemicals 
- DAPI (4',6'-Diamidino-2-phenylindole) - Sigma. 
- Alexa Fluor 488 phalloidin - Molecular probes. 
- Hoechst 33342 - Sigma. 
 
7. Buffers 
- PBS (Phosphate Buffered Saline): 10mM Na2HPO4, 2mM KH2PO4 pH7.4, 137mM NaCl, 
2.7mM KCl. 
- PBST: Phosphate Buffered Saline with 0.2% Tween20. 
- Error-prone PCR buffer: (10x) 100mM Tris-HCl pH8.3, 500mM KCl, 70mM MgCl2. 
- IP buffer: 50mM Hepes/NaOH pH7.5, 150mM NaCl, 0.5% TritonX-100, 10% glycerin. 
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- Kinase assay buffer: 80mM β-glycerophosphat pH7.2, 20mM EGTA, 15mM MgCl2, 1mM 
DTT, 50µM ATP. 
- SDS-PAGE sample buffer: 2x: 90mM Tris-HCl pH6.8, 6% SDS, 0.6% bromophenol blue, 
20% glycerol, 6% β-mercaptoethanol.  
- TE:  10mM Tris/HCl pH7.5, 1mM EDTA. 
- Lithium acetate/TE buffer - 1 volume 10x TE pH7.5, 1 volume 1M lithium acetate, 8 volumes 
ddH2O. 
- Lithium acetate/TE/PEG buffer - 1 volume 10x TE pH7.5, 1 volume 1M lithium acetate, 8 
volumes PEG 4000 (w/v). 
- Yeast DNA extraction buffer: 10mM Tris/HCl pH8.0, 2% TritonX-100, 1% SDS, 100mM 
NaCl, 1mM EDTA. 
- CNBr coupling buffer: 100mM NaHCO3 pH8.3(NaOH), 300mM NaCl, 10mM MgCl2. 
- acetate buffer (CNBr sepharose blocker): 0.1mM Na-acetate pH4.0, 0.3M NaCl. 
- Z-Buffer: 100mM Na-Phosphate pH7.0, 10mM KCl, 1mM MgSO4, 50mM β-
mercaptoethanol. 
- in vitro transcription buffer 10x: 400mM Tris/HCl pH7.5, 60mM MgCl2, 20mM spermidin. 
- SPR buffer A: 10mM HEPES pH7.4, 150mM NaCl, 50µM EDTA, 0.005% Tween20. 
- SPR buffer B: 50mM Tris pH8.0, 200mM NaCl, 3mM CaCl2, 5mM MgCl2, 10% glycerol, 
1mM DTT, 0.005% Tween20. 
- EQ buffer: 50mM Tris ph7.0, 200mM NaCl, 1mM EDTA. 
- EL buffer: 100mM Tris pH8.0, 20mM NaCl, 1mM EDTA, 80mM DTT. 
- in vitro nuclear export buffer - 20mM HEPES/KOH pH7.5, 110mM CH3COOK, 5mM 
(CH3COO)2Mg, 0.5mM EGTA, 250mM sucrose. 
 
8. Media 
Bacterial media 
- LB; per 1 liter: 10g Bactotrypton (Becton, Dickinson), 5g Yeast extract (Becton, Dickinson), 
10g NaCl, 15g Bactoagar (Becton, Dickinson) if for plates. 
- SOB; per 1 liter: 20g Bactotrypton (Becton, Dickinson), 5g Yeast extract (Becton, Dickinson), 
500mg NaCl, 10mM Mg-sulfate, 2.5mM KCl. 
- SOC; SOB supplemented with 20mM glucose (from a 1 M stock solution). 
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Yeast media 
- YPD (complete medium); per 1 liter: 10g Yeast extract (Becton, Dickinson), 20g Peptone 
(Gibco), 20g Bactoagar (Becton, Dickinson), 900ml dH2O, 20g glucose (in 100ml dH2O 
autoclaved separately), for plates with one pellet of NaOH. 
 
- CS (dropout medium, complemented synthetic medium); per 1 liter: 6.7g Yeast Nitrogen Base 
w/o Amino Acids (Base for classifying yeasts based on amino acid and carbohydrate 
requirements, Difco), 0.6g aa mix without His, Trp, Leu, Ura (CSM-HIS-LEU-TRP-URA, 
BIO 101), 20g Bactoagar (Becton, Dickinson), indicated below amounts of lacked amino 
acids/uracil if necessary, 900ml dH2O. 
 
amino acids/uracil: 
- 20mg/l    uracil  (100x stock 2.4mg/ml) 
- 20mg/l    histidine (100x stock 2.4mg/ml) 
- 60mg/l    leucine  (100x stock 7.2mg/ml) 
- 40mg/l    tryptophan (100x stock 5mg/ml) 
 
- Indicator plates medium (to assay β-Gal activity); per 0.5l: 3.35g Yeast Nitrogen Base 
without Amino Acids (Base for classifying yeasts based on amino acid and carbohydrate 
requirements, Difco), 0.3g aa mix without His, Trp, Leu, Ura (CSM-HIS-LEU-TRP-URA, 
BIO 101), 10g Bactoagar (Becton, Dickinson), appropriate amounts of lacked amino 
acids/uracil (see CS medium above), one pellet of NaOH, 400ml dH2O, 50ml 1M K-
phosphate pH7.0, 10g sucrose, 50ml H2O, after autoclave at 55°C 1ml X-Gal (20mg dissolved 
in 1ml DMF) was added. 
 
Cell cultures media 
- DMEM; Invitrogen/Gibco. 
- Schneider's Drosophila Medium; Invitrogen/Gibco. 
 
Fly food 
20l of water was cooked 2h with 160g thread agar. After2h 500g fresh baker yeast, 200g soja 
bean meal and 440g molasses were added and cooked another 2h. After 2h cooking 1.6kg malt 
extract, 1.6kg corn meal and 125ml of propionic acid, mixed and filled the vials. The vials with 
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the food were left to cool down for 2h at room temperature and closed by stoppers. Food in the 
vials was stored at 19ºC for no longer than 2 months. 
 
Apple-agar plates for Drosophila eggs collection 
In 3l of hot (90ºC) water 70g of Agar was dissolved. In parallel 100g of sucrose was dissolved 
in 1l apple juice. Both mixtures were mixed in 90ºC pre-warmed water bath, cool down to 
about 60ºC and filled into Petri dishes. The apple-agar plates were stored at 4ºC. 
 
9. Bacterial strains 
- E.coli DH5-α F–, ø80dlacZ∆M15, ∆(lacZYA-argF)U169, deoR, recA1, endA1, hsdR17(rK –, 
mK+), phoA, supE44, λ–, thi-1, gyrA96, relA1. 
- E.coli BL21(DE) B, F- , dcm, ompT, hsdS(rB -mB -), gal  λ (DE3). Contains the T7 RNA 
polymerase gene under control of the lacUV5 promoter. The polymerase gene is integrated 
into the bacterial chromosome from λ (DE3).  
 
10.  Yeast strains 
- EGY48:  Mat α, his3, leu2::op(lexA)4LEU2, trp1, ura3-52 
- RFY206:  Mat a, his3, leu2, trp1, ura3-52 
 
11.  Animal cell strains used in the cell cultures 
- HeLa cells, Invitrogen. 
- Drosophila Schneider 2 (S2) cells, Invitrogen. 
 
12.  Fly stocks 
If not noted otherwise, used fly stocks are as described in Flybase 
(http://flybase.bio.indiana.edu/) and are either part of the Großhans Lab stock collection 
(j.grosshans@zmbh.uni-heidelberg.de) or were obtained from the Bloomington Stock Center 
(http://flystocks.bio.indiana.edu).  
 
- w ; ∆KG7 e ca /∆KG19 e ca.  Deletions of the frs locus were produced by mobilization of the 
transposon KG(3)0224. white revertants were selected for lethality over Df(3L)BK10 and 
breakpoints mapped by PCR. The transheterozygotic combination of two excisions 
(KG7/KG19) delete frs and the two proximal genes gdl and Eip71CD (Großhans et al., 2003). 
- w ; Nup214{w+}/CyO, GFP{w+} ; HS-Frs[5]{w+}. 
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- w ; emb[2] b cn/CyO, GFP{w+}. 
- w ; emb[2] b cn/CyO, GFP{w+} ; HS-frs[5]{w+}. 
- w ; P{w+, UAS-Cdk2c-Myc6}[III.1] (Meyer et al. 2000). 
- yw ; HS-frs#5. (III) 
- w ; +/+ ; LyDf(3L)Bk10 e /TM3, Sb hb-lacZ{ry+}. 
- w ; frs-∆CDS-frs+{w+}[6] ; LyDf(3L)Bk10 e /TM3, Sb hb-lacZ{ry+}. 
- w ; frs-∆CDS-frs86ASA{w+}[4] ; LyDf(3L)Bk10 e /TM3, Sb hb-lacZ{ry+}. 
- w ; frs-∆CDS-frs11AxxA{w+}[18.3] ; LyDf(3L)Bk10 e /TM3, Sb hb-lacZ{ry+}. 
- w ; frs-∆CDS-frs22A48A{w+} ; LyDf(3L)Bk10 e /TM3, Sb hb-lacZ{ry+}. 
- C(3) se. 
- w ; paired-Gal4{w+}. (III) 
- w ; patched-Gal4. (II) 
- w ; patched-Gal4, UAS-frs[J]. (II) 
- w, MS1096-Gal4 ; UAS-GFP. (X, II) 
- w, MS1096{w+}/FM6, B ; UAS-frs[C]{w+}/SM6B, Roi. (II) 
- w ; Sp/CyO ; GMR-Gal4, UAS[I]/TM3, hb-lacZ. (III) 
- w ; p{UAS-GFP, w+}. (II) 
- w ; UAS-string [4]. (III) 
- yw ; UAS-frs[C]. (II) 
- w ; UAS-frs[D]. (II) 
- yw ; UAS-frs[H]. (II) 
- yw ; UAS-frs[I]. (III) 
- w ; UAS-CycA{w+}. (II) 
- w ; UAS-CycB{w+}. (II) 
- w ; UAS-CycB3{w+}. (II) 
- w ; UAS-CycE{w+}. (III) 
 
13.  PCR primer sequences 
Primers PG2-PG25 were synthesized by Invitrogen (Karlsruhe, Germany), primers PG49-P58 
and JG68-JG214 were synthesized by MWG Biotech AG (Ebersberg, Germany). Restriction 
sites are marked as bold, underlined sequence means start or stop codon, letter bold and 
underlined means mutated nucleotide, letter in parenthesis means original nucleotide. 
 
PG2   - CG GAA TTC AAT GCC AAG ATG CTG CAG A 
PG7   - CGA CAA CCT TGA TTG GAG 
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PG8   - GCC TGA CTG GCT GAA ATC 
PG11 - CG GAATTC ATG GCT GGC AAG CGA CAA C 
PG12 - GCC CTCGAG CTA GGA GTT CGT TCT GGC GCT C 
PG13 - GG GAATTC ACG GCA CAA GCT CGT TCT C 
PG14 - GCC CTCGAG CTA GAG AGA GAA GGG CGT GGC 
PG15 - GG GAATTC GCG GAG GAG GAA AAA GAA GA 
PG16 - GCC CTCGAG CTA CTT GAT GTG CTC CTT GAT 
PG17 - ACGC GTCGAC GCT GGC AAG CGA CAA GCC 
PG18 - CG GGATCC CTT GAT GTG CTC CTT GAT CTT 
PG25 - CG GAATTC ATG TAT TTC CGG GAG AGC GAG AA 
PG49 - CCG CTCGAG CTA AGT GTC TCT ATT GTA CTT TTC C 
PG55 - CCG GAA TTC ATG ATT AAC ATG CGG ACG CC 
PG56 - CCG CTC GAG TCA GGG ATT GCT TCT ACT GC 
PG57 - CTG AAA ATC GTG GAA G(A)CC CCA AAG GAG CAG C 
PG58 - G CTG CTC CTT TGG GGC(T) TTC CAC GAT TTT CAG 
JG68 - ACA CTC GAG TCA GCC CAT GTC CAC ATC C 
JG70 - GG GAA TTC AGT AGC AAA TCA GCA ACG TCA 
JG71 - GG CTC GAG AAG GCG CGG AAA GTA AAA TGT 
JG95 - GG GAA TTC ATG TCG TCG ACC AAT GAA ACC 
JG96 - GG GGA TCC ATG TCG TCG ACC AAT GAA ACC 
JG100 - GG CCATG GGA TCG TCG ACC AAT GAA ACC AAC 
JG107 - GTA ATA CGA CTC ACT ATA G 
JG116 - GG CCA TGG GA TCG TCG ACC AAT GAA ACC AAC 
JG117 - GG GGA TCC GAA GTT CAG AGA TTT GCG AGC 
JG141 - GG AGA TCT AAT AAC TGC TAG GCT GGC TGA 
JG147 - GG AGA TCT ATA GCT AGC TCA TAA TAC GAA CCG ATG TAA TC 
JG182 - GA AGA TCT ATG TCG TCG ACC AAT GAA ACC 
JG183 - GC TCT AGA TTA GAA GTT CAG AGA TTT GCG AG 
JG185 - TTC ATC AAG GCT CGC GC(AA)A TCT GC(TT)G AAC TTC TAA TCA TAA 
JG186 - TTA TGA TTA GAA GTT CGC(AA) AGA TGC(TT) GCG AGC CTT GAT GAA 
JG196 - GAA ACC AAC CAA GTG GC(CT)G CAG CGC GC(CT)G AAC AGC CTG AAA ATC 
JG197 - GAT TTT CAG GCT GTT C(AG)GC GCG CTG C(AG)GC CAC TTG GTT GGT TTC 
JG209 - ATT AGC CAC AAT GC(AT)G CGC TCC ATC GC(CT)T ATT GAT GC(TG)G CTG GTT GAG 
GTT 
JG210 - CTC CTC AAC CAG CGC(CA) ATC AAT AGC(AG) GAT GGA GCG CGC(AT) ATT GTG GCT 
AAT 
JG211 - TCC CTG GTA CCA GCC G(A)CC CCC AGC AGC TCA GGA 
JG212 - TCC TGA GCT GCT GGG GGC(T) GGC TGG CAT CAG GGA 
JG213 - GCG CC ATG GAT ATC AGC GTG GGC ACT G 
JG214 - GG AGA TCT TTA AAA CTT ATA AAA CAA ATT CAC G 
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14.  Constructs 
DNA was amplified by vent DNA polymerase (New England Biolabs) with primers 
introducing suitable restriction sites. The purified and digested PCR products were cloned into 
specified plasmids and sequenced. Site-directed mutations were produced by inverse PCR with 
appropriate oligonucleotides and Pfu DNA polymerase (Stratagene). Mutagenised clones were 
selected by DpnI (Roche) digest. The region of interest of the mutagenised plasmids was 
sequenced and recloned into a new plasmid. 
 
Table 1. List of constructs used in this study. 
Construct Primer pair UTR cloning scheme 
pCS2-frs JG70(EcoRI)/JG71(XhoI) 5'-3' PCR with P1 DS08110, cloned into pCS2 
EcoRI/XhoI (Großhans et al. 2003). 
pCS2-frs86ASA JG185/JG186 - Mutagenesis of pCS-frs. Großhans J. 
pCS2-frs11AxxA JG196/JG197 - Mutagenesis of pCS-frs. Großhans J. 
pCS2-frs48A JG211/JG212 - Mutagenesis of pCS-frs. Großhans J. 
pFus-frs JG100/unknown 3' PCR with pCS2-frs cloned into pFus NcoI/XhoI. 
Großhans J. 
pMCS1-His10-GFP-
frs 
- 3' frs NcoI/XhoI cleaved from pFus-frs and cloned 
into pMCS-His10-GFP NcoI/SalI. Gawliński P. 
pMK26/ACTSV40B
S-frs-GFP 
- - frs-GFP HindIII/XbaI cleaved from pCS2-frs-GFP 
and cloned into pMK26 HindIII/EcoRV. 
Gawliński P. 
pCS2-frs-GFP - 5'-3' GFP SpeI/NheI (PCR Lecuit T.) into pCS2-frs 
SpeI. Großhans J. 
pCS2-nup50 - - pJG4-5-nup50 EcoRI cloned into pCS2 
EcoRI/SAP. Gawliński P. 
pLex-frs JG95(EcoRI)/JG71(XhoI) 3' PCR with pCS-frs cloned into pEG202 
EcoRI/XhoI. Großhans J. 
pLex-frs86ASA JG95(EcoRI)/JG71(XhoI) 3' PCR with pCS-frs86ASA cloned into pEG202 
EcoRI/XhoI. Großhans J. 
pLex-frs11AxxA JG95(EcoRI)/JG71(XhoI) 3' PCR with pCS-frs11AxxA cloned into pEG202 
EcoRI/XhoI. Großhans J. 
pLex-trbl∆124  PG2(EcoRI)/JG68(XhoI) - PCR with pCS-trbl cloned into pEG202 
EcoRI/XhoI. Gawliński P. 
pJG4-5-nup50 - - Found in frs Y2H ovarian screen. Contains 
additional EcoRI site at the C-terminus behind 
ORF. Gawliński P. 
pJG4-5-nup50/ 
IABM (1-246) 
PG11(EcoRI)/PG12(XhoI) - PCR with pJG4-5-nup50 cloned into pJG4-5 
EcoRI/XhoI. Gawliński P. 
pJG4-5-nup50/FG 
repeats (251-423) 
PG13(EcoRI)/PG14(XhoI) - PCR with pJG4-5-nup50 cloned into pJG4-5 
EcoRI/XhoI. Gawliński P 
pJG4-5-nup50/ 
IABM+FG (1-423) 
PG11(EcoRI)/PG14(XhoI) - PCR with pJG4-5-nup50 cloned into pJG4-5 
EcoRI/XhoI. Gawliński P. 
pJG4-5-nup50/ 
RanBD (436-564) 
PG15(EcoRI)/PG16(XhoI) - PCR with pJG4-5-nup50 cloned into pJG4-5 
EcoRI/XhoI. Gawliński P. 
pQE80-ZZ-tev-frs-
His6 
JG116(NcoI+ATG 
G)/JG117(BamHI) 
- PCR with pCS-frs cloned into pQE80-ZZ-tev-His6 
NcoI/BamHI. Großhans J. 
pQE30-frs JG96(BamHI)/JG71(XhoI) 3’ PCR with pCS-frs as BamHI/XhoI cloned into 
pQE30 BamHI/SalI. Gawliński P. 
pQE80-His10-ZZ-tev-
frs 
- 3’ frs BamHI/HindIII cleaved from pQE30-frs and 
cloned into pQE80-His10-ZZ BamHI/HindIII. 
Großhans J. 
pQE80-ZZ-tev- PG17(SalI)/PG18(BamHI) - PCR with pJG4-5-nup50 cloned into pQE80-His10-
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nup50-His6 ZZ-tev SalI/BamHI. Gawliński P. 
pGEX-frs JG95(EcoRI)/JG71(XhoI) 3' PCR with pCS-frs cloned into pGEX4T-1 
EcoRI/XhoI. Großhans J. 
pGEX-frsASA JG95(EcoRI)/JG71(XhoI) 3' PCR with pCS-frsASA cloned into pGEX4T-1 
EcoRI/XhoI. Großhans J. 
pGEX-frs11AxxA JG95(EcoRI)/JG71(XhoI) 3' PCR with pCS-frs11AxxA cloned into pGEX4T-1 
EcoRI/XhoI. Großhans J. 
pGEX-frs48A JG95(EcoRI)/JG71(XhoI) 3' PCR with pCS-frs48A cloned into pGEX4T-1 
EcoRI/XhoI. Großhans J. 
pGEX-frs22A48A PG57/PG58 3' Site directed mutagenesis of pGEX-frs48A. 
Gawliński P. 
pQE-CycA∆N170 JG213(NcoI)/JG214 
(BglII) 
- PCR with pSP64 HA-CycA cloned into 
pQE80N60 NcoI/BglII. Großhans J. 
pCS2-CycA(210-
440) 
PG25(EcoRI)/PG49(XhoI) - PCR with pSP64 HA-CycA cloned into pCS2 
EcoRI/XhoI. Gawliński P. 
pGEX-thrombin-tev-
CycA∆N170 
- - CycA∆N170 NcoI/BglII from pQE-CycA∆N170 
cloned into pGEX4T-1-thrombin-tev 
NcoI/BamHI. Gawliński P. 
pGEX-thrombin-tev-
CycE∆N300 
PG55(EcoRI)/PG56(XhoI) - PCR with pSP64- CycE cloned into pGEX4T-1-
thrombin-tev EcoRI/XhoI. Gawliński P. 
pSP-CycA-AAA JG209/JG210 - Mutagenesis of pSP64-CycA, M235L239W242 to 
AAA. Großhans J. 
pBKS-frs∆CDS JG141(BglII)/JG147(BglII,
NheI) 
5’-3’ Inverse PCR with pBKS-frs-3’HSP70. Genomic 
fragment of frs without the coding sequence. 
Großhans J. 
pBKS-frs∆CDS-frs+ JG182(BglII)/JG183(XbaI) 5’-3’ PCR with pCS-frs cloned as BglII/XbaI into 
pBKS-frs∆CDS BglII/NheI. Großhans J. 
pBKS-frs∆CDS 
-frs86ASA 
JG107/JG182(BglII) 5’-3’ PCR with pCS-frs86ASA XbaI/BglII and cloned 
into pBKS-frs∆CDS BglII/NheI. Großhans J. 
pBKS-frs∆CDS 
-frs11AxxA 
JG182(BglII)/JG183(XbaI) 5’-3’ PCR with pCS-frs11AxxA BglII/XbaI and cloned 
into pBKS-frs∆CDS BglII/NheI. Großhans J. 
pBKS-frs∆CDS 
-frs22A48A 
JG182(BglII)/JG183(XbaI) 5'-3' PCR with pGST-frs22A48A BglII/XbaI and 
cloned into pBKS-frs∆CDS BglII/NheI. Gawliński 
P. 
pCasper-HS-frs - 5’ frs (cDNA) as EcoRI/XhoI from pCS-frs into 
pCasper-HS EcoRI/XhoI. Großhans J. 
pCasper-frs+ - 5’-3’ Cloned from pBKS-frs∆CDS+frs+ XbaI/XhoI into 
pCasper4 XhoI/XbaI. Großhans J. 
pCasper-frs86ASA - 5’-3’ Cloned from pBKS-frs∆CDS-frs86ASA 
XhoI/XbaI into pCasper4 XhoI/XhoI. Großhans J. 
pCasper-frs11AxxA - 5’-3’ Cloned from pBKS-frs∆CDS-frs11AxxA 
XbaI/XhoI into pCasper4 XbaI/XhoI. Großhans J. 
pCasper-frs22A48A - 5’-3’ Cloned from pBKS-frs∆CDS-frs22A48A 
XbaI/XhoI into pCasper4 XbaI/XhoI. Gawliński P.
 
 Table 2. List of provided constructs. 
Construct Origin 
pLex-pelle Großhans et al., Nature 372: 563-566 (1994). 
pCS-pelle Großhans et al., Mech Dev. 81: 127-38 (1999). 
pLex-dynein light chain Schnorrer et al., Nat Cell Biol. 2: 185-90 (2000). 
pLex-exuperantia Großhans J. (unpublished data). 
pLex-cactus Großhans et al., Nature 372: 563-566 (1994). 
pJG4-5-dorsal Großhans et al., Nature 372: 563-566 (1994). 
pBKS-frs-3'HSP70 Großhans et al., Dev Cell 5: 285-294 (2003). 
pCS-frs Großhans et al., Dev Cell 5: 285-294 (2003). 
LaminDmO His6-L(1-179) Stuurman. FEBS Lett. 401: 171-174 (1997). 
pQE-His10-ZZ-huCdk2 CAK Görlich D. (unpublished data). 
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pSP64 HA-CycA Kaspar et al., Curr Biol. 11: 685-690 (2001). 
pMK033 CycA(1-170) Kaspar et al., Curr Biol. 11: 685-690 (2001). 
pTS004 CycA(171-491) Kaspar et al., Curr Biol. 11: 685-690 (2001). 
pSP64 HA-CycB Foley et al., Curr Biol. 11: 151-160 (2001). 
pNB40 CycB3 Lehner C. (unpublished data). 
pSP-CycE Sprenger F. (unpublished data). 
pSP64 Cdk1 Sprenger F. (unpublished data). 
pGEX-huRb(379-928) Kaelin et al. Cell 64: 521-532 (1991). 
pQE-His10-ZZ-huCycA1 Görlich D. (unpublished data). 
pQE-His10-ZZ-huCycB1 Görlich D. (unpublished data). 
 
15.  Chromatography 
- Glutathione Sepharose 4B (Pharmacia Biotech). 
- HisTrap HP affinity columns (Amersham). 
- IgG Sepharose 6 Fast Flow (Pharmacia Biotech). 
- ProteinA Sepharose CL-4B (Pharmacia Biotech). 
- CNBr activated Sepharose 4B (Amersham Pharmacia Biotech). 
- Superdex200 10/300GL (Pharmacia Biotech). 
- Thiopropyl-activated Sepharose 6B (Sigma) 
 
16.  Kits for the molecular biology 
- TNT SP6 Coupled Reticulocyte Lysate System (Promega, USA). 
- VECTASTAIN Elite PK-6100 ABC kit (Vector Laboratories, Inc., USA). 
- DAB substrate kit for peroxidase (Vector Laboratories, Inc., USA). 
- ECL plus Western Blotting Detection System (Amersham Biosciences). 
- QIAGEN Plasmid Midi Kit (QIAGEN GmbH, Germany). 
- Effectene Transfection Reagent kit (QIAGEN GmbH, Germany). 
 
17.  Equipment 
Microscopy:  Leica, Zeiss, Olympus. 
PCR:   PTC-200 Peltier Thermal Cycler (MJ Research) 
Western blot:  Trans-blot SD Semi-Dry Transfer Cell (BIO-RAD) 
Radiography materials: Kodak X-OMAT AR film, XAR-5, size 13x18 cm 
    Fuji Medical X-Ray film, size 13x18 cm 
    Imaging plate BAS-MS 2040 (Fujifilm) 
Radiography registrator: FUJIFILM FLA-3000. Image Reader V1.8E program. 
Sonicator:    Cell Disruptor B15 Sonifier, BRANSON 
Micro fluidizer  EmulsiFlex-C5, Avestin (Ottawa, Canada) 
                                                                                                                                                                         Materials 
 40
Agarose gel registrator: Raytest IDA (Image Documentation & Analysis) 
Video copy processor: Mitsubishi P91 
Electroporator:  Gene Pulser™, BIO-RAD 
Protein purifier  Äcta prime, Amersham Pharmacia Biotech 
Protein condensator Vivaspin500 (10 kDa MWCO), Vivascience Satorius. 
Glass needle maker Marishige PN-30 (Japan). 
Incubators:  Kuener Switzerland ISF-1-W 
    Kuener Switzerland ISF-1-V 
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Methods 
1. Standard methods in molecular biology 
All standard methods of molecular biology that are not described in detail in this chapter were 
done according to Sambrook et al. 1998. 
 
2. Isolation of DNA from yeast cells 
Saturated overnight yeast culture was collected in 1.5 ml tube and dissolved in the extraction 
buffer (Materials). Lysate was extracted with phenol/chloroform/i-Amylalcohol (25:24:1) 
solution in the presence of glass beads (about 20µg/reaction, 0.45-0.5mm, B. Braun Melsungen 
AG, autoclaved) on the vortex. After centrifugation (10min, 13000rpm) the aqueous phase was 
transferred to a new tube with 100% ethanol and precipitated 30min at -20ºC. Centrifuged white 
DNA pellet was washed with 70% ethanol, dried with speed-vac and dissolved in 1x TE buffer 
(Materials). 
 
3. Polymerase Chain Reaction (PCR) 
 For the molecular cloning the amplification reactions were done using Vent DNA 
Polymerase (New England Biolabs) or Pfu DNA polymerase (Stratagene). For standard PCR 
reaction the following reagents were mixed in a thin-wall PCR tubes: 50-200ng template, 
0.4µM forward and reverse primers, 50µM dNTP (each), 10x standard PCR buffer (polymerase 
dependent), 1-2 units (per 50µl of the reaction) Vent or Pfu polymerase. The PCR reactions 
were done using the following conditions: 
 
 Step 1 (initial denaturation): 94°C for 2min 
 Step 2 (denaturation): 94°C for 30sec 
 Step 3 (annealing): 50-60°C for 1min 
 Step 4 (elongation): 72°C for 1min per kb to be amplified 
 Step 5: repetition of steps 2-4 for 20-35 times 
 Step 6 (final elongation): 72°C for 5-10min 
 
4. Error-prone Polymerase Chain Reaction 
To generate the library of frühstart mutants, the error-prone PCR was done. PCR reaction was 
performed in the presence of special error-prone PCR buffer. 
 
 
                                                                                                                                                                           Methods 
 42
1x reaction mix: 
- 10x Error-prone PCR buffer (Materials) 
- 10% DMSO (for GC rich template regions) 
- 0.3mM MnCl2 
- 100pM of each primer (JG95 and JG71) 
- 10ng template (pCS2-frs for 0.1ml reaction volume) 
- 25mM dNTP’s mix 
- 5u Taq DNA Polymerase (for 0.1ml reaction volume)  
- ddH20 
 
To prevent over-representation of a single mutation in all clones of the library the PCR 
reaction mix was split into four aliquots (100µl was split into 4 PCR tubes - 25µl each). 
 
PCR program: 
 Step 1 (denaturation): 94°C for 30sec 
 Step 2 (annealing): 56°C for 1min 
 Step 3 (elongation): 72°C for 40sec 
 Step 4: repetition of steps 1-3 for 30 times 
 Step 5 (final elongation): 72°C for 5min 
 
5. DNA sequencing 
All DNA sequencing was done in cooperation with Sequence Laboratories Göttingen GmbH, 
Hannah-Vogt-Strasse 1, D-37085 Göttingen, Germany. Tel.:0551-3700010, Fax:0551-3700012, 
e-mail: Bio-Service@SEQLAB.de, web page: http://www.SEQLAB.de. Sequencing samples 
were prepared according to the company instructions. 
 
6. 2-Nitrophenyl-β-galactopyranoside (ONPG) test 
From saturated overnight yeast cultures in CS glucose (-His, +Leu, -Trp, -Ura) medium, the 
fresh cultures were inoculated in CS galactose (-His, +Leu, -Trp, -Ura) medium to OD600=0.15-
0.3 density. When the cultures reached OD600=0.5-0.7 the cells were briefly centrifuged and 
1ml of Z-Buffer (Materials) added. 800µl of the yeast cells suspensions were transformed into 
new vials. To each of the vials one drop of 0.1% SDS and two drops of chloroform were added. 
To open the cells all vials were 30sec vortex. Next step was 10 min preincubation at 30ºC. After 
preincubation time to all of the vials 200µl of 2-Nitrophenyl-beta-galactopyranoside (4mg/ml in 
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Z-Buffer) were added. After few seconds or minutes (time depends from the interaction 
between tested proteins. The color appears if the interaction takes place, important is also how 
the interaction is strong, if stronger, the yellow color is more intensive) the reaction mixtures 
become yellow. To stop the reactions 0.5ml of 1M Na2CO3 were added, then reaction mixtures 
were centrifuged and supernatants measured at OD420. The β-galactosidase activity was 
calculated from the pattern: 
 
 
Where: 
 n – units of ONPG activity 
 A420 – Absorption of the yellow reaction product at wavelength 420 
 OD600 – optical density of the measured yeast culture 
 t – reaction time 
 Volume – volume of measured sample 
For each investigated protein pair the experiment was repeated three times and the results were 
summarized and averaged. 
 
7. Protein expression and purification 
GST and GST-frs expression was induced for 4h, 0.1mM IPTG, 37°C. GST proteins were 
isolated by chromatography of the cleared, ultra-centrifuged lysate (PBS, 150mM NaCl and 
1mM DTT) with 1ml GSH Sepharose columns (Amersham) and eluted with 50mM Tris/HCl 
pH8.0, 50mM NaCl, 1mM DTT, 10mM glutathione. GST-Rb protein expression was induced 
for 6h at 18°C and purified as the other GST proteins. Purification and thrombin cleavage of 
GST-thrombin-tev-CycA ∆N170 and GST-tev-CycE ∆N300 proteins are precisely described in 
the Surface Plasmon Resonance part of the Methods chapter. Two-steps purification of His10-
GFP-Frs protein is described in detail in the In vitro GFP-Frs nuclear export assay in 
permeabilized HeLa cells part of the methods chapter. His-tagged proteins were expressed by 
0.1M IPTG for 4h, 37°C, purified from the cleared lysate (20mM Na-phosphate pH8.0, 500mM 
NaCl, 20mM imidazol) by chromatography with Ni-NTA sepharose (Amersham) and eluted 
with 20mM Na-phosphate pH8.0, 500mM NaCl, 250mM imidazol. The His10-ZZ-huCdk2 
protein was expressed from a bicistronic plasmid with CAK kinase for 6h at 18°C, 0.1mM 
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IPTG. Protein concentrations were determined by Bradford assay (Sigma). Proteins were stored 
in 10% gycerol at -70°C. 
 
8. Antibody staining of embryos and tissues 
Dechorionated embryos by bleach (50-100%), dissected guts or larval and pupal discs were 
fixed with 4% formaldehyde 30min on the shaker (100-200rpm). Subsequently fixed embryos 
and tissues were briefly washed 3x with PBST and 1x with PBST 5min on the rotating wheel. 
After washing, the embryos and tissues were blocked in PBST with 5% BSA 1h on the rotating 
wheel, then washed once with PBST and incubated 2h at room temperature or overnight at 4ºC 
with primary antibodies. After incubation with the primary antibodies the embryos and tissues 
were washed with PBST 3x briefly and 4x 15min on the rotating wheel and incubated with 
secondary antibodies for 2h at room temperature or overnight at 4ºC. After subsequent washing 
procedure (3x briefly and 4x 15min with PBST) and optional immunochemicals staining 
(Phalloidin and DAPI) samples were mounted in Aquapolymount (Polyscience) and analysed 
by a confocal microscopy.  
The following concentrations of antibodies and immunochemicals were used in the results 
and appendix sections of this work: primary antibodies - 1µg/ml Frs, 0.1µg/ml Nup50, 
0.2µg/ml γ-tubulin, 0.5µg/ml pHistone3, 4µg/ml BrdU, 0.2µg/ml β-galactosidase, 0.5µg/ml 
Dlg, 4µg/ml of secondary antibodies labelled with Alexa dyes, 0.2 µg/ml DAPI, 6nM phalloidin 
coupled with Alexa dyes (Molecular Probes).  
 
9. Estimation of the Frühstart concentration in the embryo 
To estimate Frs concentration in the embryo three different amounts of recombinant His10-
ZZ-Frs (0.1, 1 and 10ng) protein and total extract from precisely staged wild-type embryos (20, 
50, and 100 embryos at mid-cellularisation stage) were compared. As a negative control total 
extract of 20 embryos deficient for frs (w;∆KG7 e ca/∆KG19 e ca) was used.  Embryos were 
collected from apple-juice agar plates under the binocular to estimate the right stage of them. 
To about 200 properly staged embryos SDS-PAGE sample buffer (Materials) was added to 
reach ~10 embryo/µl concentration. The samples were analysed by 12% SDS-PAGE 
electrophoresis and western blot with Frühstart polyclonal antibodies (1:2000) under standard 
conditions. 
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10. Yeast-Two-Hybrid frühstart ovarian library screen 
All yeast procedures and experiments were done according to Russell L. Finley Jr. and Roger 
Brent “Gene Probes – A practical Approach” 1995, unless otherwise mentioned. Y2H frs 
ovarian screen was made in EGY48 yeast strain (Materials). 
cDNA library ovoIb from ovarian RNA used in the screen was kindly provided by Dr. Jörg 
Großhans. The RNA was extracted from ovaries of Drosophila melanogaster (OregonR) wild-
type flies and isolated by extraction with guanidinium thiocyanate, followed by CsCl 
ultracentrifugation and fractionation with OligodT cellulose (Großhans et al. 1999). The cDNAs 
with EcoRI and XhoI sites at their ends were ligated into linearised vector pJG4-5 (containing 
LexA activating domain and TRP1 rescue gene). The complexity of this library is about 4mln 
clones with about 0.9mg /ml DNA concentration. 
The yeast strain EGY48 was first transformed with two plasmids, pSH18-34 (containing 
LexA binding place fused with LacZ, and URA3 rescue gene) and pLex-frs (containing 
fragment of LexA protein responsible for binding to the promoter region of β-galactosidase 
fused with full-length frühstart, and HIS3 rescue gene). Such transformed EGY48/18-34/Lex-
frs strain was grown in 50 ml of the CS glucose (-His, +Leu, +Trp, -Ura) medium at 30ºC on a 
shaker at 200rpm until OD600 reached 0.6 (start OD600=0.2 inoculated always from a fresh 
saturated overnight culture), then spin 2000rpm 3min, dissolved in 25ml sterile ddH2O and 
centrifuged again. Pellet was dissolved in 1ml 100mM Lithium acetate/TE buffer (Materials), 
transferred into 1.5ml tube, centrifuged again and dissolved in 60µl 100mM Lithium acetate/TE 
buffer.  Dissolved cells suspension was split into five tubes (10µl/transformation). To such 
prepared yeast cells fallowing ingredients were carefully added:  
- 300µl Lithium acetate/TE/PEG buffer 
- 50µl career Salmon sperm ss-DNA (stock 2mg/ml, Stratagene) 
- 1µl ovarian pJG5-5 library DNA (stock 1mg/ml) 
Subsequently the transformation mixtures were incubated in a water bath 30min at 30ºC and 
heat shocked in the other water bath 15min at 42ºC. After heat shock from a random vial as a 
control 35µl of the transformation mixture was taken and separately plated on the CS glucose (-
His, +Leu, -Trp, -Ura) agar plate to test a transformation efficiency of the experiment that 
usually was about 8x 105 transformants per one vial (what gave in all five transformation 
reactions about 4x 106 transformants). Because in the yeast cells Lex-frs (bait) fusion protein is 
constitutively expressed whereas expression of the library clones (preys) from the pJG4-5 
vectors is induced by galactose, the rest of the transformation mixtures were plated on the CS 
galactose (-His, -Leu, -Trp, -Ura) medium plates. The transformation plates were incubated at 
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30ºC for 4-6 days. After recovering time, all positive (growing) clones were transferred into a 
new CS galactose (-His, -Leu, -Trp, -Ura) plate and named by numbers.  
 To retest achieved clones for Frs interaction a LacZ (β-Gal activity) assay was done. All 
positive clones found in the screen were put on the CS glucose (-His, +Leu, -Trp, -Ura) plates 
and after 4-5 days transferred (by the stamp covered with a sterile velvet) on four indicator 
plates: 
- CS glucose + X-Gal (-His, +Leu, -Trp, -Ura) – LacZ activity test 
- CS galactose + X-Gal (-His, +Leu, -Trp, -Ura) – LacZ activity test 
- CS glucose    (-His, -Leu, -Trp, -Ura) – minus leucine growing test 
- CS galactose (-His, -Leu, -Trp, -Ura) – minus leucine growing test 
β-Gal assay reconfirm Frs-interacting clones found in the screen and uncovered four false 
positive (e.g. growing on the CS galactose -Leu plate but no LacZ activation was observed) that 
were removed from the clone collection. All positive clones found in Y2H ovarian library 
screen were amplified from total yeast DNA extract by PCR and sequenced. All PCR fragments 
were amplified from pJG4-5 vector by vent polymerase (NEB) and two primers, PG8 (sense) 
and PG7 (anti-sense).  
 
11. Yeast-Two-Hybrid frühstart* mutants library screen 
To generate frs* mutants library the coding sequence of frs (pCS2-frs) was amplified by 
error-prone PCR with Taq polymerase and cloned into pEG202 as EcoRI/XhoI. Error-prone 
PCR resulted in more than one mutation per 500bp. Full-length Nup50 (pJG4-5, EcoRI/XhoI) 
and CyclinE∆N319 (pJG4-5 EcoR/XhoI) were used as baits proteins. The frs* library was 
transformed into EGY48/pSH18-34 strain and all clones were plated into CS glucose -His, 
+Leu, +Trp, -Ura plates and numbered. In parallel RFY206/pSH18-34 strain was transformed 
with pJG4-5-Nup50 and pJG4-5-CyclinE∆N319 separately and uniformly plated on the CS 
glucose +His, +Leu, -Trp, -Ura plates. By the stamp covered with a sterile velvet EGY48 frs* 
clones were transferred from the master plates into RFY206/pSH18-34/pJGNup50 and RFY206 
CyclinE∆N319 plates and subsequently on the YPD plates for 2 days 30ºC for mating. All 
diploid clones were tested for LEU2 and lacZ reporter genes activation on the CS galactose -
His, -Leu, -Trp, -Ura plates. The frs* clones that interact with Nup50 and do not interact with 
CyclinE∆N319 and the clones that interact with CyclinE∆N319 and do not interact with Nup50 
were further analysed. The frs* clones of interest were amplified by PCR and sequenced by 
JG95 (sense) and JG71 (anti-sense) primers. 
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12. In situ hybridization of nup50 gene 
To synthesize anti-sense RNA of nup50 the pCS2-nup50 construct was linearised by HindIII 
under standard conditions. The labeling mixture was prepared as fallowing: 
 
- 1µl DNA (linearised 1µg) 
- 2µl 10x NTP+Dig labelling mix 
- 2µl 10x transcription buffer 
- 2µl RNA polymerase (40U of SP6) 
- 1µl RNase inhibitor (20U) 
- 12µl ddDEPC water 
 
Labeling mixtures were incubated 2h at 37°C, and subsequently 15min at 37°C with 2µl 
DNaseI (RNase free). RNA reaction mixture was precipitated with 1:10 volume of 3M Natrium 
acetate and 2.5 volume of 100% ethanol at -20°C at least for 30min, then pellet (10min, 
13000rpm), washed once with 70% ethanol (DEPC) and dry. Dry pellet was dissolved in 20µl 
DEPC water and store -20°C. The RNA concentration reached 1mg/ml.  2µl of such prepared 
probe (2µg) was mixed with 1µl of tRNA (50mg/ml) and 20µl DEPC water, boiled 4min at 
100°C and rapidly cooled down in ice water. 200µl of hybridization solution was added to the 
reaction mixture. The wild-type embryos were dechorionated in 50% bleach, fixed for 30min in 
heptain/4% formaldehyde in PBS and pop in methanol. Fixed embryos were transferred in 
PBST, rinsed 3x and washed 2x 5min. Washed embryos were incubated 10min in 1:1 
hybridization solution/PBST, then 10min in hybridization solution at room temperature. In the 
next step the embryos were pre-hybridized in hybridization solution for 1h at 57°C. After 1h 
incubation appropriate anti-sense probes were added to the embryos and over night incubation 
at 57°C followed. Such once used probe can be reused several times. After over night 
incubation the embryos were rinsed 3x with pre-warmed hybridization solution, and then 
washed 3x30min in hybridization solution at 57°C. In the next steps the embryos were washed: 
10min 4:1 hybridization solution/PBST at 57°C, 10min 3:2 hybridization solution/PBST at 
57°C, 10min 2:3 hybridization solution/PBST at 57°C, 10min 1:4 hybridization solution/PBST 
at room temperature. To reduce the background and block unspecific epitopes the embryos 
were washed 2x20min in PBST with 1% BSA at room temperature and washed 1x with PBST 
in the end. To such prepared embryos a digoxigenin antibody coupled with alkaline 
phosphatase (Boehringer, Fab fragments) at 1:2000 in PBST were added and incubated for 
about 2h at room temperature (optionally overnight at 4°C). After incubation time the embryos 
were rinsed 3x with PBST and washed 4x 15min in PBST. Then the embryos were washed 3x 
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5min with AP buffer. The reaction was initiated by adding to 1ml of AP buffer 4.5µl NBT 
(Nitro-blue tetrazolium chloride, 50mg/ml) and 3.5µl BCIP (5-bromo-4-chloro-3'-
indolyphosphate p-toluidine salt, 50mg/ml). The incubation time may vary from few minutes to 
3h or even over night and the reaction should be kept in the darkness. To stop the developing 
reaction the embryos were rinsed 4x with PBST, washed 1x 1:1 ethanol/PBST and washed 
1x10min with 100% ethanol. Finally the embryos were rinsed 1x 1:1 ethanol/PBST, washed 1x 
with PBST 10min and mounted in aquapolymount.  
digoxigenin antibody:  (stored at 4°C) a-Dig-AP (alkaline phosphatase, Fab fragments, Roche 
1093274): preadsorbed on wt embryos at 1:10, stored at 4°C with 0.02% Natrium azide 
(NaN3). 
NTP+Dig labelling mix (10x) Dig-11-UTP: 10mM solution (25 µl, Roche #1209256) -10mM 
ATP, 10mM GTP, 10mM CTP, 6.5mM UTP, 3.5mM Dig-11-UTP, pH7.5. 
transcription buffer (10x) for SP6, T3, T7 RNA polymerase, store at -20°C: 400mM Tris-
HCl, pH 8.0, 60mM MgCl2, 100mM DTT, 20mM spermidine, 100mM NaCl. 
DEPC treatment: 2ml diethyl pyrocarbonate per 1 l of water/solution incubated at 37°C 
overnight and autoclaved. 
NBT/BCIP:  NBT (nitro-blue tetrazolium, Sigma), 75 mg/ml in 70% DMF, BCIP (5-bromo-4-
chloro-3'-indolyphosphate p-toluidine salt, Sigma), 50 mg/ml in DM, stored at -20°C. 
Hybridization solution: stored at -20°C (else formamide hydrolyses): 25% formamide, 5x 
SSC, 50µg/ml heparin, 0.2% Tween, 100µg/ml tRNA, DEPC water.  
AP buffer (AP buffer forms a precipitate after some time): 100mM Tris pH9.5, 100mM NaCl, 
50mM MgCl2, 0.2% Tween, ddDEPC water. 
 
13. Polyclonal antibodies against DmNup50 protein 
To raise polyclonal antibodies against Drosophila melanogaster Nup50 a full-length ZZ-
Nup50-His6 fusion protein was used. ZZ-Nup50-His6 was E. coli expressed and purified under 
native conditions. A rabbit was injected four times, each time with 550µg of the protein. Before 
first injection preimmune serum was taken as a negative control. Injection mixture was 
prepared as following: 
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First injection:  
- 550µl of ZZ-Nup50-His6 (1mg/ml=0.55mg) 
- 550µl of Freund’s adjuvants incomplete 
- 30µg dipeptide N-muramyl-alanyl-isoglutamin (Sigma) 
 
Each next injection: 
- 550µl of ZZ-Nup50-His6 (1mg/ml=0.55mg) 
- 550µl of Freund’s adjuvants complete 
- 30µg dipeptide N-muramyl-alanyl-isoglutamin (Sigma) 
 
Between one and another injection were always 4 weeks break for immunoresponse of the 
rabbit. Before each next injection a blood sample was taken and immunoresponse was tested by 
western blot analysis with embryonic total protein extract (0-4h wild-type collection). The 
antibodies were additionally affinity purified from the serum with CNBr-activated Sepharose 4 
B (Amersham, Pharmacia Biotech). 6mg ZZ-Nup50-His6 protein was dissolved in coupling 
buffer (Materials). 1ml of CNBr-activated Sepharose was activated by 15min 1mM HCl 
incubation, washed with 100ml 1mM HCl, subsequently washed with coupling buffer (50ml), 
mixed with ZZ-Nup50-His6 protein and incubated at 4ºC degrees over-night. CNBr sepharose 
beads coupled with ZZ-Nup50-His6 were blocked by 2h RT incubation with acetate buffer 
pH4.0 (Materials), loaded onto the column and washed with 5 cycles of low (acetate) and high 
(coupling) pH buffers. Before use, the column was equilibrated with 5 volumes of PBS. The 
5ml of serum was ultra-centrifuged 30min, 40k at 4ºC degrees and loaded on the column 
(0.2ml/min). The column was washed with 20 volumes of PBS+0.3M NaCl and the antibodies 
were eluted with 4M MgCl2 pH3.5. Collected fractions were immediately neutralized with 1M 
Na-phosphate pH.8.0 and dialyzed with PBS. The protein concentration was measured with 
A=280 (1mg/ml=1.36) and reached 1mg/ml. The activity of the antibodies was tested in 
Drosophila embryo staining (Ab concentration 1:10000) and western blot analysis (Ab 
concentration 1:40000).  
 
14. Polyclonal antibodies against C-terminus of DmCdk1 protein 
Polyclonal antibodies against peptide corresponding to the C-termini of the Drosophila cdc2 
(cdk1) kinase (CILEHPYFNGFQSGLVRN) were done with Imject Maleimide Activated 
Keyhole Limpet Hemocyanin (PIERCE Biotechnology). The peptide was synthesized at 
Peptide Specialty Laboratories GmbH, Heidelberg (www.peptid.de) and delivered in 
                                                                                                                                                                           Methods 
 50
powder form. 10mg peptide was hardly dissolved in the 0.7ml of PBS and 0.9ml of 
DMSO that gives 60% DMSO final concentration. Dissolved peptide ended with CONH2 
group (CILEHPYFNGFQSGLVRN- CONH2) was covalently coupled with KLH protein by 
cross-linking cysteine residues with Sulfo-SMCC linker. The injection mixture with KLH 
conjugate was prepared as following: 
 
First injection:  
- 250µl of KLH-peptide (4mg/ml=1mg) 
- 250µl of Freund’s adjuvants incomplete 
- 30µg dipeptide N-muramyl-alanyl-isoglutamin (Sigma) 
 
Second, third and fourth injections: 
- 250µl of KLH-prptide (4mg/ml=1mg) 
- 250µl of Freund’s adjuvants complete 
- 30µg dipeptide N-muramyl-alanyl-isoglutamin (Sigma) 
 
Between injections there always was a 4 weeks break for immunoresponse of the rabbit. 
Before each next injection a sample of the blood was taken and immunoresponse was tested by 
western blot analysis with embryonic total protein extract (0-4h wild-type collection). The 
antibodies were not affinity purified and were used in all experiments as a plain serum. 
Similarly raised antibodies were already published by Knoblich et al. 1994. 
 
15. Immunoprecipitation of Frs from embryonic lysate 
To immunoprecipitate Frs protein complex from Drosophila embryonic extract polyclonal 
antibodies against DmCycA were used. The embryos were staged (0-4h), heat-shocked (1h 
37ºC) and collected from HS-frs#5 and frs deficient flies (w ; ∆KG7 e ca /∆KG19 e ca). 
Dechorionated embryos (1min in 100% Chlorix) were weighted, frozen in liquid nitrogen and 
stored at -80°C. The 1000 embryos/reaction were homogenized with several strokes in a 
Dounce homogenizer in 1ml IP buffer (Materials) at 4ºC. Homogenized embryos were 
centrifuged for 10min at 13000rpm speed and the supernatant extracted with 1,1,2-
Trichlorotrifluoroethane (1:1) to remove lipids. To extracted supernatant 10µl of R Ab 
DmCycA serum was added. Total embryonic protein extract with the antibodies was incubated 
for 2h at 4ºC on the rotating wheel and then 60µl of ProteinA Sepharose CL-4B was added and 
the mixture was incubated for another 1h at 4ºC. After incubation the beads were washed three 
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times with IP buffer and suspended in 40µl SDS-PAGE sample buffer. The beads coupled with 
immunoprecipitated complexes were divided in four equal parts and separated in 12% SDS 
PAGE gel. After semi-dry western blot analysis the nitrocellulose stripes were incubated with 
the primary antibodies (M Ab CycA 1:200, M Ab Cdk1 PSTAIR 1:50 000 and R Ab Frs 1:2500 
separately. M α-Tubulin 1:50 000 antibody was used as a beads washing control) overnight at 
4ºC. After incubation with the primary antibodies, the nitrocellulose stripes were incubated with 
the secondary peroxidase (POD) anti-Mouse and anti-Rabbit antibodies (Sigma, 1:500 each) for 
2h at room temperature, washed and developed by ECL plus Western Blotting Detection 
System (Amersham Biosciences). 
 
16. In vitro binding test with TNT Coupled Reticulocyte Lysate System expressed proteins 
To test protein-protein interactions the following constructs were in vitro expressed in TNT 
Coupled Reticulate Lysate System kit (Promega): SP64-HA-CycA, CS2-CycA AAA, MK033-
CycA(1-170), TS004-CycA(171-491), CS2-CycA(210-440), SP64-HA-CycB, NB40-CycB3, 
SP64-CycE, SP64-Cdk1), CS2-nup50, CS2-pll, NB His10-ZZ-huCycA1, NB-His10-ZZ-huCycB1. 
The proteins were expressed according to the protocols delivered by the manufacturer 
(www.promega.com) and stored at -80ºC. A few examples of such expressed and labeled by 
[35S]methionine (Materials) proteins are presented below (Figure 1). 
 
 
 
Figure 8. SDS-PAGE gel with an example Drosophila proteins expressed with TNT Couplet Reticulocyte Lysate 
and used in in vitro binding assays (in all cases 2µl of the lysate were loaded  and autoradiography). 
 
All in vitro binding assays with TNT Reticulocyte expressed proteins were performed in 
PBST buffer (Materials) + 150mM NaCl and 1mM DTT. GST, GST-frs, GST-frs86ASA, GST-
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frs48A, GST-frs22A48A and His10-ZZ-huCdk2 fusion proteins were used as baits. Bait proteins 
were expressed in E.coli BL21, the cultures were centrifuged, the pellet was suspended in 
binding buffer (see above) in the presence of 1mM PMSF and frozen at -20ºC. Each pellet 
containing the expressed bait protein (20µl per reaction) was suspended in 1ml of binding 
buffer, sonicated four times (30sec burst, 1min break) and centrifuged. The supernatant was 
transferred into new tube containing Glutathione Sepharose 4B beads slurry (20µl per reaction) 
or IgG Sepharose (20µl per reaction) and incubated 1h 4ºC on a rotating wheel. After 
incubation time the Sepharose beads were centrifuged and washed 4 times with binding buffer. 
The beads were divided into new tubes (about 10µl coupled beads per reaction) and suspended 
in 500µl of the binding buffer. 2µl of TNT expressed protein was added to the tubes and 
incubation of 2h at 4ºC on a rotating wheel followed. After incubation, the beads were washed 
four times with binding buffer, dissolved in 15µl of SDS-PAGE sample buffer and 50% (15µl) 
of it loaded on a gel. Unbound fractions were precipitated with 10% trichloroacetic acid (TCA) 
30min on ice and centrifuged for 10min at 13000rpm. The pellets were washed with 100% 
ethanol, dried, dissolved in 15µl of SDS-PAGE sample buffer and loaded on 12% SDS PAGE 
gel together with the bound fractions. After SDS PAGE analysis the gel was stained with 
coomassie, dried and autoradiography was performed. 
 
17. Surface plasmon resonance (SPR) 
A standard amine coupling procedure via N-Hydroxysuccinimide (NHS) and N-ethyl-N´-(3-
diethylaminopropyl)carbodiimide (EDC) was used to immobilized 200 response units (RU) of 
E.coli purified His10-ZZ-frs on the surface of one flow cell of a CM5 sensor chip. 1000RU 
correspond to a change of about 1ng/mm2 in surface protein concentration. A reference flow 
cell was generated by treatment with the same coupling reagents but without protein 
immobilization. GST-thrombin-tev-CycA(171-491) and GST-thrombin-tev-CycE(300-709) 
proteins were expressed in E.coli BL21 (6h at 18°C with 0.1mM IPTG), the cultures were 
centrifuged and the pellets were suspended in binding buffer (PBST) + 150mM NaCl and 1mM 
DTT in the presence of 1mM PMSF and frozen -20ºC. 1ml of such prepared cultures was 
sonicated four times (30sec. burst, 1min break) in 2ml tube and centrifuged for 10min at 13000 
rpm. The supernatant was transferred into a new 1.5ml tube containing 200µl Glutathione 
Sepharose 4B beads slurry and incubated 1h 4ºC on a rotating wheel. The GST beads were 
subsequently washed 4 times with binding buffer. The beads were divided into 4 new 1.5ml 
tubes (50µl beads/reaction) and suspended in 90µl of the SPR buffer B (Materials). 10U of 
thrombin protease from bovine plasma (SERVA Electrophoresis GmbH) were added in each 
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tube and 4h incubation at 4ºC on a rotating wheel followed. After incubation, the cleaved 
proteins were blocked by 1mM PMSF (10min at 4ºC), purified by gel filtration on the 
Superdex200 10/300GL column in the buffer A for CycA(171-491) or buffer B for CycE(300-
709) and concentrated by Vivaspin columns (Satorius). Protein concentration was measured by 
Bradford assay. The measurements were done in two different running buffers, buffer A for 
CycA(171-491)  and buffer B for CycE(300-709). Both buffers were filtered and degassed 
before use. SPR data were collected at a flow rate of 20µl/min at 25º C with 120µl injection 
volume of increasing cyclins concentrations (31.25nM, 62.5nM, 75nM, 125nM, 150nM, 
250nM, 300nM, 500nM and 1000nM) passed over the sensor chip with immobilized His10-ZZ-
frs (Figure 2). 
 
 
Figure 9. SPR association and dissociation kinetics with different concentrations of Drosophila CycA171-491. 
Injection part of the sensogram (red arrow) and chip washing procedure (black arrow) indicated above. The parts 
of the association and dissociation curves that were used for Koff, Kon and KD calculations are marked in bold 
and by black bars below the graph. 
 
The signal of an uncoated reference cell was subtracted from the measurements. Data were 
collected at a rate of 1Hz. To calculate the binding constant of two interacting proteins 
information of the dissociation phase of the curves was analyzed in order to calculate the off-
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rate using a double exponential fitting model. Using the determined off-rate and the information 
of the association phase of the curves, the on-rate was calculated by fitting to 1:1 langmuir 
binding model using a global fitting method from the BIAevaluation 4.0.1 software. Based on 
off-rate and on-rate the dissociation constant KD was determined. 
 
18.  Kinase assay 
Immunocomplexes used in kinase assays were immunoprecipitated from frs deficient (w ; 
∆KG7 e ca /∆KG19 e ca) or from a cross of paired-Gal4 with UAS-Cdk2-Myc6 0-12h embryos 
in IP buffer with the following antibodies: R Cdk1 (5µl serum/reaction), R CycA (2µl 
serum/reaction), M CycB (5µl ascites/reaction), R CycE (2µl serum/reaction) or anti-Myc (5µg 
M anti-c-Myc/reaction). In all cases the equivalent of 50 embryos (plain protein extract) was 
used per reaction unless otherwise mentioned. 10µl/reaction of ProteinA Sepharose CL-4B 
beads coupled with indicated immunocomplexes was incubated for 10min at 25ºC (or at 4ºC) 
with 2µCi [32P] ATP/reaction in kinase buffer (Materials) in the presence of 3µM substrate 
protein and indicated amounts of Frs. The final volume of all kinase reactions was always 16µl. 
The substrates were expressed in E.coli and affinity purified - His6-LaminDmO(1-179), GST-
Rb(379-928) or purchased - HistoneH1 (Calbiochem). The kinase reaction was stopped by 
addition of SDS-PAGE sample buffer and loaded on the 12% SDS-PAGE gel. The gel was 
dried and autoradiography was performed with a FUJIFILM FLA-3000 phosphor-imager. For 
quantification of [32P] incorporation the original picture was analysed in Image Reader V1.8E 
program. 
In the kinase assay with total protein extract, Cdk1 immunocomplexes (50 embryo-equivalent 
per reaction coupled to 10µl of ProteinA Sepharose via R anti-Cdk1 antibodies 5µl/reaction) 
were incubated for 10min at 25ºC with 1µl of total protein extract (protein concentration about 
20µg/µl) per reaction and 1µM GST, GST-frs and GST-frs86ASA in a total volume of 16µl. 
 
19. In-gel tryptic digestion and LC-MS/MS analysis 
Proteins present in the gel lane were visualized with colloidal coomassie staining. Visible 
bands were cut out with a scalpel. Gel slices were transferred to a 96-well plate and reduced, 
alkylated and digested with trypsin (Catrein et al., 2005) using a Digest pro MS liquid handling 
system (Intavis AG, Germany). Following digestion tryptic peptides were extracted from the 
gel pieces with 50% acetonitrile/0.1% TFA, concentrated nearly to dryness in a Speed-Vac 
vacuum centrifuge and diluted to a total volume of 30µl with 0.1% TFA. 25µl of the sample 
was analysed by a nanoHPLC system (Ultimate, Dionex, Netherlands equipped with a Famos 
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autosampler) coupled to a ESI QTOF hybrid mass spectrometer (Allied Biosystems). Sample 
was loaded on a C18 trapping column (Inertsil, LC Packings) with a flow rate of 20µl/min 0.1% 
TFA. Peptides were eluted and separated on an analytical column (75um x 150mm) packed 
with Inertsil 3µm C18 material (LC Packings) with a flow rate of 200nl/min in a gradient of 
buffer A (0.1% formic acid/ 5% acetonitrile) and buffer B (0.1% formic acid, 80% acetonitrile): 
0-2min: 5% B; 2-50min: 5-40% B; 50-60min:40-60% B; 60-63min: 60-90% B. The column 
was connected with a nano-ESI emitter (New Objectives). 2000 V were applied via liquid 
junction. The QTOF MS operated in positive ion mode. One MS survey scan (0.7 sec) was 
followed by one information dependent product ion scan (3 sec). Only double and triple 
charged ions were selected for fragmentation. The peptide sequences of the phosphorylated 
peptides were confirmed by manual evaluation of the fragment spectra. The MS was done in 
cooperation with the ZMBH Core Facility for Biomolecular Chemistry division (Dr. Thomas 
Ruppert). 
 
20. FACS analysis 
For one FACS analysis 30 wing imaginal discs of 3rd instar larvae UAS-Frs[C] x MS1096 
UAS-GFP transgene were cut in ice cold PBST buffer and trypsinized in 0.5ml Trypsin (0.5g/l) 
-EDTA (0.2g/l) solution (Gibco) 3.5h at 30ºC on the rotating wheel. As a negative control 30 
wing imaginal discs of 3rd instar larvae MS1096 UAS-GFP were used. The discs were 
incubated in 5ml polystyrene round-bottom tubes (Falcon – Becton-Dickinson) and the cell 
suspension was subsequently transferred into new polystyrene round-bottom tube and filtered 
with cell strainer cap (Falcon – Becton-Dickinson). 0.3ml of the cell suspension was stained 
with Hoechst 33342 (0.5mg/ml) and 0.2ml was left as a control. Unstained and stained samples 
were sorted according to the GFP signal and analysed according to cell size and DNA staining 
(Becton Dickinson FACS AriaTM). The data were analysed with BD CellQuest Pro version 5.2 
program (BD Bioscience). 
 
21. Ventral furrow frs rescue phenotype 
frs alleles used in the ventral furrow frs rescue experiment (except wild-type sequence) were 
site-directed mutagenised by PCR with JG182(BglII)/JG183(XbaI)  primer pair and cloned into 
pBKS-frs∆CDS that contains frs genomic region (-1205 to 468, +1 transcription start site, 
amplified from P1 clone DS08110 by PCR with XhoI and ClaI sites, Großhans et al., 2003) 
with deleted wild-type sequence by XbaI/BglII. In the next step, frs allele with frs genomic 
region was recloned from pBKS-frs∆CDS-frs-allele by XhoI/XbaI into pCasper4 XhoI/XhoI 
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vector. Such prepared constructs were used for making transgenic flies. To get a respectively 
high number of embryos the flies were kept in plastic cages, about 50 transgenic for frs males 
and about 200 C(3) females. Collected embryos were staged 2-4h, dechorionated with 50% 
bleach, collected from the apple juice plates, fixed (methanol) and stained with hunchback β-
Gal4 M Ab (1:5000) and pH3 R Ab (1:5000) primary antibodies and biotinylated secondary 
antibodies (1:500). Staining and developing procedures were done with DAB substrate kit for 
peroxidase (Vector Laboratories, Inc., USA) and VECTASTAIN Elite PK-6100 ABC kit 
according to the manufacturer protocols. No β-Gal4 staining indicated embryos deficient for frs 
whereas pH3 staining indicated cells during mitosis. Several steps of ethanol and acetone 
washing (50%, 75%, 100%) dehydrated stained embryos.  Waterless embryos were mixed with 
acetone/araldite mixture (1:1) in a 1.5ml tube overnight at 4ºC, plated on the microscope glass 
plate and segregated. The embryos were counted for proper ventral furrow formation (according 
to Großhans et al., 2003) from following crosses: w; LyBke10/Tm3,hb x C(3), frs6; 
LyBke10/Tm3,hb x C(3), frs86ASA; LyBke10/Tm3,hb x C(3), frs11AxxA; LyBke10/Tm3,hb x 
C(3), frs22A48A; LyBke10/Tm3,hb x C(3).  
 
22. In vitro GFP-Frs nuclear export assay in permeabilized HeLa cells 
His10-GFP-frs protein was expressed and purified by HisTrap HP affinity column with 
lysis/binding buffer (50mM Tris pH7.0, 200mM NaCl) and eluted with elution buffer (50mM 
Tris pH7.0, 200mM NaCl, 500mM imidazol) in the presence of 5mM β-mercaptoethanol 
(added already to the E.coli lysate before sonication) under standard conditions described in 
Protein expression and purification chapter of the methods section. 2mM EDTA was added to 
the eluted His10-GFP-frs protein. In the next step of purification, Thiopropyl-activated 
Sepharose 6B was used. Thiopropyl-activated sepharose beads were first equilibrated with 10 
volumes of EQ buffer (50mM Tris pH7.0, 200mM NaCl, 1mM EDTA) and incubated with 
His10-GFP-frs protein 1h 4ºC, washed with EQ buffer and eluted with EL buffer (100mM Tris 
pH8.0, 20mM NaCl, 1mM EDTA and 80mM DTT added directly before use). 
An interphase extract (low speed spin) from Xenopus laevis eggs was prepared as previously 
described by Leno and Laskey, 1991. Nuclear transport receptors were depleted from the 
extract with phenyl-Sepharose (low substitution, Pharmacia), using 500µl beads per ml of 
extract. Permeabilized HeLa B cells were prepared in suspension as described previously by 
Ribbeck et al., 1998. For export experiment 0.5µl HeLa nuclei were mixed with 20µl of 
Xenopus eggs extract, energy-regenerating complement (5mM creatine phosphate, 25µg/ml 
creatine kinase, 0.25mM GTP and 0.25mM ATP), 1µM Ran, 0.6µM NTF2 (import factor for 
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RanGDP), 0.5µM GFP-Frs, 2µg/ml DAPI and 0.5µM DmCrm1 protein in the in vitro nuclear 
export buffer. Export reactions were performed at 18°C. For confocal laser scanning 
microscopy, 2µl of each of the export sample was placed into a well of 10-well multi-test slide 
and covered with a cover slip. Chromatin was detected by DAPI staining (see above) and 
excitation at 405nm to indicate the positions of the nuclei. GFP was excited at 488nm. All 
materials used in this assay (except His10-GFP-frs fusion protein and in vitro nuclear export 
buffer) were kindly provided by Dr.Theis Stüven (FG Görlich, ZMBH). 
 
23. Transgenic flies 
3µg DNA of pCasper4 carrying insert with appropriate transgene was precipitated with 1µg of 
pDelta2-3 turbo vector (contains transposase gene) and dissolved in ddH2O DEPC to 0.2-
0.6mg/ml DNA concentration. The embryos were collected (0-30 min) from the apple juice 
agar plates, aligned on the microscope glass plate and covered by oil (Voltalef H3S, ARKEMA, 
France). The DNA plasmid mixture was injected with a prepared glass needle into the pole 
plasma at the posterior tip of the w background embryo prior to pole cell formation. Injected 
embryos were incubated 48h at 25ºC and the larvae were transferred into fresh agar apple juice 
plate with a drop of liquid yeast. Close before pupation larvae were transferred into a small food 
vial. F1 flies were sorted according to color of the eyes (from bright yellow to intensive red, 
only one fly per vial because other flies may have this same insertion) and crossed with double 
balancer stock. In frs case it was w; Sp/CyO; LyBk10 e/Tm3, hb, Sb. Based on F2 generation 
flies the chromosome of w+ insertion was determined and balanced stock was established. 
 
24. Preservation and analysis of adult Drosophila wings 
All analyzed adult Drosophila wings were dissected from the flies and mounted in 
Hoyer's/lactic acid solution on the microscope glass plates and analysed under bright-field 
illumination microscope. 
Hoyer's/lactic acid solution - 30g Arabic gum was dissolved in 50ml dH2O overnight on the 
rotating wheel.  When Arabic gum was completely dissolved 200g of chloral hydrate was 
carefully added. Subsequently 20g glycerol was added and the solution was mixed and 
centrifuged for 1h at 13200rpm in order to get clarified. Hoyer's solution was mixed with lactic 
acid (1:1)(Roberts, D.B. 1998). 
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25. Cell cultures 
Mammalian HeLa cells were kept in 6cm plates in complete DMEM medium containing 10% 
heat-inactivated fetal bovine serum (FBS) at 37ºC and 3.5% CO2. Drosophila S2 cells were 
kept in 6cm plates in complete Schneider's Drosophila medium containing 10% FBS at 28ºC 
without CO2. A penicillin-streptomycin solution was added to both media to a final 
concentration of 50 units penicillin G and 50µg streptomycin sulfate per milliliter of medium. 
HeLa cells were passaged after 5min trypsinization with 1:250 Trypsin-EDTA solution (0.5g/l 
trypsin, 0.2g/l EDTA, Gibco). Both cell lines were transfected with 1µg of frs-GFP plasmid 
DNA (pCS2-frs-GFP for HeLa cells and pMK26/ACTSV40BS-frs-GFP for S2 cells) and 
Effectene transfection reagent kit (Qiagen) according to manufacturer protocol 
(www.qiagen.com). The transfected cells were incubated for 24h and GFP signals in living cells 
were analyzed using an Olympus BX60 fluorescence microscope. 
                                                                                                                                                                             Results 
 59
Results 
1. Frühstart interacts with Nucleoporins, export factor Crm1 and CyclinE 
1.1 Yeast-two-hybrid ovarian library screen for Frühstart protein interactors 
It was already known that frühstart antagonizes string (cdc25) activity (Grosshans and 
Wieschaus 2000) but the molecular mechanism of this inhibition remained unknown. To 
investigate the molecular mechanism of frs activity the binding partners of frs were found by a 
yeast-two-hybrid ovarian cDNAs library screen. Frs interacting clones were isolated with lexA 
fused to full-length Frs with a lacZ and LEU2 reporter genes (Materials and Methods). Among 
7.3 million of transformants analysed in the screen, 60 positive clones that interact with Frs bait 
protein were found. All Frs interacting clones that were isolated from the screen were amplified 
by PCR from the yeast DNA and sequenced (Table 3. The truncations are shown for selected 
examples). 
 
Table 3. Interacting clones isolated in the frs yeast-two-hybrid ovarian library screen 
Gene/CG number Function Frequency Clones 
nup50/CG2158 Nuclear pore component 23x Full-length (4x), ∆N554, ∆N551(3x), 
∆N535, ∆N533, ∆N524(2x), ∆N522, 
∆N496(2x), ∆N443, ∆N416, ∆N409, 
∆N385(2x), ∆N378, ∆N375, ∆N264 
nup214/CG3820 Nuclear pore component 8x ∆N905, ∆N876 (2x), ∆N645, ∆N572, 
∆N508, ∆N413, ∆N322 
nup358/CG11856 Nuclear pore component 5x ∆N552, ∆N531 (2x), ∆N509, ∆N475 
nup54/CG8831 Nuclear pore component 5x ∆N560, ∆N546 (2x), ∆N545(2x) 
nup153/CG4453 Nuclear pore component 1x ∆N376 
cyclinE/CG3938 G1/S Cdk2 activity regulator 2x ∆N319, ∆N244 
ctp/CG6998 Dynein ATPase/ microtubule 
motor 
2x - 
hsc70-4/CG4264 Chaperone/ 
adenosinetriphosphatase 
2x - 
dd4/CG2682 Transcription factor 1x - 
CG4639 Transcription factor 1x - 
bip2/CG2009 Transcription factor 1x - 
crc/CG8669 Transcription factor/calcium 
binding 
1x - 
CG12163 Cathepsin F 1x - 
Msp-300/CG33715 larval muscle specific protein 1x - 
CG9986 Function unknown 1x - 
CG12114 Function unknown 1x - 
CG12797 Function unknown 1x - 
Unknown genes Function unknown 3x - 
 
Based on the frs mitotic phenotype, and on the molecular function of the identified genes, two 
groups of clones that could be putative functional interactors were selected. The first group 
includes five different nucleoporins, CG2158/nup50 (23 different clones), nup214 (8 clones), 
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CG8831/nup54 (5 clones), nup358 (5 clones) and nup153 (1 clone) and the second group, two 
independent clones of cyclinE. The rest of the genes that were found in the screen e.g. hsc70-4 
(chaperone) or CG33715 (larval muscle specific protein) do not seem to be correlated with the 
frühstart mitotic phenotype in the early embryo (Table 3). 
To confirm the interaction specificity of Lex-Frs with JG-nucleoporins and JG-cyclinE in 
Y2H, a series of other Lex-fusion proteins was used. In the Y2H Frs interaction specificity test 
Lex-pelle, Lex-exuperantia, Lex-cactus and Lex-dynein light chain fusion proteins that do not 
play any role in cell cycle control machinery were tested (Figure 10). Y2H Frs interaction 
specificity test for CycE is presented in figure 23 of this section. 
 
 
 
Figure 10. Specificity test of frs and nup50 interaction in the Y2H β-Gal plate assay. Lex-Frs specifically interacts 
only with JG-Nup50. The interaction was tested with LacZ (blue color) and LEU2 (growth) reporter genes. As 
specificity control Lex-pelle, Lex-exuperantia, Lex-cactus and Lex-dynein light chain proteins were used. 
Galactose (Gal+) dependent promoter activates nup50 gene expression. Gluc+ plates contain glucose instead of 
galactose. 
 
The specificity test was done for all five nucleoporins found in the screen (only for one, the 
longest one clone from each gene) and for both clones of cyclinE. All tested clones showed 
specific interactions only with Lex-frs while no interactions with other Lex fusion proteins were 
observed (for Nup50 figure 10, for the rest of the nucleoporins data not shown, for cycE figure 
23). This experiment showed that frs-interactors interactions that were found in the Y2H screen 
are specific. 
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1.2 nup50 mRNA and Nup50 protein are present at mid-blastula transition 
For further analysis of Frs-nucleoporins interactions I employed CG2158 gene called by me 
nup50 because of its high structural homology to human nup50 (often used old name of this 
gene was NPAP60 e.g. Lindsay et al., 2002) and mouse/rat nup50 genes. Full-length 
Drosophila nup50 gene was the strongest activator of the LacZ and LEU2 reporter genes in the 
frs Y2H screen. Additionally, nup50 was the most frequent gene found in the Y2H screen and 
gave the highest number of accessible clones that were useful for further research. Moreover, 
the advantages of nup50 for molecular engineering were its size (564aa, whereas e.g. Nup214 
has 1751aa) and its high solubility when expressed in E.coli what facilitated the purification 
process necessary for further investigations.  
The very first question was whether nup50 gene is expressed during early development of 
Drosophila where the peak of frs anti-mitotic activity takes place. To address this question, in 
situ hybridization with in vitro synthesized anti-sense nup50 RNA was performed (Materials 
and Methods, figure 11). 
 
 
 
Figure 11. In situ hybridization showing the expression pattern of nup50 gene during early embryonic development 
of Drosophila. a) nup50 is maternally  contributed. b and c) At the later stages nup50 is ubiquitously expressed 
until stage 11. d) At stage 13-14 nup50 expression is localized mostly to the body somites and gut. The scale bar 
represents 50µm. 
 
In situ hybridization of wild-type OrR 0-12h embryos with anti-sense RNA revealed that 
nup50 gene is maternally contributed (Figure 11a) and ubiquitously expressed during the 
embryonic development of Drosophila (Figure 11a-d). The next question was then whether 
Nup50 protein is available during early Drosophila development. To test it, rabbit polyclonal 
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antibodies against Nup50 were raised and affinity purified (Materials and Methods). Staged 
wild-type embryos were collected, fixed, stained with anti-Nup50 antibodies under standard 
conditions and analysed by confocal laser scanning microscopy (Figure 12-16). 
 
 
 
Figure 12. Polyclonal anti-Nup50 antibody staining of stage 5 (syncytial blastoderm) wild-type OrR embryo. a) 
DNA staining (DAPI), b) Polyclonal anti-Nup50 antibodies, c) Monoclonal γ-tubulin antibodies used as a control 
of the staining conditions, d) Overlay where DNA is marked blue, Nup50 red and γ-tubulin green. It was found 
that Nup50 protein is localized to the nuclear membrane of the cells (b and d). The scale bar represents 10µm. 
 
The Nup50 antibody staining illustrated that Nup50 protein is present in the early embryo 
(Figure 12b,) as well as in the later stages (Figure 15 and figure 16) and is localized to the 
nuclear membrane during interphase (Figure 12b and d). As specificity control γ-tubulin 
antibodies were employed (Figure 12c). Both antibodies used in the staining showed 
independent place-specific localization what showed that Nup50 antibodies are specific and that 
staining conditions were established properly.  
It was also found that during M-phase of Drosophila early embryo Nup50 protein colocalises 
with chromosomes and microtubules (Figure 13). 
 
 
 
Figure 13. Polyclonal anti-Nup50 antibody staining of stage 3 (syncytial blastoderm) wild-type OrR embryo 
during mitotic division (anaphase). DNA staining was done with DAPI and marked in white or blue if overlay (left 
and right panels), whereas polyclonal anti-Nup50 antibodies are marked in white or red if overlay (middle and 
right panels). It was found that during mitotic division Nup50 protein localizes to the chromosomes and 
microtubules. The scale bar represents 20µm. 
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The question that remains open is whether the observed colocalization of Nup50 with 
chromosomes and microtubules has any functional meaning in the embryo or if it only is an 
unspecific interaction. The next observation was that the pole cells of the embryo are stained 
more strongly by Nup50 antibodies compared to the somatic cells (Figure 14).  
 
 
 
Figure 14. Polyclonal anti-Nup50 antibody staining of stage 4 (syncytial blastoderm) wild-type OrR embryo. DNA 
staining was done with DAPI, marked in white or blue if overlay and polyclonal anti-Nup50 antibody are marked 
in white or red if overlay. It was found that the pole cells are much strongly stained compared to the somatic cells. 
The scale bar represents 50µm. 
 
It also remains unclear whether this phenomenon has any physiological significance and 
explanation. Stronger Nup50 antibody staining might be due to the fact that the pole cells e.g. 
might contain more Nup50 protein or that the pole cells are better penetrant for the antibody 
compared to the somatic cells.  
Moreover, it was found that Nup50 protein is not only present in the early embryo but also 
later in subsequent developmental stages. Indeed, Nup50 protein is present in the cells during 
the entire embryonic development of Drosophila as well as in the epithelial cells of the larvae 
(Figures 15 and 16). 
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Figure 15. Polyclonal anti-Nup50 antibody staining of stage 8 wild-type OrR embryo. DNA staining was done 
with DAPI and marked in white or blue if overlay, polyclonal anti-Nup50 antibody staining is shown in white or 
red if overlay. To visualize cell compartments an actin staining was performed (phalloidin, Materials and 
Methods), here marked in white or in green if overlay. It was found that Nup50 protein is also present during later 
stages of Drosophila embryonic development. The scale bar represents 50µm. 
 
In order to better visualize the wing imaginal disc epithelial cells nuclei the MS1096 Gal4 x 
UAS-Frs[D] flies were used for anti-Nup50 antibodies staining. Ectopic expression of Frs in the 
wing imaginal discs gives bigger, more diverse in size nuclei and disrupts the monolayer 
structure of the epithelium what makes the pictures much better for analysis. Transgenic for Frs 
wing imaginal discs were dissected, fixed, stained for Nup50 and tested for presence and 
localization of Nup50 (Materials and Methods, figure 16).   
 
 
 
Figure 16. Polyclonal anti-Nup50 antibody staining of the wing imaginal disc of third instar MS1096 Gal4 x UAS-
Frs [D] larvae. DNA staining was done with DAPI and marked in white or blue if overlay, polyclonal anti-Nup50 
antibody staining is marked in white or red if overlay. It was found that Nup50 protein is also present during later 
stages of Drosophila development, here in the epithelial cells of the wing imaginal disc. The scale bar represents 
50µm. 
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It was found that in the epithelial cells of wing imaginal discs, Nup50 is localized to the 
nuclear membrane as in the embryo. It was published before that rat Nup50 protein is a 
nucleoplasmically oriented component of the nucleoporin basket (Guan et al., 2000; Cronshaw 
et al., 2002). To test whether Drosophila Nup50 has a similar position electron microscopy 
staining and analysis would be required. In order to confirm in a different approach that Nup50 
is present in the early Drosophila embryo, western blot analysis of embryonic total protein 
extract was performed. As in the case of embryonic staining, polyclonal anti-Nup50 antibody 
was used in a series of dilutions (Figure 17). 
 
 
 
Figure 17. Western blot analysis of embryonic total protein extract with affinity purified rabbit polyclonal anti-
Nup50 antibodies. In each line total protein extract from about 10 staged (0-4h) wild-type OrR embryos was 
loaded. The antibodies dilutions are indicated above the blot. As a negative control preimmune serum was used. 
 
Western blot analysis of embryonic total protein extract confirmed the presence of Nup50 
protein in the early Drosophila embryos and additionally showed the very high specificity of 
the rabbit polyclonal anti-Nup50 antibody in this technique. Anti-sense nup50 RNA in situ 
hybridization and polyclonal Nup50 antibody staining in addition to western blot analysis 
revealed that nup50 mRNA and Nup50 protein are present at mid-blastula transition where Frs 
acts as a mitotic inhibitor. This means that these two proteins that were found to interact in the 
Y2H system might also interact in the Drosophila embryo. 
 
1.3 Frühstart interacts with the N-terminal part of Nup50 in Y2H system 
The next question was whether all five nucleoporins that were found in the frs Y2H screen 
share a common binding motif or domain that is responsible for interaction with Frs. In order to 
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test this, the amino acid sequences of all of them were compared. The blast analysis did not 
show any similarities that could suggest the existence of a common Frs binding motif or 
domain and because of this, for further analysis of Frs-nucleoporins interactions, the nup50 
gene was used. Nup50 protein contains three main domains in its amino acid sequence. An 
Importin-α Binding Motif (IABM) is localized in the N-terminal part, a so called FG-repeats 
domain (FG) in the middle of the protein and a Ran Binding Domain (RanBD) in the C-
terminal end. To determine which part of Nup50 is responsible for interaction with Frs all three 
domains were cloned into the JG4-5 vector (Materials and Methods, figure 18) and tested for 
interaction with full-length frühstart in the yeast-two-hybrid β-Gal plate assay. Full-length 
Nup50 and Nup50/67 constructs were used as referees (Figure 18). Nup50/67 was the shortest 
nup50 clone found in the frs Y2H screen that showed interaction with Frs. As a negative control 
for Frs interaction full-length Dorsal protein was used. 
 
 
 
 
 
Figure 18. This scheme presents full-length Nup50 protein and a set of different deletion constructs that were used 
for mapping of the region that is responsible for interaction with Frs. Full-length Nup50 (1-564aa) and Nup50/67 
(300-564aa) constructs were used as referees. Nup50/67 (300-564aa) was the shortest nup50 clone found in the frs 
Y2H screen that showed interaction with Frs. ONPG activation levels part of the graph presents summary of an 
ONPG assay presented in table 4 and described below. 
 
All constructs used in the test showed positive activation of LacZ and LEU2 reporter genes, 
except Nup50/RanBD. To quantify which fragment of Nup50 shows the strongest interaction 
with Frs, an ONPG test in Y2H liquid cultures was performed (Materials and Methods). The 
ONPG assay is based on the chemical reaction of 2-Nitrophenyl-β-galactopyranoside with β-
galactosidase that is expressed during LacZ reporter gene activation by two interacting proteins 
in Y2H system. In this assay, the stronger the interaction between the two tested proteins, the 
higher is the β-galactosidase expression. The ONPG reaction with β-galactosidase gives a 
yellow staining that is measured at OD420 = ONPG units. All measurements were repeated three 
times for each tested interacting couple at the same time and averaged (Table 4). 
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Table 4. Mapping of the nup50 region that is responsible for interaction with frühstart in the ONPG assay. 
 
Interacting partners Number of measurement ONPG units
ONPG units 
(Averaged) 
Frs + Nup50 1 122 87 
 2 80.6  
 3 60.4  
Frs + Nup50/IABM+FG 1 37.4 53 
 2 57.8  
 3 65.1  
Frs + Nup50/IABM 1 11.3 10 
 2 9.4  
 3 9.7  
Frs + Nup50/FG 1 1.8 2 
 2 1.8  
 3 1.8  
Frs + Nup50/RanBD 1 0.7 1 
 2 0.5  
 3 0.8  
Frs + Nup50/67 1 1.9 2 
 2 1.4  
 3 1.9  
Frs + Dorsal 1 0.6 1 
 2 0.6  
 3 1  
 
The strongest interaction with Frühstart was exhibited by the construct that contained full-
length Nup50 protein and the Nup50/IABM+FG fragment showed only slightly weaker 
interaction. Nup50/67 referee clone showed minimal activation of the LacZ reporter gene, 
which means that this fragment of the C-terminal nup50 end is sufficient for interaction with 
frs, whereas no interaction was detected in the case of the Nup50/RanBD fragment (Table 4 and 
figure 18). Based on the β-Gal plate Y2H and ONPG Y2H in the liquid culture assays the 
interaction domain of Nup50 that is required for Frs interaction was determined. In these 
experiments it was shown that the N-terminal part of Nup50 is required and sufficient for 
interaction with Frs in Y2H system. 
 
1.4 Frühstart interacts with [S35] labelled Nup50 protein in an in vitro binding assay 
The next question was whether the Frs-Nup50 interaction that was found in the frs Y2H 
screen is only Y2H specific or if it is possible to reproduce the result in a different approach. In 
order to confirm the Frs-Nup50 interaction an in vitro binding assay was performed. Two 
proteins, Nup50 and Pelle (used as a control) were expressed in vitro in a TNT Coupled 
Reticulocyte Lysate System in the presence of [35S] methionine (Materials and Methods) and 
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tested for interaction with Frühstart. Glutathione sepharose beads coupled with GST-Frs fusion 
protein or GST alone were used as baits (Figure 19). 
 
 
 
Figure 19. In vitro binding assay with Frühstart, Nup50 and Pelle. GST and GST-Frs proteins were used as baits. 
Frs interacts with [35S] labelled Nup50 and does not interact with Pelle (bound panel). Unbound and coomassie 
panels are shown as protein loading controls. 
  
In the in vitro binding assay it was found that Frs interacts with Nup50. This experiment was 
repeated three times and each time the result was positive. Surprisingly, when a new box of 
TNT kit was delivered, the binding signal from the Frs and Nup50 was gone. The problem with 
the TNT Coupled Reticulocyte Lysate kit is that it is a mixture of many undefined proteins. It is 
possible that the first batch of the TNT kit lysate contained the protein or proteins that 
contributed to the Frs-Nup50 complex formation. This could suggest that Frs indeed interacts 
with Nup50, but indirectly in the presence of other regulatory protein or proteins e.g. members 
of RanGTPase system (Görlich et al., 1999). 
 
1.5 Nup214 affects Frühstart cytoplasmic localization in vivo 
It was published before that Nup214 protein affects the function of Drosophila nuclear export 
machinery and the activity of the main nuclear export factor Crm1 (Roth et al. 2003). nup214 
was the only one available mutant out of all five nucleoporins found in the frs Y2H screen that 
could be used for Frs-nucleoporins interaction analysis in vivo. The question was then, whether 
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nucleoporin Nup214 affects Frs nucleocytoplasmic localization. To address this question, Frs 
was ectopically expressed in a nup214 background. As the homozygous nup214 mutant is lethal 
at late second instar larvae stage, expression of Frs was induced by 1h heat-shock procedure 
shortly before death of the larvae. The guts of GFP negative (homozygote for nup214) and 
positive (heterozygote) second instar larvae were dissected, fixed, stained with polyclonal anti-
Frs antibody and analysed by confocal laser scanning microscopy (Materials and Methods, 
figure 20). 
 
 
 
Figure 20. Nucleocytoplasmic localization of Frühstart in the nup214 late second instar larvae gut cells. 
Nucleoporin Nup214 affects Frühstart cytoplasmic localization in the 2nd instar larvae gut cells. In the nup214 
heterozygous mutant Frs cytoplasmic localization is affected. Frs is localized mostly in the nucleus and in the 
cytoplasm whereas in the nup214 homozygous larvae Frs is localized exclusively in the nucleus. DNA DAPI 
staining (white or blue if overlay), Frs antibody staining (white or red if overlay). Genotypes: w; 
Nup214{w+}/CyO, GFP{w+}; HS-Frs[5]{w+} for heterozygous larvae and w; Nup214{w+}/Nup214{w+}; HS-
Frs[5]{w+} for homozygous. The scale bar represents 50µm. 
 
In the wild-type stage 5 (syncytial blastoderm) embryos, Frs appears to be excluded from the 
nucleus, despite its positive charge and its size that is below the apparent exclusion limit of the 
nuclear pores (Großhans et al., 2003). In this experiment, ectopically expressed Frühstart 
localization in the gut cells of heterozygous nup214/GFP larvae was affected and strong nuclear 
localization was observed. In the nup214 homozygous mutant, Frs was exclusively localized in 
the nucleus. Frs localization changes in nup214/GFP heterozygous and nup214 homozygous 
mutant gut cells, suggesting that Nup214 protein is required for Frs cytoplasmic localization in 
vivo. It still remains unclear whether Frs localization has any functional significance. As Frs 
acts in the early embryo and Nup214 protein is maternally contributed it is not possible to do 
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the functional assay in this model. Nevertheless it would be interesting to test whether Frs cell 
localization is also affected in other mutants of the nucleoporins found in the frs Y2H screen. 
 
1.6 Crm1 affects Frühstart cytoplasmic localization in vivo 
As it was found that nucleoporin Nup214 affects Frs nucleocytoplasmic localization the next 
question was whether export factor Crm1 also plays a role in Frs cytoplasmic localization. In 
order to investigate this, Frs was ectopically expressed in an embargoed (Drosophila crm1 
homolog) mutant background. Similarly to nup214, homozygous emb mutant is lethal at late 
second instar larvae stage and because of that expression of Frs was induced by 1h heat-shock 
procedure shortly before death of the larvae. The guts of GFP negative (homozygote) and 
positive (heterozygote) second instar larvae were dissected, fixed, stained with polyclonal anti-
Frs antibody and analysed by confocal laser scanning microscopy (Materials and Methods, 
figure 21). 
 
 
 
Figure 21. Nucleocytoplasmic localization of Frühstart in the export factor emb (crm1) late second instar larvae gut 
cells. In the emb heterozygous mutant Frs is localized mostly in the nucleus and in the cytoplasm whereas in the 
emb homozygous larvae Frs is localized exclusively in the nucleus (like in the case of nup214 gene, figure 20). 
This experiment showed that export factor emb affects Frühstart cytoplasmic localization in the second instar 
larvae gut cells. Genotypes: w;emb[2]/CyO, GFP{w+};HS-frs[5]{w+} for heterozygous larvae and 
w;emb[2]/emb[2];HS-frs[5]{w+} for homozygous. The scale bar represents 50µm. 
 
This experiment showed that nucleocytoplasmic localization of ectopically expressed Frs in 
the emb/GFP heterozygous second late instar larval gut cells is affected. In the emb/GFP gut 
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cells Frs was found to localize in the nucleus and in the cytoplasm, whereas in the emb 
homozygous mutant Frs was exclusively localized in the nucleus, what suggests that 
Drosophila Crm1 protein activity is required for Frs nucleocytoplasmic localization in vivo. It 
is not possible to perform a functional assay with Frs in emb mutant background during mid-
blastula transition embryo because similarly to Nup214, Crm1 is maternally contributed. 
To confirm nucleocytoplasmic Frs localization changes observed in the emb mutant an in 
vitro nuclear export assay in the permeabilized HeLa cells was done. The HeLa nuclei were 
incubated in a Xenopus egg extract, from which nuclear transport receptors had been depleted 
with the phenyl-Sepharose method and replenished with an energy-regenerating system 
(Ribbeck and Görlich., 2002; Stüven et al., 2003). The main task of the Xenopus egg extract 
was to stabilize HeLa nuclei. Frühstart was added as a GFP-fusion protein (Figure 22).  
 
 
 
Figure 22. In vitro GFP-Frs nuclear export assay in permeabilized HeLa cells. Nuclei were incubated in a Xenopus 
egg extract, which had been previously depleted of endogenous nuclear transport receptors and replenished with an 
energy-regenerating system. Pictures a, c and e present DAPI staining used as a nuclear area marker. In the control 
samples (b) after 60 minutes incubation strong nuclear localization of GFP-Frs was observed. In the Crm1 samples 
after 15 minutes incubation (d) clear nuclear envelope localization of GFP-Frs was observed with similar effect 
after 60 minutes incubation (f). The scale bar represents 10µm. 
 
In this experiment Frs was added to the sample and allowed to equilibrate between nuclei and 
cytoplasm. The sample was then split in two and Drosophila Crm1 was added to the first half, 
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and sample reaction buffer was added to the other half as a negative control. The distribution of 
the Frs export substrate was monitored 15 and 60 minutes later by confocal laser scanning 
microscopy (Materials and Methods). DAPI staining was used as a nuclear area marker (Figure 
22a, c, e). In the control sample after 60 minutes of incubation, strong nuclear localization of 
Frs was observed (Figure 22b). In the sample containing Crm1 export factor, Frs was localized 
to the nuclear envelope already after 15 minutes (Figure 22d) and after the next 45 minutes of 
incubation the localization did not significantly change (Figure 22f). In the in vitro export 
assay, it was found that Drosophila main nuclear export factor Crm1 affects Frs 
nucleocytoplasmic localization in the HeLa nuclei in vitro (Figure 22), nevertheless it still 
remains unclear whether Frs cytoplasmic localization has any functional significance in the 
Drosophila embryo. The main role of Crm1 is to export proteins from the nucleus into the 
cytoplasm, surprisingly GST-Frs was not exported into the cytoplasm but localized to the 
nuclear envelope what may have at least two possible explanations. Firstly, the Crm1 complex 
with Frs tagged by GFP might have stuck in the nuclear envelope without any functional 
significance. The second explanation might be that the Crm1 complex with GST-Frs interacts 
stably with a set of nucleoporins (e.g. all five that were found in the frs Y2H screen) and by this 
it modifies or blocks the function of the nucleopores. This kind of modification or blocking 
could suppress the entry into the nucleus of proteins that trigger mitosis e.g. phosphatase String 
or kinase Twine. Nevertheless, no wild-type Frs colocalization to the nuclear envelope was 
observed in stage 5 embryos (Großhans et al. 2003). 
 
2. Frühstart directly interacts with the hydrophobic patch of cyclins but does 
not stably interact with Cdk1 in vitro 
 
2.1 Frühstart specifically interacts with CycE in the Y2H system 
In the frs Y2H ovarian cDNAs library screen two sets of clones that interact with frs were 
found; the nucleoporins that were described above and two independent clones of G1/S cyclinE 
(Table 3). The question was then whether Frs - cycE interaction is specific, like the interaction 
of Frs with nucleoporins in the Y2H system. As a specificity control of Frs - cycE interaction 
three other LexA-fusion proteins were used: Lex-dynein light chain, Lex-cactus and Lex-
tribbles∆N124 (Figure 23).  
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Figure 23. Specificity test of frs and cyclinE ∆N319 interaction in the Y2H β-Gal indicator plates assay. As 
specificity controls Lex-cactus, Lex-dynein light chain and Lex-tribbles∆N124 constructs were used. Lex-Frs 
specifically interacts only with JG-CycE∆N319. Galactose (Gal+) dependent promoter activates cyclinE gene 
expression. The interaction was tested with LacZ (blue color) and LEU2 (growth) reporter genes. Gluc+ plates 
contain glucose instead of galactose. Lex-tribbles ∆N124 clone showed auto activation with LEU2 reporter gene 
(LEU2 black panel). 
 
In this experiment JG-cyclinE∆N319 clone showed specific interaction only with Lex-frs 
whereas no interaction with other Lex fusion proteins was observed (Figure 23). Additionally, 
Lex-tribbles∆N124 construct showed auto activation of LEU2 reporter gene (Figure 23, LEU2 
black panel). However, this auto activation has no significance for Frs-CyclinE interaction 
specificity. This experiment confirmed the specificity of the Frs-CycE interaction, found in the 
frs Y2H screen. 
 
2.2 Frühstart interacts with [S35] labelled CyclinA, B, B3 and E, but does not interact with 
Cdk1 in an in vitro binding assay 
In order to confirm in a different approach the Frs-CycE interaction data provided by the frs 
Y2H screen, an in vitro binding assay was done (Materials and Methods). For this experiment, 
Drosophila CycE, CycA, CycB, CycB3 and Cdk1 proteins were in vitro expressed in TNT 
Coupled Reticulocyte Lysate System in the presence of [35S] methionine (Materials and 
Methods). As baits, glutathione beads coupled with GST-Frs fusion protein and GST alone 
(negative control) were used (Figure 24). 
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Figure 24. In vitro binding assay with Frühstart and [35S] labelled Drosophila CyclinA, CyclinB, CyclinB3, 
CyclinE and Cdk1. As baits, GST and GST-Frs proteins were used. Frs interacts with all cyclins used in the 
experiment but does not interact with Cdk1 (bound panel). Unbound fractions and coomassie gel are showed as 
protein loading controls. 
 
In the in vitro binding assay, it was found that Frühstart interacts not only with CyclinE but 
also with CyclinA, B and B3. In addition, no interaction with Cdk1 protein was observed. 
Nevertheless, this kind of binding assays where in vitro translated proteins are used, presents 
certain limitations. An in vitro translated protein mixture contains more than one [35S] labelled 
proteins, there are many additional undefined proteins required for proper translation process. 
Base on this experiment we cannot assume whether the interaction that was found is direct or 
indirect. 
 
2.3 Frühstart interacts with human CyclinA1 and CyclinB1 in the in vitro binding assay 
To determine whether Frühstart – Cyclins interactions are specific only for Drosophila 
cyclins, two another proteins, human Cyclins A1 and B1 were in vitro expressed in the presence 
of [35S] methionine and the in vitro binding assay was performed under standard conditions 
(Materials and Methods, figure 25). 
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Figure 25. In vitro binding assay with Frühstart, human and Drosophila Cyclins. As baits GST and GST-Frs 
proteins were used. Frs interacts with [35S] labelled DmCyclinA, huCyclinA1 and huCyclinB1 and does not 
interact with the N-terminal part of Drosophila CyclinA (DmCycA/1-170) protein that was used as a negative 
binding control (bound panel). Unbound fractions and coomassie gel are showed as protein loading controls. 
 
In vitro binding assay showed that Frs interacts not only with Drosophila cyclins but also 
with two human cyclins huCycA1 and huCycB1. This experiment suggests that Frs or Frs-
related proteins might act as mitotic inhibitors also in other organisms. 
 
2.4 Frühstart interacts 2.5 times more strongly with CycA compared to CycE 
In order to test whether Frs directly binds to Cyclins and to better characterize the formation 
of the Frs-Cyclins complex, the kinetic parameters of the binding were determined by real time 
surface plasmon resonance (SPR). Immobilized to the sensor chip Frs was analysed for 
interaction with Drosophila CyclinA and huCdk2 (Materials and Methods). In this experiment, 
human Cdk2 protein was used instead of Drosophila Cdk1 because DmCdk1 is hardly soluble 
in bacterial cells and because of this, difficult to isolate. Moreover, the binding effect of another 
cyclin kinase inhibitor, p27, on the huCycA and huCdk2 protein complex had been investigated 
by SPR before (Lacy et al. 2004).  
It was found that CycA binds to Frs with a nanomolar binding constant KD=38nM. 
Additionally, no Frs-huCdk2 interaction was detected, what gives the KD>1µM (Figure 26).  
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Figure 26. Association and dissociation kinetics of 500nM CycA∆N170 and 500nM His10-ZZ-huCdk2 to 
immobilized His10-ZZ-Frs measured by surface plasmon resonance. Frs directly binds to CycA but does not bind to 
huCdk2 in vitro. CycA association and dissociation curves showed in blue, huCdk2 curve showed in green. RU - 
response units, t - time in seconds. This experiment was done with kind help of dr. Rainer Nikolai (FG Bukau, 
ZMBH). 
 
This experiment confirmed the data of the in vitro binding assay (Figure 24) and it 
additionally showed that Frs binds directly to CycA with high affinity and does not interact 
with huCdk2 in vitro. The next questions were whether Frs interacts with mitotic CycB and 
G1/S CycE as tightly as with CycA and whether Frs-CycA interaction affects CycA-huCdk2 
complex stability. To address these questions real time surface plasmon resonance of Frs with 
CycB, CycE and CycA-huCdk2 complex was performed (Figure 27) and the binding constants 
were calculated (Materials and Methods). 
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Figure 27. Dissociation (off-rate) and association (on-rate) kinetics of CycA∆N170 (a), CycE∆N299 (b), 
CycB∆N218 (c) and His10-ZZ-huCdk2-CycA∆N170 complex (d) with immobilized to the sensor chip His10-ZZ-
Frs. RU - response units, t - time in seconds. Kinetic parameters of Frs-CycA, Frs-CycE and Frs-CycA-huCdk2 
complex interactions are presented in table 5. These experiments were done with the kind help of dr. Rainer 
Nikolai and dr. Matthias Mayer (FG Bukau, ZMBH). 
 
To calculate the binding constant of two interacting proteins, information from the 
dissociation phase of the curves was analyzed in order to calculate the off-rate using a double 
exponential fitting model. Taking into account the determined off-rate and the information of 
the association phase of the curves, the on-rate was calculated using a 1:1 langmuir fitting 
model. The dissociation constant KD was determined based on the off-rate and on-rate values 
(Table 5). In the case of CycA, CycE and Cdk2-CycA complex (Figure 27a, 27b and 27d) 
evaluation of the binding constants was possible because of the correct behavior of the 
interacting proteins on the sensor chip. In the case of CycB during the on-rate phase we 
observed an unspecific signal accumulation (Figure 27c) what cold be due to e.g. CycB-CycB 
complex formation or CycB-sensor chip unspecific interaction, and because of that Frs-CycB 
binding constant was not estimated. Nevertheless, based on the Frs-CycB on-rate and off-rate 
sensograms changes according to increasing amounts of CycB we can conclude that CycB 
interacts specifically and directly with Frs.  
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Table 5. Kinetic parameters of the Frs-Cyclins and Frs-CycA-huCdk2 complex interactions measured by SPR 
Protein couple koff (x10-3 s-1) s.d. kon(x104M-1s-1) s.d. KD (nM) s.d. 
Frs-CycA 2.8 0.01 7.3 0.03 38.4 0.2 
Frs-CycE 6.78 0.05 7.04 0.09 96.3 1.4 
Frs-CycB - - - - - - 
Frs-CycA-huCdk2 4.39 0.04 4.0 0.03 111 1 
s.d. - standard deviation. 
 
The SPR data revealed that the interaction of Frs with mitotic CycA is 2.5 times stronger 
compared to the interaction with G1/S CycE. Such high Frs binding specificity might be an 
explanation of the frs mitotic phenotype in the early embryo on the molecular level. The 
remaining question in this hypothesis was only how highly is the concentration of Frs protein in 
the embryo during mid-cellularisation (see figure 29). The meaning of Frs-CycA-huCdk2 
111nM binding constant is hard to interpret according to the proposed affinity model. The 
possible explanation might be that CycA alone and together with huCdk2 has different access 
to the Frs binding place, what might be a consequence of e.g. the conformational changes that 
takes place when Cyclins bind to Cdks. Moreover, based on the complex concentration 
dependent off-rate and on-rate sensograms changes we can assume that Frs binding to the 
CycA-huCdk2 complex does not lead to CycA-huCdk1 dissociation.    
The purity of the proteins used in the surface plasmon resonance experiments is demonstrated 
in figure 28. 
 
 
 
 
Figure 28. Polyacrylamide gel with E.coli purified protein preparations used in the surface plasmon resonance 
experiments. 2µg of each protein were analysed by 12% SDS-PAGE and stained with Coomassie to demonstrate 
the purity (The cloning and purification procedures are described in detail in the Materials and Methods sections of 
this work). 
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2.5 Frühstart reaches a physiological concentration of 100nM in the mid-cellularising 
embryo 
 It is known that frühstart is expressed during mid-blastula transition stage during Drosophila 
embryonic development (Großhans et al., 2003), but the in vivo concentration of the protein had 
not been estimated so far. To better characterize and understand the molecular mechanism and 
the biological function of Frühstart the concentration of the protein was measured. In order to 
estimate Frs concentration in vivo different amounts of recombinant His10-ZZ-Frs and total 
extracts from precisely staged embryos (mid-cellularisation) were analysed by SDS-PAGE and 
western blot with polyclonal Frs antibody (Figure 29). Total protein extract from 20 embryos 
deficient for frs was loaded as a negative control (Materials and Methods). 
 
 
 
Figure 29. Western-blot analysis of mid-cellularisation embryos (stage 5) with polyclonal Frühstart antibody. a) To 
determine Frs physiological concentration indicated amounts of precisely staged WT embryos were analysed. As a 
negative control 20 ∆frs embryos were loaded. b) As a referee indicated amounts of recombinant His10-ZZ-Frs 
protein were used. Frühstart physiological concentration in the embryo during mid-cellularisation reaches 
approximately 10-11 g. If volume of one embryo is 10-8 l then Frühstart reaches approximately 100nM 
concentration in vivo. 
  
Frs in vivo concentration was estimated by comparing the optical density of the bands 
detected in western blot analysis. During mid-cellularisation, one embryo contains 
approximately 10-11g of Frs. If 1 embryo weighs 10-5g and we assume that the main ingredient 
of the embryo is water (>90%) so a volume of the embryo will be 10-8 l (1l of water equals 
1kg), this gives at 10-7M physiological concentration of Frühstart. 
The nanomolar Frs concentration in vivo taken together with the nanomolar binding constants 
of Frs-CycA and Frs-CycE are consistent with the proposed affinity model for Frs mitotic 
CycA-Cdk1 complex inhibition (see also table 5). 
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2.6 Frühstart has two different activities 
In the Y2H screen two different sets of clones were found, the nucleoporins and two 
independent clones of cyclinE what suggests that Frs has two different activities. For further 
analysis of the inhibitory mechanism of Frs, the residues that are responsible for its interaction 
with nucleoporins and cyclins were determined. Since Frs is a novel protein it was no possible 
to predict a putative binding interface by usual sequence comparison. In order to identify the 
residues that are responsible for the interaction of Frs with nucleoporins and cyclins a library of 
random frs* mutants was prepared and was screened for Frs clones that bind to Nup50 but do 
not bind to CycE and for clones that bind to CycE and do not bind to Nup50, in the yeast two-
hybrid system (Materials and Methods). The reason why the G1/S CycE∆N319 clone (Table 3) 
was used as bait instead of one of the mitotic Cyclins A, B or B3 was that expression of these 
proteins or even their small fragments in yeast is lethal. Out of about 15000 frs* mutants that 
were screened, 23 showed the expected phenotype. Out of the 23 frs* clones found in the 
screen, 18 clones interacted with Nup50 but did not interact with CycE, whereas 5 clones 
interacted with CycE but did not interact with Nup50 anymore. Every single mutated frs* clone 
that did not interact with CycE or Nup50 in the Y2H assay was amplified by PCR and 
sequenced (Table 6). 
 
Table 6. List of all clones isolated in the yeast-two-hybrid frs* library screen 
Clone 
number 
frs 
residue
Original 
amino acid 
Mutated 
amino acid
CycE 
interact.
Nup50 
interact. Type of mutation 
1 9 CAA (Q) CAC (H) - + substitution 
 15 AAC (N) GAC (D)   substitution 
 24 AAG (K) AGG (R)   substitution 
 32 CGC (R) CGA (R)   substitution (R/R) 
 60 GAA (E) GAC (D)   substitution 
 72 ATG (M) ACG (T)   substitution 
 86 AAA (L) GAA (E)   substitution 
2 28 GAG (E) GGG (G) - + substitution 
 74 ACT (T) TCT (S)   substitution 
 80 AAT (N) GAT (D)   substitution 
3 58 CAA (Q) CAG (Q) - + substitution (Q/Q) 
 60 GAA (E) GAG (E)   substitution (E/E) 
4 9 CAA (Q) AAA (K) - + substitution 
 24 AAG (K) GAG (E)   substitution 
 27 AAT (N) CGT (R)   substitution 
 60 GAA (E) GTA (V)   substitution 
 69 CTG (L) TTG (L)   substitution (L/L) 
 86 AAA (K) AAC (N)   substitution 
5 34 TGC (C) AGC (S) - + substitution 
 41 AAG (K) GAG (E)   substitution 
 49 CCC (P) ACC (T)   substitution 
 55 GGA (G) AGA (R)   substitution 
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 65 CGC (R) CTC (L)   substitution 
 70 AAT (N) TAT (Y)   substitution 
 79 AAG (L) TAG (stop)   substitution (stop codon) 
6 8 AAC (N) CAC (H) - + substitution 
 24 AAG (K) AGG (R)   substitution 
 58 CAA (Q) TGA (stop)   double substitution (stop codon) 
7 40 AAG (K) TAG (stop) - + substitution (stop codon) 
8 24 AAG (K) ATG (M) - + substitution 
 39 AGC (S) GGC (K)   substitution 
 40 AAG (K) TAG (stop)   substitution (stop codon) 
9 25 GAG (E) GCG (A) - + substitution 
 28 GAG (E) GTG (V)   substitution 
 29 TTC (P) CTC (L)   substitution 
 33 GAG (E) TAG (stop)   substitution (stop codon) 
10 90 TAA (stop) TAT (Y) - + insertion (stop codon) 
11 48 ACC (T) CCC (P) - + deletion (shifted ORF) 
12 48 ACC (T) CCC (P) - + deletion (shifted ORF) 
13 33 GAG (E) GGG (G) - + substitution 
 47 GCC (A) GCA (A)   deletion (shifted ORF) 
14 14 CTG (L) CTT (L) - + substitution (L/L) 
 16 AGC (S) GGC (G)   substitution 
 39 AGC (S) TGC (C)   substitution 
 46 CCA (P) CAG (Q)   deletion (shifted ORF) 
15 45 GTA (V) GTT (V) - + insertion (shifted ORF) 
16 44 CTG (L) CGG (R) - + deletion (shifted ORF) 
17 34 TGC (C) TCT (S) - + deletion (shifted ORF) 
18 22 ACC (T) CCC (P) - + deletion (shifted ORF) 
19 11 CTG (L) CCG (P) + - substitution 
20 11 CTG (L) CCG (P) + - substitution 
 36 TCC (P) TCT (S)   substitution 
 38 GAC (D) GGC (G)   substitution 
 73 TAC (Y) AAC (N)   substitution 
 81 TTC (F) TCC (S)   substitution 
21 8 AAC (N) CAC (H) + - substitution 
 74 ACT (T) CCT (P)   substitution 
 79 AAG (K) AGG (R)   substitution 
22 20 GTG (V) ATG (M) + - substitution 
 34 TGC (C) CGC (R)   substitution 
 48 ACC (T) CCC (P)   substitution 
 70 AAT (N) CAT (H)   substitution 
23 19 ATC (I) TTC (F) + - substitution 
 
In this screen seven groups of frs* mutants that affect Nup50 or CycE interactions were 
found:  
- clones that had a point mutation (substitution) in one of the last six Frs amino acids 
sequence (clones 1 and 4). 
- clone that has some C-terminal mutations but not among last six amino acids sequence 
(clone 2). 
                                                                                                                                                                             Results 
 82
- clone that has changes in the nucleotide level but not in the amino acid level what can affect 
translation process (clone 3). 
- clones with point mutations (single or double substitutions) that introduced a premature stop 
codon (clones 5-9). 
- clone with a point mutation (substitution) in the stop codon, that caused no proper 
transcription termination (clone 10). 
- clones with a point mutation (insertion or deletion) that changed the open reading frame 
(clones 11-18). 
- clones that had a point mutation (substitution) in the leucine rich N-terminal part (clones 19-
23). Schematic representation of all frs* mutants found in the screen is shown in figure 30. 
 
 
 
 
Figure 30. Schematic representation of Frs*-CycE (1-18) and Frs*-Nup50 (19-23) interacting mutants found in the 
frs* Y2H screen. Over the frs* clones the amino acid sequence of wild-type Frs is shown as an indicator for 
mutated residues. The blue panel shows the position of the putative nuclear export signal (NES) sequence, the 
green panel presents the putative, lysine rich nuclear localization signal (NLS) sequence whereas the red panel 
presents a cyclin binding motif (KxL) sequence. New C-terminal sequences, caused by frame-shift mutations are 
marked in red. This experiment was done with the help of Catherine Goursot. 
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This experiment showed that the N-terminal part of Frs is required for interaction with Nup50 
whereas the C-terminal part of Frs is required for binding to CycE. Mutations among the 
leucine rich N-terminal fragment of Frs, that might be putative nuclear export signal (NES), 
abolished interaction with Nup50 in Y2H system. Amino acid analysis of the C-termini of Frs 
uncovered a KxL motif with a basic residue in front (RKxL) and subsequent phenylalanine 
(KxLxxP) (Appendix 1., Großhans J.). The KxL motif was already found and described in other 
Cdk inhibitors like mitotic Drosophila Roughex (Foley et al. 1999), M/G1-S-phase S.cerevisiae 
SIC1 (Sanchez-Diaz et al. 1998), G2/M-phase S.cerevisiae RUM1 (Moreno and Nurse 1994, 
Sanchez-Diaz et al. 1998) and Cdk phosphorylation substrates like Rb (Adams et al. 1999; 
Brown et al. 1999), E2F1 (Adams et al. 1996), p53 (Lowe et al. 2002), p21 (Adams et al. 1996; 
Chen et al. 1996), p27 (Lowe et al. 2002) and p107 (Zhu et al. 1995). Moreover, it was found 
that the putative nuclear localization signal (NLS) does not affect Frs-Nup50 or Frs-CycE 
interactions. To confirm that putative NES and KxL motifs are indeed responsible for Frs - 
Nup50 and Frs-CyclinE interactions in the Y2H system, two binding mutants were generated. 
In frs11AxxA mutant two leucines of the putative NES motif were substituted by alanines and 
in frs86ASA mutant the basic (K) and hydrophobic (L) amino acids of the KxL motif were 
mutated to alanines. The interaction test showed that frs11AxxA interacts with CycE but does 
not interact with Nup50, whereas frs86ASA mutant interacts with Nup50 but does not interact 
with CycE in the Y2H β-Gal plate assay (Appendix 2., Großhans J.). In summary, in the Y2H 
frs* mutant library screen two interacting motifs were identified, a putative nuclear export 
sequence (NES) at the N-terminus that is responsible for interaction with Nup50 and a KxL 
motif at the C-terminal end that is responsible for interaction with CyclinE. 
 
2.7 Mutation of Frs the KxL motif severely affects Frs-CyclinA complex formation in vitro 
The next question was whether the Frs KxL motif is required and specific only for interaction 
with CycE or for interaction with another cyclins as well. To confirm the specificity of frs KxL 
motif found in the frs* Y2H mutant library screen a competitive in vitro binding assay was 
performed. Equal amounts of in vitro expressed [35S] CyclinA were preincubated with 
increasing amounts of Frs C16 peptide that contains the last 16 residues of Frs including the 
KxL motif, and tested for interaction with GST-Frs. GST-Frs86ASA and GST proteins were 
used as negative binding controls (Materials and Methods, figure 31). 
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Figure 31. A competitive in vitro binding assay with Frühstart, [35S] DmCyclinA and increasing concentrations of 
C16 peptide that contains last 16 C-terminal residues of Frs. GST-Frs86ASA, GST and GST-Frs proteins were 
used as baits. GST-Frs86ASA and GST were used as non-binding controls. The 16C peptide interferes with 
binding of CycA to GST-Frs. Concentration of the peptide and quantification of the autoradiograph are indicated 
by numbers. 
 
It was found that in the competitive in vitro binding assay increasing amounts of C16 peptide 
affect Frs - CyclinA complex formation. This result, taken together with the data from the frs* 
Y2H screen demonstrate that Frs KxL motif plays crucial role in the Frs-Cyclins complex 
formation in Y2H and in vitro binding assays. 
 
2.8 Frühstart interacts with hydrophobic patch of CycA in vitro 
After finding that the Frs KxL motif is responsible for interactions with cyclins, the next issue 
was which fragment of cyclins is required for the interaction with Frs. To test this, the amino 
acid sequences of all four Drosophila cyclins that were shown as Frs interactors in the in vitro 
binding assay (CycA, CycB, CycB3 and CycE) were compared. The blast analysis revealed that 
the most conserved region of all four cyclins is the cyclinbox domain, which has a size of about 
100aa. Due to the mitotic phenotype of frs, mitotic CyclinA was used for further analysis of 
Frs-Cyclins interactions (Figure 32). 
 
 
Figure 32. Schematic representation of Drosophila CyclinA protein and the truncations that were used to map a 
domain that is responsible for interaction with Frühstart in the in vitro binding assay (see also figure 33, bound 
panel). The CyclinA(1-491aa) construct contains full-length sequence of the protein, CyclinA(1-170aa), contains 
the N-terminus with destruction box region, CyclinA(171-491aa) contains the cyclinbox region and the entire C-
terminal end and CyclinA(210-440aa) contains the cyclinbox region only. 
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To find the domain of CyclinA that is responsible for interaction with Frs three truncated 
forms of CycA were in vitro expressed in the presence of [35S] methionine and tested in the in 
vitro binding assay. As a referee control full-length CyclinA was used (Figure 33).  
 
 
 
Figure 33. Mapping the interaction region of Drosophila CyclinA that is responsible for interaction with Frs in the 
in vitro binding assay. As baits GST and GST-Frs proteins were used. Frs interacts with [35S] labelled full-length 
CyclinA(1-491aa), CyclinA(171-491aa) that contained the cyclinbox region and the entire C-terminal end and 
CyclinA(210-440aa) that contained cyclinbox domain only, but it does not interact with CyclinA(1-170aa) what 
means that the cyclinbox of CyclinA(210-440aa) domain is sufficient for interaction with Frühstart. Unbound 
fractions and coomassie gel are shown as protein loading controls. 
 
The in vitro binding assay showed that Frs interacts with the cyclinbox domain of CyclinA 
and does not interact with the N-terminal end containing two destruction box domains. The 
cyclinbox as a Frs interacting domain and the presence of the KxL motif on the Frs amino acid 
sequence suggested that the hydrophobic patch of the cyclinbox could be the part of CyclinA 
that is required for interaction with Frs. To confirm the hypothesis that Frs binds to the 
hydrophobic patch of CyclinA, three amino acid residues that belonged to this motif were 
mutated to alanines (according to Schulman et al. 1998). The CycA-AAA hydrophobic patch 
mutant was in vitro expressed in the presence of [35S] methionine and an in vitro binding assay 
was performed (Materials and Methods, figure 34). 
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Figure 34. Mapping the interaction residues of the CyclinA cyclinbox domain that are responsible for interaction 
with Frs in the in vitro binding assay. Glutathione beats coupled with GST-frs and GST-frs86ASA or IgG beads 
coupled with His10-ZZ-huCdk2 were used as baits. Frs interacts with [35S] labelled Drosophila CycA but does not 
interact with Drosophila CycA-AAA (three residues of the hydrophobic patch were mutated to alanines) what 
means that the hydrophobic patch of the CycA cyclinbox domain is required for binding to Frs. Additionally, 
CycA-AAA mutation among the hydrophobic patch does not affect the complex formation with huCdk2. Bound 
and unbound fractions were analysed by SDS-PAGE and autoradiography. Unbound and coomassie fractions are 
shown as a protein loading controls. 
 
Frs, huCdk2 and Frs86ASA (as cyclin non-binding control) proteins were used as baits. The 
in vitro binding assay showed that mutation among the CycA hydrophobic patch does not 
interfere with the formation of the CycA-huCdk2 complex but affects binding to Frs (Figure 
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34). In conclusion, the KxL motif found in the C-terminus of Frs is required for binding to the 
hydrophobic patch of CyclinA in vitro. 
 
2.9 Frühstart forms a complex with CycA and Cdk1 in vivo 
The next question was whether the Frs - Cyclin complex is also formed in vivo? In order to 
address this question an immunoprecipitation assay was performed. In this experiment embryos 
carrying a transgene with frs under control of a heat-shock promoter were used. Before 
immunoprecipitation experiment, the expression of the new construct was tested (Figure 35). 
 
 
 
Figure 35. HS-Frs#5 transgene expression test of 0-12h embryos. Heat-shocked (HS+) and non heat-shocked (HS-, 
as a referee control) embryos were stained with anti-Frs antibodies under standard conditions (Materials and 
Methods). The pictures of Frs HS+ and Frs HS- were taken using the same settings at the confocal microscope. 
HS-Frs#5 transgenic embryos showed heat-shocked dependent expression of the frs gene. Scale bar represents 50 
µm. 
 
Anti-Frs staining confirmed that the HS-Frs#5 transgene is expressed in the embryo and can 
therefore be used for immunoprecipitation. HS-Frs#5 embryos were heat shocked to induce Frs 
expression, lysed and incubated with sepharose beads coupled with polyclonal CycA 
antibodies. Extract from frs deficient embryos was used as a negative control. Bound and 
unbound fractions were subjected to SDS-PAGE and analysed by western blotting with 
antibodies against CycA, Cdk1, Frs and α-tubulin (Materials and Methods, figure 36). 
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Figure 36. Western blot analysis of immunoprecipitated protein complexes from HS-frs and frs deficient embryos, 
using Drosophila CycA polyclonal antibodies. α-tubulin antibody was used as a specificity control and to show 
that washing of the ProteinA beads was done properly. The precipitates contained CycA together with Cdk1 and 
Frs, but not the control protein α-tubulin indicating that CycA-Frs interaction is specific also in vivo. 
 
The immunoprecipitation assay showed that Frs-CycA complexes are formed also in vivo and 
can be immunoprecipitated from the embryos that ectopically expressed frs. The precipitates 
contained CycA together with Cdk1 and Frs, but not the control protein α-tubulin 
demonstrating that Frs-CyclinA association is specific in vivo (Figure 36). 
 
2.10 Frs affects Cdk1 and Cdk2 kinase activity 
The next question was whether Frs-Cyclins interactions have any functional meaning and 
whether they affect Cdk1 and Cdk2 kinase activity. In order to investigate this, a series of 
kinase assays were done. To test the influence of Frs on Cdk1 kinase activity, the Cdk1 
complexes were immunoprecipitated from the embryonic lysate of frs deficient embryos by 
polyclonal antibodies raised against a peptide corresponding to the last 18 C-terminal residues 
of the Cdk1 kinase (Materials and Methods). In all kinas assays where Cdk1 was 
immunoprecipitated, the polyclonal anti-DmCdk1 antibodies were used as a plain not purified 
rabbit serum. As they were newly raised antibodies (according to Knoblich et al., 1994), it was 
first of all necessary to characterize their specificity.  
To test whether Cdk1 serum is specific for Cdk1 protein and does not contain any additional 
antibodies that could recognize other kinases and by this affect the phosphorylation levels of 
Cdk1 substrates, immunoprecipitation and a kinase assay with Cdk1 and Nup50 rabbit serums 
(used as a negative control) were done (Figure 37). The immunocomplexes used in the kinase 
assay were immunoprecipitated from equal amounts of frs deficient embryos. Drosophila 
LaminDmO protein was used as a phosphorylation Cdk1 substrate (Materials and Methods). 
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Moreover, GST-Frs22A48A (a hypo-phosphorylated Frs allele) was used to test whether E.coli 
purified proteins used for further experiments were not contaminated during the purification 
process by some other kinases that could unspecifically increase Cdk1 phosphorylation activity 
signal and phosphorylation of the substrates. 
 
 
 
Figure 37. Specificity test of the anti-Cdk1 rabbit serum used in the kinase assays. Nup50 and Cdk1 
immunocomplexes were isolated from embryonic lysates, incubated with His6-Lamin(1-179aa) and GST-
Frs22A48A hypo-phosphorylating Frs allele in kinase buffer in the presence of [32P] γ-ATP. The reaction mixture 
was analysed by SDS-PAGE and autoradiography. The numbers indicate the quantification of the optical density 
of the bands. ProteinA sepharose beads coupled with Nup50 immunocomplexes showed minimal (4%) Lamin 
phosphorylation compared to the Cdk1 serum (100%) what means that Cdk1 antibodies from Cdk1 serum are 
specific. Additionally Frs22A48A incubation with Nup50 immunocomplexes showed 14% background 
phosphorylation compared to the Cdk1 serum (100%). 
 
In the kinase assay, it was found that Nup50 immunocomplexes immunoprecipitated with 
anti-Nup50 serum showed minimal (4%) Lamin phosphorylation compared to the Cdk1 
immunocomplexes immunoprecipitated with anti-Cdk1 serum (100%). This experiment proved 
that anti-Cdk1 antibodies are Cdk1 specific and that ProteinA sepharose beads coupled with 
anti-Cdk1 serum IgG do not associate unspecifically with another kinases available during 
immunoprecipitation. In addition, GST-Frs22A48A preparation did not significantly affect 
Lamin phosphorylation signal what means that the protein preparation was not contaminated by 
another unspecific kinases. 
This same question concerning specificity was addressed in the case of the mouse monoclonal 
anti-c-Myc antibodies that were used to immunoprecipitate Cdk2 immunocomplexes from 
embryos transgenic for Cdk2-Myc6. The Cdk2-Myc6 immunoprecipitates and the unbound 
fractions were analysed by SDS-PAGE and western blot for presence of Cdk2 and Cdk1 
proteins (Materials and Methods, figure 38). 
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Figure 38. Western blot analysis of Cdk2-Myc6 immunocomplexes immunoprecipitated with mouse anti-Myc 
antibody from paired-Gal4 x UAS-Cdk2-Myc6 transgenic embryos. Unbound fractions were analyzed as a negative 
control. It was found that mouse monoclonal anti-c-Myc antibodies immunoprecipitate only Cdk2-Myc6 protein 
kinase and do not co-immunoprecipitate Cdk1 from Cdk2-Myc6 transgenic embryos. 
 
Western blot analysis of the immunoprecipitated Cdk2-Myc6 complexes showed that mouse 
monoclonal anti-c-Myc antibodies are specific for Cdk2-Myc6 complexes and do not co-
immunoprecipitate Cdk1 kinase protein.  
The next important issue was to establish the optimal kinetic parameters of kinase assay 
conditions such as substrate concentration, kinase amount per reaction or reaction time of the 
experiment. The first question was then whether the amount of substrate is not a limiting factor 
in the assay. To test this, Cdk1 immunocomplexes isolated from embryonic lysate (100 embryo 
equivalents and 5µl Cdk1 serum per reaction) were incubated with 3µM GST-Rb substrate in 
kinase buffer with [32P] γ-ATP for 1, 3, 10, 20 and 40 minutes at 25 ºC (Figure 39). 
 
 
 
Figure 39. Kinase assay with Cdk1 immunocomplexes and GST-Rb(379-928) substrate. a) SDS-PAGE gel with 
[32P] signal of phosphorylated GST-Rb from 1 minute up to 40 minutes. The measured optical density [OD] of the 
bands is indicated on the gel. b) Optical density values presented as a graph, which shows that the substrate is not a 
limiting factor in the assay if the reaction time is 10 minutes or even longer. 
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In the assay 3µM GST-Rb substrate was almost constantly being phosphorylated by 
immunoprecipitated Cdk1 protein kinase along the 40 minutes of reaction time. This means that 
under these conditions 3µM concentration of the substrate is not a limiting factor for Cdk1 
immunoprecipitated from 100 embryos if the reaction time is 10 minutes or even longer. 
It was also not clear whether Cdk1 immunocomplexes by themselves are not a limiting factor 
in the kinase assay. To test this, the Cdk1 immunocomplexes (5µl Cdk1 serum per reaction) 
were isolated from increasing amounts of frs deficient embryos (1, 10, 100 and 1000) and 
incubated with 3µM substrate in kinase buffer with [32P] γ-ATP for 10 min at 25ºC (Figure 40). 
 
 
 
Figure 40. Kinase assay with Cdk1 isolated from increasing amounts of embryos. 3µM GST-Rb(379-928) was 
used as a substrate. a) SDS-Page gel with [32P] signal of phosphorylated Rb substrate incubated 10 min at 25°C 
with Cdk1 immunocomplexes immunoprecipitated from 1, 10, 100 and 1000 frs deficient embryos. Increasing 
amounts of embryos are indicated above the gel. The optical density [OD] of the bands was measured and is 
indicated on the gel. b) Optical density values presented as a graph. 
 
This experiment showed that the amount of Cdk1 kinase immunoprecipitated from 10-100 or 
even more embryos by 5µl of anti-Cdk1 serum used in the kinase reaction is not a limiting 
factor if the substrate concentration is 3µM.  
Based on the test experiments that established the proper conditions of the kinase assay with 
immunoprecipitated native Cdk1 complexes the following reaction parameters were used for 
further Frs-Cyclins interactions: per reaction - Cdk1 immunocomplexes were isolated from 50 
embryo equivalents by 5µl of anti-Cdk1 rabbit serum and incubated with 3µM substrate 10 
minutes at 25°C unless otherwise mentioned (Materials and Methods).  
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When the kinase assay conditions with newly raised anti-Cdk1 antibodies were properly 
established the functional assay with Frs was performed. Because of the Frs mitotic phenotype 
in vivo the first question was whether Frs affects mitotic Cdk1 kinase activity. 
To test the influence of Frs on Cdk1 function, Cdk1 immunocomplexes were isolated from 
embryonic lysate and incubated with increasing amounts of Frs in the presence of different 
Cdk1 in vitro substrates: HistoneH1, Rb or LaminDmO. The kinase assay reactions were done 
in the kinase buffer and  [32P] γ-ATP. As a referee GST and GST-Frs86ASA proteins were 
used. The samples were analysed by SDS-PAGE and autoradiography (Materials and Methods, 
figure 41). 
 
 
 
Figure 41. Kinase assay with Cdk1 immunocomplexes titrated by increasing amounts of Frs. Increasing amounts 
of Frs inhibited all three model substrates used in the assay. Cdk1 was immunoprecipitated from embryonic lysate 
by anti-Cdk1 serum, incubated with HistoneH1, Rb or LaminDmO substrate and increasing amounts of GST-Frs. 
As a negative control (100 = 100%) GST protein was used (first line). GST-Frs86ASA allele was used as a Cyclin 
non-binding control. All reactions were done in the kinase buffer with  [32P] γ-ATP, analysed by SDS-PAGE and 
autoradiography. The relative [32P] incorporation by the substrates is indicated below the respective bands.  
 
The Cdk1 kinase assay showed that Frs inhibited Cdk1 kinase activity and decreased the 
phosphorylation level of all three substrates used in the experiment. Moreover, GST-Frs fusion 
protein was a substrate for Cdk1 as well and was strongly phosphorylated. It was already 
known that Cdk1 triggers mitosis as a complex with CycA (essential) and as a complex with 
CycB (not essential). The next question was whether Frs is Cdk1-CycA or Cdk1-CycB complex 
specific inhibitor or if it can equally block both complexes. In order to address this question, 
Cdk1 complexes were immunoprecipitated from embryonic lysate by anti-Cdk1 serum, anti-
CycA serum and anti-CycB antibodies separately and tested for Frs inhibition (Materials and 
Methods, figure 42).  
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Figure 42. Kinase assay with Cdk1, CycA and CycB immunocomplexes titrated by increasing amounts of Frs. It 
was found that Frs inhibits kinase activity of Cdk1, CycA and CycB immunocomplexes to a comparable degree. 
The immunocomplexes were isolated from embryonic lysate by anti-Cdk1 serum, anti-CycA serum and anti-CycB 
antibodies and incubated with LaminDmO and increasing amounts of GST-Frs. GST protein was used as a 
negative control (100 = 100%). GST-Frs86ASA allele was used as a Cyclin non-binding control. All reactions 
were performed in the kinase buffer with  [32P] γ-ATP, analysed by SDS-PAGE and autoradiography. Relative 
[32P] incorporation by the substrates is indicated below the respective bands.  
 
No Frs specificity was observed in this experiment, as it equally inhibited Cdk1, Cdk1-CycA 
and Cdk1-CycB immunocomplexes kinase activity. The next question was then, whether Frs is 
only a mitotic Cdk1 specific inhibitor or if it is also able to inhibit G1/S Cdk2 kinase activity. 
To address this question, Cdk2-Myc6 immunocomplexes were isolated from transgenic for 
Cdk2-Myc6 transgenic embryos by anti-Myc antibodies and titrated by increasing amounts of 
Frs under standard conditions (Materials and Methods). Because in Drosophila G1/S Cdk2 
kinase is active in the complex with CyclinE, the same experiment was done in parallel for 
CycE immunocomplexes that were isolated from frs deficient embryos (Figure 43). 
 
 
 
Figure 43. Kinase assay with Cdk2 and CycE immunocomplexes titrated by increasing amounts of Frs. Frs did not 
show any Cdk2 or CycE specificity and affected the kinase activity of both immunocomplexes to a comparable 
degree. The immunocomplexes were isolated from transgenic for Cdk2-Myc6 embryos by anti-Myc antibodies, and 
from embryos deficient for frs by anti-CycE antibodies. The immunocomplexes were incubated with LaminDmO 
substrate and increasing amounts of GST-Frs. As a negative control (100 = 100%) GST was used. GST-Frs86ASA 
allele was used as a Cyclin non-binding control. All reactions were done in the kinase buffer with  [32P] γ-ATP, 
analysed by SDS-PAGE and autoradiography. Relative [32P] incorporation by the substrate is indicated below the 
respective bands. 
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The kinase assay with Cdk2 and CycE showed strong kinase activity inhibition by Frs, like in 
the case of Cdk1 and CycA, and no specificity was found. The observed lack of Cdk specificity 
was very striking, especially in the context of the SPR data that showed 2.5x stronger Frs 
affinity to CycA compared to the CycE. For closer analysis of Cdk1 and Cdk2 kinase activity 
inhibition by Frs another kinase assay test was done. Cdk1 and Cdk2 immunocomplexes were 
incubated with a narrow range of Frs protein concentrations (0-1µM) that cover the nanomolar 
range of Frs-CycA and Frs-CycE binding constants values only. Each experiment was repeated 
three times with always this same immunocomplexes preparation and averaged (Materials and 
Methods, figure 44). 
 
 
 
Figure 44.  Kinase assay with Cdk1 and Cdk2 immunocomplexes titrated by increasing amounts of Frs. Both Cdk 
immunocomplexes were inhibited to a comparable degree. The immunocomplexes were incubated with 
LaminDmO used as a substrate and with increasing concentrations of GST-Frs in the kinase buffer. [32P] 
incorporation was quantified following SDS-PAGE analysis and autoradiography. Each measurement was repeated 
three times and the average was calculated. Error bars represent standard deviations. 
 
 The in vitro kinase assays revealed that Frs equally inhibits phosphorylation of three model 
substrates by Cdk1 and no substrate specificity was observed. Moreover, Frs inhibited mitotic 
Cdk1 and G1/S Cdk2 kinase activity to a comparable degree, even though Frs has 2.5x higher 
affinity to CycA compared to the CycE. Another astonishing finding was that Frs inhibited 
Cdk1 and Cdk2 kinase activity at the micromolar range what is about ten times higher than the 
Frs-CycA, Frs-CycA-huCdk2 and Frs-CycE binding constants. 
 
2.11 The hydrophobic patch is not required for HistoneH1, Rb and LaminDmO 
substrates interaction with Cdk1 
In the kinase assay specificity test, it was found that Frs inhibits Cdk1 and Cdk2 kinase 
activity in the micromolar range that is about 10x higher than the binding constants of Frs-
CycA, Frs-CycE and Frs-CycA-huCdk2 complex (Figure 44). A different activity was shown 
e.g. by p27 inhibitor that inhibits Cdk activity in vitro at the nanomolar range that is around its 
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nanomolar binding constant values (Toyoshima and Hunter 1994, Lacy et al. 2004). The 
difference between Frs binding constant values and Frs concentration that efficiently inhibits 
Cdk kinase activity in vitro suggests that binding of Frs to the hydrophobic patch of cyclins is 
not required for the inhibition of HistoneH1, Rb and LaminDmO model substrates 
phosphorylation. To investigate the role of the hydrophobic patch in Cdk1 substrate 
phosphorylation a competitive in vitro kinase assay was performed with the Frs C16 peptide 
that contains the last 16 C-terminal amino acids sequence of Frs with the KxL motif. Full-
length wild-type Frs was used as a phosphorylation referee control (Materials and Methods, 
figure 45).  
 
 
 
Figure 45. Competitive kinase assay with Cdk1 immunocomplexes titrated by increasing amounts of Frs C16 
peptide. It was found that Frs C16 peptide does not inhibit Cdk1 kinase activity. Cdk1 was immunoprecipitated 
from embryonic lysate by anti-Cdk1 serum, incubated with LaminDmO substrate and increasing amounts of Frs 
C16 peptide. As a negative control (100 = 100%) GST protein was used (first line). GST-Frs was used as a referee 
control (last line). All reactions were performed in the kinase buffer with  [32P] γ-ATP and analysed by SDS-PAGE 
and autoradiography. Relative [32P] incorporation by the substrates is indicated below the respective bands.  
 
As it was demonstrated before, Frs C16 peptide affects Frs-CycA complex formation in vitro 
(Figure 31). The competitive kinase assay showed that Frs C16 peptide does not inhibit the 
Cdk1 kinase activity even at high 10µM concentration what shows that the hydrophobic patch 
is not required for LaminDmO substrate interaction with Cdk1 and most likely with two other 
model substrates HistoneH1 and Rb used in the previous kinase assay experiments.  
 
2.12 Frs is a Cdk substrate in vitro 
The kinase assay experiments revealed that Frs is also a Cdk substrate in vitro (Figures 37, 41 
and 45). The question was then whether the observed phosphorylation of Frs has any functional 
meaning. In order to examine whether Frs phosphorylation affects Frs-CycA complex 
formation an in vitro binding assay with phosphorylated and unphosphorylated GST-Frs forms 
was performed. Frs86ASA allele was used as a non-binding control. The GSH beads coupled 
with Frs and Frs86ASA were mixed and incubated for 20min at 25ºC with ProteinA beads 
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coupled or not coupled with Cdk1 immunocomplexes in kinase buffer that contained [32P] γ-
ATP prior to the binding test with [35S] labelled CyclinA (Materials and Methods). GSH bound 
and unbound fractions were analysed by SDS-PAGE and autoradiography (Figure 46). 
 
 
 
Figure 46. In vitro binding assay with phosphorylated and unphosphorylated forms of GST-Frs and [35S] labelled 
Drosophila CyclinA. It was found that phosphorylated and non phosphorylated GST-Frs equally bind to [35S] 
labelled Drosophila CyclinA (bound panel). GST-Frs and GST-Frs86ASA were used as baits. Unbound fractions 
and coomassie gel are shown as protein loading controls. Autoradiography (32P) panel is shown as a Cdk1 kinase 
phosphorylation activity control.  
 
The in vitro binding assays with phosphorylated and unphosphorylated Frs revealed that both 
forms equally bind to [35S] labelled Drosophila CyclinA. This result together with Frs C16 
competitive kinase assay (Figure 45) suggests that Frs might inhibit the Cdk1 and Cdk2 kinase 
activity via competition on the Cdk catalytic centre with the phosphorylation substrates used in 
the assay. In order to test this hypothesis, Frs phosphorylation sites were determined and a 
hypo-phosphorylated mutant was constructed. To determine the phosphorylation sites of Frs 
mass-spectroscopy analysis was applied. The Cdk1 phosphorylated and unphosphorylated 
forms of GST-Frs were subjected to SDS-PAGE and digested with trypsin. Cleaved peptides 
were separated with nanoHPLC system, high voltage protonised and analysed by mass-
spectroscopy (Materials and Methods, figure 47).  
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Figure 47. Mass-spectroscopy analysis of phosphorylated and unphosphorylated forms of Frs. GST-Frs 
phosphorylated by Cdk1 was trypsinized from SDS-PAGE gel, separated by nanoHPLC system and analysed by 
mass-spectroscopy. Unphosphorylated form of GST-Frs was used as a negative control.  Mass-spectroscopy 
analysis revealed that Frs is phosphorylated at T48  (a) and T22 (b). Axis Y presents the intensity of the signal 
(arbitrary units), axis X presents the mass of the analyzed peptides (m/z is mass of peptide divided by charge of the 
ions). Each peak represents one peptide signal. Rings indicate spectra with and without phosphate groups. This 
experiment was done in cooperation with the ZMBH Core Facility for Biomolecular Chemistry division (Dr. 
Thomas Ruppert). 
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The mass difference between phosphorylated and unphosphorylated 11 amino acid Frs 
peptides was about 40 m/z (mass of peptide divided by charge of the ions). If the molecular 
weight of a phosphate group is 80Da and the peptide is double charged it means that the peptide 
contains one bound phosphate group (80Da : 2 ions = mass shift 40 m/z). 
The mass-spectroscopy analysis revealed that Frs has two main phosphorylation residues, 
threonine 48 (Figure 47a) and threonine 22 (Figure 47b). It was also found that T48 is almost 
completely phosphorylated and T22 at about 50% under in vitro conditions. Both 
phosphorylated sites match the T/SP Cdk1 consensus sequence that is required for the 
substrates to be phosphorylated by Cdk1. To confirm the mass-spectroscopy data, Frs48A and 
Frs22A48 mutants, where T22 and T48 residues of Frs were submitted to alanines, were created 
by site-directed mutagenesis. Subsequently, the phosphorylation levels of both alleles were 
tested in vitro in the kinase assay. Wild-type Frs and Cyclin non-binding Frs86ASA alleles 
were used as a referee (Materials and Methods, figure 48). 
 
 
 
Figure 48. Kinase assay with equal amounts of GST-Frs, GST-Frs86ASA, GST-Frs48A and GST-Frs22A48A 
alleles phosphorylated by Cdk1. Frs22A48A allele with both its main phosphorylation sites mutated, is about five 
times less phosphorylated compare to the wild-type (32P). GST-Frs was used as a fully phosphorylated referee (100 
= 100%). The phosphorylation levels of the proteins were measured after SDS-PAGE and autoradiography. 
Coomassie gel is shown as a protein loading control. 
 
 The kinase phosphorylation test of Frs, Frs86ASA, Frs48A and Frs22A48A alleles showed 
that phosphorylation of Frs22A44A mutant is reduced to about 10-20% compared to the wild-
type Frs (Figure 48). If we now consider that the unspecific kinase activity background of the 
IgG antibodies couplet with ProteinA sepharose used for Cdk1 immunoprecipitation equals 
about 14% (see Figure 37), we can assume that for Cdk1 kinase, Frs22A48A is a non-
phosphorylating form of Frs.  
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The next question was then whether Frs phosphorylation affects Cdk kinase activity. To test 
the influence of non-phosphorylating Frs22A48A mutant on the Cdk1 activity the kinase assay 
was performed. Equal amounts of Cdk1 immunocomplexes were incubated with increasing 
concentrations of Frs22A48A and with LaminDmO in kinase assay buffer with [32P] γ-ATP. 
Wild-type Frs and Frs86ASA alleles were used as a referees (Materials and Methods, figure 
49). 
 
 
Figure 49. The diagram presents Cdk1 kinase activity in the presence of increasing amounts of GST-Frs, GST-
Frs22A48A and GST-Frs86ASA. Frs22A48A is about 10x less active compare to the wild-type. The Cdk1 
immunocomplexes were incubated with Lamin in kinase buffer and [32P] γ-ATP. Relative degree of 
phosphorylation was quantified following SDS-PAGE and autoradiography. 
 
The kinase assay with Cdk1 and Frs22A48A mutant revealed that the non-phosphorylating 
Frs allele is about 10 times less active compared to the wild-type Frs. Ten times higher amount 
of Frs22A48A protein was required for inhibition of Cdk1 kinase activity. In addition, 
Frs86ASA allele that does not bind to the cyclins was much less active even at high 
concentrations (Figure 49) what suggests that for efficient Cdk1 inhibition in vitro, Frs has to 
be bound to the Cyclin. This hypothesis seems to be true especially if we also consider the fact 
that Frs86ASA is usually much less phosphorylated in the kinase assay compared to the 
normally bound to cyclin wild-type form of Frs (Figure 41).  
It was estimated before that during mid-cellularisation stage Frühstart reaches approximately 
100nM concentration in vivo (Figure 29), whereas the in vitro kinase assay data showed that Frs 
is able to inhibit Cdk1 kinase activity at about ten times higher concentration (Figure 49). In 
consequence, unphysiologically high concentration of Frs may inhibit Cdk phosphorylation by 
substrate competition in vitro. This shows that the cyclin hydrophobic patch is not critical for 
the recognition of the used in the kinase assay model substrates in vitro. 
The next question was whether it is possible to find substrates the phosphorylation of which is 
independent of even high Frs concentration in vitro. In order to find such substrates, the kinase 
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assay with Cdk1 and total embryonic protein extract was done  (Materials and Methods, figure 
50).  
 
 
 
Figure 50. Kinase assay of embryonic total protein extract with Cdk1. Cdk1 immunoprecipitates were incubated 
with embryonic total protein extract and GST-Frs in the kinase buffer containing [32P] γ-ATP. As controls equal 
amounts of GST and GST-Frs86ASA were used. The first line shows [32P] γ-ATP incubated with total protein 
extract only to demonstrate the kinase activity of internal kinases. The last lane shows Cdk1 immunocomplexes 
incubated with GST-Frs to present Cdk1 kinase activity. It was found that at least one Cdk1 substrate is inhibited 
by GST-Frs (black arrow) and is not inhibited by control proteins GST and GST-Frs86ASA. 
 
One undefined Cdk1 substrate that is affected by Frs and is not affected by control proteins 
GST and Frs86ASA was found in the kinase assay with embryonic total protein extract (Figure 
50). Unfortunately, no protein that is substrate of Cdk1 and is not inhibited by Frs was detected. 
Moreover, this experiment showed that in the Drosophila embryo there are some Cdk1 
substrates (at least one) that are inhibited by Frs. The limitation in this experiment was the high 
[32P] background that made phosphorylated proteins hard to detect. 
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The purity of the proteins used in the kinase assays is demonstrated in figure 51. 
 
 
 
Figure 51. Polyacrylamide gel with E.coli purified protein preparations used in the kinase assays. 2µg of each 
protein were analysed by 12% SDS-PAGE and stained with Coomassie to demonstrate the purity (Cloning and 
purification procedures are described in detail in the materials and methods section of this work). 
 
2.13 Binding of Frs to the Cyclins is essential for its function in vivo 
To test whether 86KxL, 11LxxL motifs and the two phosphorylating threonines (T22 and 
T48) of frs play an essential role for frs mitotic function in vivo, frs86ASA, frs11AxxA and 
frs22A48A mutations were introduced into genomic rescue constructs and tested for their 
ability to complement the frs ventral furrow phenotype. The embryos from the C(3) x frs rescue 
constructs crosses were fixed, stained with β -galactosidase and phospho-histone3 and counted 
for premature mitosis in the mesoderm anlage and proper ventral furrow formation according to 
Großhans et al., 2003 (Materials and Methods, table 7). 
 
Table 7. Statistics of ventral furrow rescue phenotype embryo stainings. 
 
The numbers indicate amounts of embryos obtained from C(3) flies crossed with frs rescue transgenes (Genotype 
of male) that were scored for proper ventral furrow formation according to Grosshans et al. 2003. The penetrance 
means percentage of the homozygous for frs transgene embryos that rescue ventral furrow phenotype.  The 
embryos were stained with β -galactosidase and phospho-histone3. Only embryos without β-galactosidase staining 
were scored as deficient for endogenous wild-type frs. In this class the expected proportion of Df frs hemizygous 
embryos is 50%. 
 
Genotype of male normal VF open VF penetrance (%) 
Df frs/TM3,hb 100 78 88 
frs+;Df frs/TM3, hb 120 20 28 
frs86ASA;Df frs/TM3, hb 59 53 94 
frs11AxxA;Df frs/TM3, hb 121 19 27 
frs22A48A;Df frs/TM3, hb 55 25 62 
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The ventral furrow rescue phenotype data showed that the wild-type sequence and the 
frs11AxxA allele (where the putative NES is mutated) complemented, whereas the frs86ASA 
allele did not complement (Table 7), suggesting that the physiological function of frs requires 
binding to the hydrophobic patch of cyclins. Nevertheless, frs11AxxA allele still showed 
cytoplasmic localization (Figure 53c and d) what suggests that mutation of two leucines among 
the putative nuclear export signal is not sufficient to disrupt frs nuclear export activity. To test 
whether frs nucleocytoplasmic localization plays or does not play a role in the frs anti-mitotic 
activity it might be necessary to mutate the third leucine that belongs to the putative NES 
sequence. If frs11AxxAxxA allele would not be exclusively cytoplasmic anymore the frs 
ventral furrow rescue experiment with this transgene should finally clarify the connection 
between frs localization and frs anti-mitotic function in vivo. Another possible way to test the 
correlation between frs function and localization might be the frs ventral furrow rescue 
experiment with transgenic flies expressing GFP-frs fusion protein. The GFP-frs fusion protein 
is accumulating exclusively in the nucleus when expressed in Drosophila Schneider cells or 
human HeLa cells (Figure 52a and 52b). 
 
 
 
Figure 52. Cell culture expression of GFP-frs constructs. a) Drosophila Schneider cells expressing GFP-frs fusion 
protein. b) Human HeLa cells expressing GFP-frs fusion protein.  
 
It has not been tested yet whether GFP-frs construct is still functional in the fly, but this might 
be possible to check by injecting early Drosophila embryos with in vitro translated GFP-frs 
RNA (according to method described already by Grosshans et al., 2003). 
  frs22A48A transgene complemented the frs ventral furrow phenotype only to about 60% 
(Table 7). The explanation for this could be that phosphorylation of Frs by Cdk1 somehow 
contributes to the Frs mitotic phenotype or that the frs22A48A allele used for the assay had 
lower expression level of the transgene (Figure 53f). 
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For proper interpretation of the ventral furrow phenotype rescue data it was necessary to 
check whether the frs transgenes that were used in the assay are expressed in the embryo and 
whether the expression levels of all of them are comparable. In order to test the expression 
levels of the frs transgenes, stage 5 embryos were stained with anti-Frs antibodies. 
Additionally, an anti-β -galactosidase antibody staining was done to distinguish the embryos 
that are deficient for endogenous Frs protein (Materials and Methods, figure 53). 
 
 
 
Figure 53. Expression test of frs transgenes used in the VF rescue phenotype assay. Embryos from stocks carrying 
frs deficiency and frs+ transgenes were fixed and stained with Frs (white) and β-galactosidase (red) antibodies 
(Materials and Methods). Endogenous Frs deficient embryos were distinguished by the absence of β-galactosidase 
staining. Scale bar represents 50µm. Genotypes of stained transgenes: a) frs86ASA ; Df(3L)BK10 / TM3, hb-lacZ, 
b) frs86ASA ; Df(3L)BK10 / Df(3L)BK10, c) frs11AxxA ; Df(3L)BK10 / TM3, hb-lacZ, d) frs11AxxA ; 
Df(3L)BK10 / Df(3L)BK10, e) frs22A48A ; Df(3L)BK10 / TM3, hb-lacZ, f) frs22A48A ; Df(3L)BK10 / 
Df(3L)BK10, g) +/+ ; Df(3L)BK10 / TM3, hb-lacZ, h) +/+ ;  Df(3L)BK10 / Df(3L)BK10. 
 
The Frs antibody staining with frs86ASA (Figure 53a and 53b) and frs11AxxA (Figure 53c 
and 53d) transgenes demonstrated proper Frs expression levels. frs22A48A transgene (Figure 
53e and 53f) showed slightly lower level of Frs expression compared to the frs86ASA and 
frs11AxxA. As a negative control, embryos deficient for Frs were stained (Figure 53g and 53h) 
and no Frs staining was observed (Figure 53h). 
The test of Frs expression level of the transgenes positively confirmed the ventral furrow 
rescue phenotype data (Table 7). The lower expression level of Frs22A48A transgene compared 
to the rest of tested transgenes might explain the not complete rescue of the ventral furrow 
phenotype. 
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3. Frühstart is G2/M specific inhibitor in vivo 
3.1 Ectopically expressed Frs during the last (16th) zygotic division blocks mitosis but 
does not affect S-phase 
In order to put the in vitro data into a physiological context, the cell cycle specificity of Frs in 
vivo was defined. In frs mutant embryos the precocious 14th mitosis during ventral furrow 
formation showed that Frs inhibits entry into mitosis (Großhans et al. 2000). The question then 
was in which step of the cell cycle Frs acts. Does Frs directly inhibit only the G2/M transition 
or are G1/S and S phases also affected? To determine whether frs also affects the S-phase of the 
cell cycle, it was ectopically expressed in a striped pattern during mid-embryogenesis (stage 
10). The ectopic expression of Frs inhibited the last zygotic cell cycle (cycle 16) as shown by 
50% reduced cell density. Moreover, the embryos did not show inhibition of S-phase because 
BrdU was incorporated in S phase 16 (Appendix 2b and 2c., Großhans J.).  
 
3.2 Wing imaginal disc epithelial cells that ectopically express frs are bigger and have a 
several fold higher DNA content compared to the wild-type 
For further analysis of the frs phenotype, frs was ectopically expressed in the epithelial cells 
of wing imaginal discs. This expression revealed strong morphological defects in pupal wing 
discs and adult wings. Microscopy analysis showed that disc cells were several times larger and 
had bigger nuclei with enormously strong DNA staining compared to the wild-type. Moreover, 
the wing hairs were grouped and had disturbed polarity (Appendix 3b and 3c., Großhans J.). 
 To confirm the Frs ectopic expression phenotype in the epithelial cells of wing imaginal 
discs the FACS analysis was done (Figure 54). Wing imaginal discs from third instar larvae 
(Figure 54a and 54b) were dissected and trypsinized (Materials and Methods). Following 
staining with Hoechst, cells were sorted according to the GFP signal (Figure 54c and 54d) and 
analysed according to cell size (Figure 54e) and DNA staining (Figure 54f). 
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Figure 54. Ectopic expression of frs in the epithelial cells of wing imaginal discs. a, b) frs expression domains are 
indicated by GFP expression signal (green), DNA (white). c, d) Dissociated cells of larval wing discs that did or 
did not express Frs were stained with Hoechst, sorted by GFP expression and analysed according to cell size (e) 
and DNA staining (f). Selected cell population from the discs without Frs (c, WT gate) and population of large 
cells from the frs expressing discs (d, Frs+ gate) were analysed. Scale bar represents 50µm. Genotypes: a) w,1096-
Gal4 ; UAS-GFP. b) w,MS1096-Gal4/+; UAS-GFP/UAS-frs[C]. 
 
The FACS analysis complemented the previous microscopy observations. The epithelial wing 
imaginal disc cells with ectopically expressed Frs were several times bigger and indeed 
contained several times more DNA compared to the wild-type cells (Figure 54e and 54f). The 
higher DNA content suggests that in the wing epithelial cells frs induces endocycles what is 
typical Cdk1 or CycA in Drosophila and mitotic Cdk phenotype in yeast (Sauer et al. 1995; 
Hayashi et al. 1996; Weigmann et al. 1997; Vidwans et al. 2002). 
 
3.3 Larval salivary gland cells ectopically expressed frs show normal growth of the tissue 
compare to the wild-type 
To test whether frs has an effect on the naturally occurring endocycles, ectopic expression of 
frs in Drosophila larval salivary glands was performed (Figure 55). 
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Figure 55. Ectopic expression of frs in third instar larval salivary glands. Ectopic expression of frs does not affect 
salivary glands formation and naturally occurring endoreplication. The glands were stained for DNA with DAPI 
(a,b., white or blue if overlay) and for Frs (c,d., white or red if overlay). Scale bar 50 µm. Genotypes: WT - 
w;patched-Gal4. Frs+ - patched-Gal4/UAS-frs[C]. 
 
This experiment showed that ectopic expression of frs allowed the growth of the salivary 
gland tissue (Figure 55b, 55d and 55f), what indicates that ectopic frs does not affect naturally 
occurring endocycles. To test the expression pattern of UAS-frs in the salivary glands of 
patched-Gal4 line, the UAS-GFP transgene was used first and analysed according to GFP 
localization and expression level. Transgenic patched-Gal4/UAS-GFP salivary glands showed 
strong and ubiquitous expression of GFP marker protein (data not shown).   
 
4. Frühstart genetically interacts with CycA, CycB, CycB3 and CycE 
4.1 Frühstart genetically interacts with CycB3 in the Drosophila eyes 
A genetic interaction test was performed in order to further analyse the biological function of 
Frühstart in the fly. Drosophila cyclinA, cyclinB, cyclinB3 and cyclinE genes were over-
expressed in the Drosophila eyes with and without ectopically expressed frs. In this experiment 
GMR-Gal4 flies were crossed with UAS-frs[I], UAS-cycA, UAS-cycB, UAS-cycB3 and UAS-
cycE transgenes (Materials and Methods). Surprisingly, only mitotic cycB3 showed genetic 
interaction with Frs (Appendix 4., Bartoszewski S.). Over-expression of cyclins A, B, B3, E and 
frühstart in the eyes separately caused a rough eyes phenotype (e.g. appendix 4a. for frühstart, 
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4b. for cycB3. Bartoszewski S.). When cyclins A, B, or E were over-expressed together with frs 
no rescue phenotype was observed (data not shown), whereas cyclinB3 over-expressed together 
with frs restored the rough eye phenotype to wild-type. This demonstrates that frs genetically 
interacts with cycB3 in the Drosophila eye. To confirm eyes genetic interaction data, cycA, 
cycB, cycB3, cycE and frs were also over-expressed in the epithelial cells of Drosophila wings 
(Figure 56). 
 
4.2 Frühstart genetically interacts with cycA, cycB and cycE in the Drosophila wing 
imaginal discs 
To reconfirm genetic interaction data achieved in the Drosophila eyes the genetic interaction 
of frs, stg, cycA, cycB, cycB3, and cycE genes were tested in the wings (Figure 56). 
 
 
 
Figure 56. The pictures present Drosophila wings with ectopically expressed frühstart alone (a) or in the presence 
of stg (b), cycA (c), cycB (d), cycB3 (e) or cycE (f) co-expressed genes. It was found that in the Drosophila wings 
frs genetically interacts with cycA, cycB and cycE. Genotypes: a) w,MS1096-Gal4/+;UAS-frsC/+. b) w,MS1096-
Gal4/+;UAS-frsC/+;UAS-stg/+. c) w,MS1096-Gal4/+;UAS-frsC/UAS-cycA. d) w,MS1096-Gal4;UAS-frsC/UAS-
cycB. e) w,MS1096-Gal4;UAS-frsC/UAS-cycB3. f). w,MS1096-Gal4/+;UAS-frsC/+;UAS-cycE/+. 
 
When frs is ectopically expressed in the wings by MS1096-Gal4 driver, it gives a slightly 
hypomorphic, contracted wing phenotype (Figure 56a). When it is ectopically expressed in 
parallel with string, the frs phenotype is not affected (Figure 56b). frs ectopically expressed 
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together with cycB3 seems to only very slightly enhance the frs phenotype (Figure 56e), the 
wings become more hypomorphic compared to the wings where frs is expressed alone. Two 
mitotic cyclins, cycA and cycB, when over-expressed with frs strongly enhanced the frs 
phenotype, the size of the wings is severely reduced (Figure 56c and 56d). The G1/S cycE gene 
when over-expressed with frs restored frs wing phenotype to the wild-type (Figure 56f). It 
showed that in the assay frs genetically interacts with cycA (enhanced frs phenotype), cycB 
(enhanced frs phenotype) and cycE (suppressed frs phenotype). All analyzed wings were 
dissected from adult flies, mounted in Hoyers/lactic acid (Materials and Methods; Roberts, D.B. 
1998) and observed under bright-field illumination microscope. 
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Discussion 
The aim of this study was biochemical, molecular and genetic characterization of the 
Drosophila CG17962 zygotic gene called z600 (Schulz and Miksch 1989; Schulz et al., 1989; 
Galewsky et al., 1990) or frühstart (Großhans and Wieschaus, 2000). Originally, frühstart (frs) 
was identified in screens for mutations that disrupt mesoderm invagination during gastrulation 
process (Müller et al., 1999; Seher and Leptin 2000). Further analysis revealed that frs is a 
mitotic inhibitor that specifically counteracts protein phosphatase string and in this way delays 
mitosis in the ventral furrow cells. This inhibition prevents the interference of mitotic events 
and morphogenetic movements during ventral furrow formation (Großhans and Wieshaus 
2000). Subsequent studies demonstrated that frs is also sufficient and partially required for 
pausing the rapid nuclear cycles after the last (13th) cleavage division during celularisation 
(Großhans et al., 2003). The premature entry into mitosis 14 of the ventral cells that affects 
proper ventral furrow formation in the homozygote mutant of frs indicated the physiological 
function of this gene in G2/M transition in the embryo. Moreover, ectopically expressed frs in 
the epidermal cells of the embryo caused inhibition of the 16th (and last) zygotic mitosis 
whereas the 16th S-phase occurred normally (Appendix 3, Großhans J.), what once again 
confirmed the mitotic specificity of frs. 
This study revealed, at least partially, the molecular mechanism of frs anti-mitotic activity and 
demonstrated how Frs might inhibit Cyclins-Cdk1 activity and mitosis in vivo. 
 In Drosophila, full activation of Cdk1 kinase requires its association with a mitotic cyclin (A, 
B or B3), phosphorylation of Thr 161 in the T-loop domain and dephosphorylation by protein 
phosphatase String/Twine (Cdc25 homologues) of Thr14 and Tyr15 phosphorylation sites 
phosphorylated before by Wee1/Myt1 kinases. The molecular features of Frs, like its primary 
amino acid structure (Frs is not a kinase or phosphatase) and its association with nucleoporins 
and cyclins suggest that Frs affects Cdk1 kinase activity via protein inhibitory mechanism 
rather than by Cdk1 phosphorylation. This study showed that Frs negatively regulates entry into 
mitosis by high affinity binding to the hydrophobic patch of mitotic CyclinA in vitro and in 
vivo. The remaining question then is how Frs-CyclinA interaction affects the mitotic function of 
Cdk1. The first possible explanation could be that Frs acts as a nucleocytoplasmic transport 
factor that modulates nucleocytoplasmic localisation of mitotic proteins like e.g. Cyclins, Cdk1 
or String. 
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Is Frs a new nucleocytoplasmic transport factor? 
Drosophila Cdk1 kinase complex with the only essential mitotic cyclinA (Jacobs et al., 1998) 
is cytoplasmic during interphase and accumulates in the nucleus during prophase (Lehner et al., 
1989; Dienemann and Sprenger 2004). It is then possible that Frs might act as a molecular 
"anchor" where its C-terminus directly binds to the hydrophobic patch of CycA via the KxL 
motif and its N-terminus indirectly interacts with nucleoporins and by this interferes with the 
entry and accumulation of Cdk1 into the nucleus before mitosis 14. Frs might also have an 
opposite activity and promote the export of Cdk1-cyclin complexes, which can be another way 
of preventing the nuclear accumulation of Cdk1 that is required for entry into mitosis (Figure 
57).  
 
 
 
Figure 57. Frs might inhibit nuclear accumulation (import) or promote nuclear exclusion (export) of Cdk1-cyclins 
complexes before entry into mitosis 14. In the nuclear pore basket model, the nucleocytoplasmic localization of 
nucleoporins found in frs Y2H screen is indicated. *) Nup54 is localized to the cytoplasmic and nuclear parts of the 
nuclear pore. 
 
This theory is indirectly supported by the fact that Frs interacts with a set of nucleoporins and 
with the main export factor Crm1 in vitro and in vivo. The clear association of GFP-Frs with the 
nuclear envelope in the nuclear export assay performed in permeabilized HeLa cells could also 
be an argument in favor of the proposed mechanism. Nevertheless, no localization of wild-type 
Frs to the nuclear envelope in stage 5 embryos where Frs anti-mitotic activity takes place was 
previously observed (Großhans et al. 2003). There are also several arguments that seem to 
contradict this hypothetic model.  
It is rather unlikely that Frs is a new transport receptor, as it is not a hydrophobic protein like 
almost all nuclear transport receptors (Görlich and Kutay 1999). Frs is a basic polypeptide that 
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contains 19 basic residues (Schulz and Miksch 1989; Großhans et al., 2003). In addition, Frs is 
a cytoplasmic protein, despite its positive charge and its size that is below the 40kDa exclusion 
limit of the nuclear pores (Großhans et al., 2003; Görlich and Kutay 1999), contains two 
predicted NLS and NES motifs and is actively exported from the nucleus on the Crm1 
dependent way. Moreover, it was published before that almost all nucleoporins (Nup50, 
Nup214, Nup358, Nup153) that were identified as Frs interactors in the Y2H screen, are 
involved in the Crm1 nuclear export pathway (Askjaer et al., 1999; Smitherman et al., 2000; 
Guan et al., 2000; Bernad et al., 2004). The fact that Frs interacts with so many nucleoporins 
that do not associate with one particular fragment of the nucleopore complex but are spread all 
over the pore (Fan et al., 1997; Allen et al., 2000; Guan et al., 2000; Cronshaw et al. 2002; 
Figure 57) might also argue against this theory. Another argument that the interaction of Frs 
with nucleoporins has no connection to its anti-mitotic activity might be frs ventral furrow 
phenotype rescue experiment data with non-Nup50 interacting frs11AxxA allele that showed 
complete rescue of the Frs ventral furrow phenotype (Results, table 5). Nevertheless, the 
frs11AxxA allele still showed cytoplasmic localization (Results, figure 53c and d) what 
suggests that mutation of two leucines among the predicted nuclear export signal is not 
sufficient to disrupt frs nuclear export activity and by this makes difficult to reach a final 
conclusion. Remarkable might also be an observation made by Smitherman, et al., 2000. They 
found that another cell cycle inhibitor p27CIP interacts with Nup50 protein in the Y2H screen 
(similarly to Frs) and that in the Nup50-null mouse embryo fibroblasts p27CIP cell cycle activity 
is not affected. 
Taken together, the above data suggest that Frs is not a new nucleocytoplasmic transport factor 
and that the observed Frs-nucleoporins interactions are due to its nucleocytoplasmic shuttling.  
 
Does Frs belong to the INK4 cyclin dependent kinase inhibitors family? 
Currently, there are two known cyclin dependent kinase inhibitors families, INK4 and 
KIP/CIP. The INK4 family includes p15, p16, p18 and p19 proteins that specifically bind to 
Cdk4 and Cdk6 and act as inhibitors of CycD. Crystal structure analysis of p19 - Cdk6 complex 
(Russo et al., 1998; Brotherton et al., 1998) revealed that mammalian p19 inhibitor binds 
exclusively to Cdk6 and does not interact with the cyclin subunit. Frs in vitro binding assays 
together with surface plasmon resonance data clearly show that Frs binds with high affinity to 
the Cyclins and does not stably interact with the kinase subunit, suggesting that Frs does not 
share a common molecular mechanism with p19 and does not belong to the INK4 inhibitor 
family. 
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Is Frs a member of the KIP/CIP cyclin dependent kinase inhibitors family? 
Among the members of the KIP/CIP family are the p27, p57 and p21 inhibitors. The best 
characterized member of this family is the G1/S inhibitor p27 and its Drosophila homolog 
dacapo. The 3D structure of p27 revealed that its N-terminus is extended along the surface of 
huCdk2-CyclinA complex, forming hydrophobic contacts with regions on both cyclin and 
kinase (Russo et al., 1996; Barberis et al., 2005). p27, similarly to Frs, binds to the Cyclin 
hydrophobic patch via its KxL motif. This binding blocks the hydrophobic patch that is required 
for proper phosphorylation of some Cdk protein substrates and Cdk protein inhibitors like Rb 
(Adams et al., 1999) E2F1 (Adams et al., 1996), p53 (Lowe et al., 2002), p21 (Adams et al., 
1996; Chen et al., 1996), p27 (Lowe et al., 2002; Brown et al., 1999), p107 (Zhu et al., 1995; 
Schulman et al., 1998; Brown et al., 1999) and many more (Loog and Morgan, 2005). In 
parallel p27 binds to the catalytic center of Cdk2, disrupts its active site and blocks ATP 
binding to Cdk2 (Russo et al., 1996). Even if both p27 and Frs stably bind with high affinity to 
the hydrophobic patch of the cyclin subunit (p27-huCycA KD=25nM, Lacy et al. in 2004; Frs-
CycA=38nM, this work) it seems that they do not share a common molecular mechanism, 
because Frs does not bind stably to the Cdk subunit. Moreover, it was found that in the in vitro 
kinase assay Frs inhibits Cdk1 and Cdk2 kinase activity in the micromolar range that is about 
ten times higher than the binding constants of Frs-CycA, Frs-CycE and Frs-CycA-huCdk2 
complex (Results, figure 35). A different activity was exhibited by the p27 inhibitor, which 
inhibits Cdk2 activity in vitro at the nanomolar range that is around its nanomolar binding 
constant values (Toyoshima and Hunter 1994, Lacy et al. 2004). 
 
Does Frs belong to a new family of inhibitors? 
There is also a third, informal and poorly characterized group of cell cycle inhibitors that do 
not belong to any of the previously described families. This group includes M/G1-S Sic1 
(Saccharomyces cerevisiae), M/G1 Rum1 (Shizosaccharomyces pombe), mitotic Rux 
(Drosophila melanogaster) and G2/M Frs (Drosophila melanogaster). It was published before 
that Sic1, Rum1 and Rux are able to functionally replace each other in vivo (Sanchez-Diaz et 
al., 1998; Foley and Sprenger, 2001) even if there is no obvious sequence homology between 
these proteins and their sequence similarity is negligible. Nevertheless, all members of the third 
class of cell cycle inhibitors contain the KxL motif among their primary amino acid sequence 
(Rux contains even three KxL motifs). Moreover, it was found that Sic1 and Rux, similarly to 
Frs, directly interact with mitotic cyclins via their RxL motif and specifically inhibit mitotic 
cyclin-Cdk1 complexes in vitro (Hodge and Mendenhall, 1999; Avedisov et al., 2000; Foley 
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and Sprenger 2000; this work). Additionally, Frs, Sic1 and Rux, when over-expressed, they 
induce cycles of endoreplication in proliferating epithelial cells of Drosophila wing imaginal 
discs (Foley at al., 1999; Thomas et al., 1997; this work) what shows their common mitotic 
specificity also in vivo. We can also include among their similarities the fact that all of these 
proteins are non-essential, as they cooperate with other mechanisms such as cyclin proteolysis 
(for Frs not yet investigated) and that all of them are phosphorylated and subsequently degraded 
through the ubiquitin-dependent proteolytic pathway (Benito et al., 1997; Verma et al., 1997; 
Foley et al., 1999; in the case of Frs the significance of its phosphorylation still remains not 
completely understood). All the similarities described above, might indicate that all these 
proteins share a common molecular mechanism to inhibit the cell cycle. Nevertheless, there are 
also some important differences that might suggest that Frs has its own, individual way of 
regulation the cell cycle. 
The zygotic gene rux is expressed throughout most of Drosophila development at low levels, 
that cannot be detected by in situ hybridization (Foley and Sprenger, 2001), whereas the zygotic 
gene frs is expressed only at the beginning of cell cycle 14, reaches at narrow peak during 
cellularisation and persists until the end of gastrulation (Großhans et al., 2003). In contrast to 
rux, the level of frs mRNA expression is high enough to be easily detect by in situ 
hybridization. Furthermore, Frs is a site-specific inhibitor of mitosis and even if it is 
ubiquitously expressed all over the embryo, it affects only a narrow stripe of the ventral cells 
that invaginate to form a mesoderm anlage (Großhans et al., 2003), whereas expression and 
activity patterns of rux tightly match each other (Foley and Sprenger, 2001). Another important 
difference is the fact that Frs and Rux block two different aspects of mitosis. Frs blocks the 
entry into mitosis (G2/M transition, Großhans and Wieschaus, 2000) whereas Rux regulates the 
exit from mitosis (metaphase/anaphase transition, Foley and Sprenger, 2001).  
Another important difference between Frs and Rux was revealed by functional assays. In vitro 
kinase assays demonstrated that Frs inhibits mitotic Cdk1 and S phase Cdk2 kinase activity to a 
comparable degree, whereas when ectopically expressed in the later stages of embryonic 
development, Frs does not inhibit Cdk2-dependent progression through S phase. In contrast to 
Frs, Rux does not inhibit Cdk2 kinase activity in vitro and when over-expressed in the embryo, 
it does not inhibit Cdk2-dependent S phase progression (Foley et al., 1999; Thomas et al., 
1997). Unfortunately, we still do not have enough molecular data to make clear statements 
about the inhibitory mechanisms of Sic1, Rum1, Rux and Frs. 
This study showed that the anti-mitotic activity of Frs is directly correlated with the function 
of the hydrophobic patch of mitotic CyclinA. The cyclin non-binding frs86ASA allele did not 
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rescue the frs ventral furrow phenotype, what was direct evidence supporting this statement. 
Further kinase assay analysis with Cdk1 and Cdk2 immunocomplexes revealed that increasing 
amounts of Frs inhibit the phosphorylation of LaminDmO, Histone H1 and Rb substrates. 
Phosphorylation of the substrates by Cdk1 and Cdk2 was inhibited to comparable degree, even 
if the SPR data revealed that Frs preferentially binds to CycA compared to CycE. Another 
striking observation was that complete inhibition of Cdk1 and Cdk2 kinase activity was 
achieved only with ten times higher Frs concentration compared to its nanomolar binding 
constants. This phenomenon suggests that Frs-hydrophobic pocket interaction by itself cannot 
be the reason of the decrease in Cdk kinase activity. This hypothesis was confirmed by the 
kinase assay performed with the C16 peptide that contained the last 16 residues of Frs and the 
KxL motif that compromised Frs-CycA complex formation in the in vitro binding assay. In this 
assay it was shown that even high concentration of C16 peptide (10µM) was not able to affect 
Cdk kinase activity. This evidence clearly demonstrates that the hydrophobic pocket is not 
essential for phosphorylation of the substrates used in the in vitro kinase assays. The fact that 
Frs is also a Cdk substrate, might suggest that the observed decrease of the kinase activity at so 
high Frs concentration is not due to binding to the hydrophobic patch but due to Frs competition 
on the Cdk catalytic cleft with the phosphorylation model substrates used in the assay. The 
kinase assay with non-phosphorylating frs22A48A allele revealed that this allele is about ten 
times less active compared to the wild-type in vitro what supports this assumption. In 
comparison, cyclin non-binding Frs86ASA allele was even less active than Frs22A48A.  
These results show that at non physiologically high concentration Frs may inhibit Cdk kinase 
activity by competing on the catalytic cleft of Cdk with other substrates in vitro. It also 
suggests, that in order to achieve efficient inhibition of Cdk1 kinase activity by Frs, binding of 
Frs to the hydrophobic pocket of the cyclins is at least partially required in vitro. The question 
that naturally followed was then whether so high phosphorylation of Frs has any functional 
significance. It was found in the in vitro binding assay, that the prephosphorylated form of Frs 
interacts with CyclinA as strongly as the unphosphorylated form, what shows that Frs 
phosphorylation does not affect Frs-CycA complex formation. Moreover, the rescue construct 
carrying the Frs22A48A allele rescued up to 62% mitotic ventral furrow phenotype of Frs, what 
implies that phosphorylation of Frs has a functional meaning, even if it is not a major aspect of 
the anti-mitotic activity of Frs in the mid-blastula embryo. 
 Taking all together, a possible role of Frs in the inhibition of mitotic Cyclin-Cdk1 complexes 
might rely on occupying the hydrophobic pocket on the Cyclin subunit what would block the 
cyclin binding site for an undefined yet group of Drosophila Cdk1 mitotic substrates that in 
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order to be efficiently phosphorylated by Cdk1 require to bind to CycA subunit as well. This 
hypothesis is supported by the fact that there are already identified such Cdk substrates (e.g. Rb, 
p107 or p27) that to be efficiently phosphorylated by Cdk have to first bind to the hydrophobic 
pocket on the cyclin subunit (Brown et al., 1999; Lowe et al., 2002; Lacy et al., 2004; Loog et 
al., 2005). 
The reason why in this study we were not able to show Frs substrate specificity is the fact that 
in general not many Cdk substrates have been identified and characterized so far. I could test 
only one Drosophila specific substrate, LaminDmO, which was far not enough. In parallel, the 
tested calf HistoneH1 and human Rb substrates did not solve this problem either. 
The substrate specificity correlated with hydrophobic pocket function was recently described 
in detail in the yeast. Loog and Morgan, 2005 demonstrated that mitotic Cdk1-Clb2 complex 
equally phosphorylates all 150 substrates tested in the kinase assay, whereas in the case of G1/S 
Cdk1-Clb5 there was a group of about 24% of the substrates containing the KxL motif that 
were more strongly phosphorylated in comparison to the rest of the substrates. We then 
wondered, whether similar situation exists in Drosophila. It is possible that most of the mitotic 
Cdk1 kinase substrates are phosphorylated by direct interaction with the kinase (Figure 58a) 
and blocking the hydrophobic pocket by Frs does not affect their phosphorylation level (Figure 
58b). Nevertheless, the phosphorylation of a small group of yet undefined Drosophila Cdk1 
substrates that in order to be efficiently phosphorylated (activated) first have to bind to the 
cyclin hydrophobic pocket (Figure 58c), might be inhibited by Frs (Figure 58d).  
 
 
 
Figure 58. Molecular model of the inhibitory mechanism of Frs. Substrates without KxL motif like HistoneH1 are 
phosphorylated normally without (a) and with Frs (b). The mitotically specific substrates with KxL motif are 
properly phosphorylated without Frs (c) and are not properly phosphorylated in the presence of Frs. Substrate A is 
equally phosphorylated with or without Frs (a and b) whereas Substrate B phosphorylation is inhibited (weakened) 
by blocking of the hydrophobic patch by Frs (c and d). 
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The substrate specificity that is observed in yeast may contribute a potential explanation for 
the Frs-Cyclin hydrophobic patch interaction requirement in the embryo, with the difference 
that in the yeast it plays a role in the G1/S transition whereas in Drosophila it is important for 
the entry into mitosis. Further proteomic studies can reveal more Drosophila Cdk1 and Cdk2 
specific substrates, thus leading in the elucidation of not only anti-mitotic function of Frs but 
also another Drosophila mitotic inhibitor, Rux. 
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Appendix 
 
Appendix 1 
 
 
Appendix 1. Interaction test of Lex-Frs, Lex-Frs11AxxA and Lex-Frs86ASA alleles with JG-Nup50 and JG-CycE 
proteins in Yeast-Two-Hybrid assay. Alanine substitutions in the KxL motif (Frs86ASA) and in the putative NES 
motif (Frs11AxxA) strongly compromise the interaction of Frs with CycE (CycE∆N319) and Nup50 (full-length) 
respectively. Blue staining of the lacZ reporter gene indicates interaction (Großhans J.). 
 
 
 
Appendix 2 
 
 
Appendix 2. Drosophila paired-Gal4/UAS-frs[H] embryos. frs inhibits M but not S phase. a) Cell number in the 
epidermis in segments with frs expression was half the number compared to neighboring segments (38±3 versus 
20±3 cells per 34 µm2, n=10). Cell borders were labelled by staining with Dlg antibody. b, c) Progression through 
S phase was marked by BrdU incorporation (25 min pulse), BrdU - white/green; Frs - red; DNA - blue. Scale bar 
20 µm (Großhans J.). 
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Appendix 3 
 
 
Appendix 3. frs expressed in a stripe (indicated by the black bar) in pupal wing imaginal discs of w;patched-Gal4, 
UAS-frs[J] flies. a, b) Pupal discs fixed and stained with Phalloidin (green - cell borders, red - higher optical 
section showing the trichomes) and DAPI (white). c) Section of a differentiated wing. Scale bar 20 µm (Großhans 
J.). 
 
 
 
 
Appendix 4 
 
 
Appendix 4. The pictures present ectopically expressed frühstart in the Drosophila eyes without and with co-
expressed cyclinB3. Over-expression of CycB3 together with frühstart in the Drosophila eyes rescued the rough 
eye phenotype, what means that frühstart genetically interacts with CycB3 in the Drosophila eyes. Genotypes: a) 
w;Sp/CyO;GMR-Gal4, UAS-frs[I]/TM3,hb-lacZ. b) yw;+/CyO;GMR-Gal4;+/+. c) w;UAS-cycB3/CyO;GMR-
Gal4, UAS-frs[I]/TM3,hb-lacZ (Bartoszewski S.). 
 
 
